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Pluripotency, the ability of a cell to differentiate towards any type of somatic cell is a 
transient feature of the developing embryo. In vitro, pluripotency can be captured in the form of 
embryonic stem cells (ESCs). In this study, I developed a microfluidic-based system to 
encapsulate ESCs into agarose microgels, three-dimensional scaffolds that are in terms of their 
mechanical and biochemical properties fundamentally different from conventional tissue culture 
in plastic dishes. Subsequently, I investigated how these microenvironmental changes influence 
pluripotency. Interestingly, microgel culture of ESCs was not just accompanied by drastic 
changes in morphology, but also a promotion in naïve pluripotency. RNA-sequencing of microgel 
cultured ESCs elucidated global transcriptional changes of which many affected members of the 
pluripotency network. I then identified plakoglobin, a homologue of b-catenin, as one of the 
strongest upregulated proteins upon microgel encapsulation. However, molecular functions of 
plakoglobin in embryonic stem cells remain largely elusive. To investigate plakoglobin’s 
potential role during naïve pluripotency, I created several ESC lines that constitutively expressed 
plakoglobin at varying levels. Cells expressing high amounts of plakoglobin, portrayed a distinct 
naïve phenotype with homogeneous transcription factor expression even under serum-based 
conditions. Single cell RNA-seq and the formation of blastocyst chimaeras were then used to 
confirm the re-establishment of the complete naïve network. In contrast, plakoglobin is absent or 
greatly reduced during primed pluripotency in epiblast-derived stem cells and conventional 
primate pluripotent stem cells. A finding that was further confirmed in the corresponding pre- and 
post-implantation embryo and naïve and primed marmoset and human pluripotent stem cells. 
Remarkably, forced expression of plakoglobin during primed pluripotency, unlike b-catenin, 
leads to stabilisation of the pluripotency network rather than differentiation. Finally, after having 
extensively elucidated plakoglobin’s role within the continuum of pluripotency I used the 
microgel system to co-encapsulate ESCs with extraembryonic endoderm (XEN) cells. 
Co-encapsulation of these cell types led to the formation of self-organising aggregates in which 
the XEN cells surrounded an inner core of ES cells. These aggregates, termed EX-structures, 
exhibited deposition of a basal lamina, acquired apical-basal polarity, and initiated lumen 
formation with subsequent lineage-specific differentiation. Taken together, I have developed a 
cross-species compatible, compartmentalised system, for the suspension-culture of 
microgel-encapsulated embryonic stem cells that is generated in microfluidic devices. This 
interdisciplinary approach led to the identification of plakoglobin as a hitherto unknown, 
evolutionary conserved, regulator of naïve pluripotency. Furthermore, I have shown that 
co-culture of ES and XEN in microgels can mimic spatiotemporal events reminiscent to the 
peri-implantation embryo. 
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1.1 Early embryonic development 
The eukaryotic zygote, formed after a sperm entered the oocyte, is the one truly totipotent 
cell. It contains the complete blue print to form a new organism and is able to develop into all 
embryonic and extra-embryonic lineages. Embryogenesis is a tremendously complex interplay 
between internal and external signals controlling spatiotemporal localization as well as gene 
expression of all embryonic and extraembryonic cells. Generally speaking, embryogenesis can 
be separated into pre- and post-implantation development. Over the course of development, the 
single cell embryo develops into a complex structure with distinct morphological features and a 
multiplicity of cell types. When focusing on mammalian development, the developing 
pre-implantation embryo shows a surprisingly high degree of conservation across different 
species. The pre-implantation mouse embryo, looks in design and shape very similar to the human 
or any other mammal. A trait which is abruptly lost upon implantation of the embryo into the 
maternal uterus (or at time of gastrulation, which in some species happens before implantation). 
At this point, one must mention, that even though the embryos look similar, the underlying 
biological pathways are not always the same. For the purpose of clarity, in the following 
paragraphs, I shall only be describing the development of the early mouse embryo and merely 
mention other species when needed. 
 
1.1.1 Pre-implantation embryo 
After fertilization, the zygote immediately starts with the degradation of maternally 
stored RNA and initiates transcription of the zygotic genome, a process known as zygotic genome 
activation (ZGA). In the mouse, ZGA is initiated at the 2-cell stage, but protracted in primates, 
including the human (Boroviak et al., 2018). Initially, the zygote undergoes several cleavage 
divisions, in which the total cytoplasmic volume of the embryo remains the same (Aiken et al., 
2004), to generate blastomeres. At this stage the embryo is still surrounded by the zona pellucida 
(ZP) (Dumont and Brummett, 1985), a glycoprotein layer surrounding the mammalian oocyte. 
Hence, the embryo can be seen as a self-contained system that is able to develop in the absence 
of maternal tissue, extracellular matrix or even be cultured in vitro without any developmental 
consequences (Whitten and Biggers, 1968). After three divisions the eight blastomeres are 
morphologically indistinguishable, almost spherical non-adherent cells. However, over the last 
several years a variety of studies have shown that, even though morphologically 
indistinguishable, heterogeneity can be detected as early as the 2-cell stage. Indeed, when 
separated, often only one of the blastomeres maintains the ability to form an embryo, suggesting 
unequal distribution of developmental potential (Casser et al., 2017; Katayama et al., 2010). This 
finding has been further supported by single-cell RNA sequencing of individual blastomeres, 




firstly appear too small to affect cell behaviour, but when amplified could steer cells towards a 
specific fate. Timing and origin of heterogeneity still remain heavily debated questions. The latest 
perspectives and hypotheses have been thoroughly reviewed by Chen and colleagues (Chen et 
al., 2018). At the 8-cell stage, the embryo undergoes its first fundamental change in morphology 
(Figure 1.1). The so far loosely attached blastomeres compact to a point where they become 
visually indistinguishable, a state referred to as the compacted morula (Johnson et al., 1986; 
Johnson and Ziomek, 1981). The process of compaction is heavily based on the increase of 
cell-cell adhesion, a phenomenon that can be observed across different mammalian species during 
pre-implantation development and seems to be of utmost importance for healthy embryonic 
development (White and Plachta, 2015). Already in the 1970’s, it was shown that compaction 
can be impaired when chelating metal ions during embryogenesis (Wales, 1970). Yet, it took 
another decade before this observation could be linked to a specific protein: Uvomorulin (Hyafil 
et al., 1981; Hyafil et al., 1980). The group of François Jacob managed to raise a monoclonal 
antibody against this protein, which when applied before blastomere compaction, would hinder 
the former. Nowadays, Uvomorulin is commonly known under the name epithelial cadherin 
(E-cadherin), encoded by the Cdh1 gene, and has been studied extensively and described in a 
variety of functions. E-cadherin, amongst other cadherins, is a major component of cell-cell 
adherens junctions (Takeichi, 1991), which I will designate the following paragraph as they (and 
their individual components) played such crucial role throughout this work. Recently 
live-imaging of 8-cell stage embryos has shown, that besides being the major constituent of 
adherens junctions, which hold cells together, E-cadherin is also found to great extend in 
blastomere membrane protrusions (Fierro-Gonzalez et al., 2013). These protrusions, recognized 
as filopodia, extend and retract several times during the course of compaction and are thought to 
help enabling initial membrane contact between the blastomeres (Figure 1.2). However, Maître 
and colleagues argue that E-cadherin alone is unable to generate the forces needed to initiate 
compaction (Maitre et al., 2012), an argument which has been further supported by the absence 
of changes in E-cadherin expression and motility during compaction (Samarage et al., 2015). 
Micropipette aspiration, to investigate tension amongst the blastomeres of the 8-cell stage 
Figure 1.1 | Development from zygote to the compacted morula. Initially, the zygote undergoes several cleavage 
divisions until the 8-cell stage. At this point, the 8 blastomeres compact, a process in which individual cells become a 




embryo, has shown an increase of cortical tension over the course of compaction. A phenomenon 
believed to be driven via pulsed contractions of the actomyosin cortex (Maitre et al., 2015). 
Concomitant with the compaction event is the appearance of distinct apical-basal polarity (White 
et al., 2018; Zhu et al., 2017; Ziomek and Johnson, 1980) (Figure 1.3). The outwards facing side 
of the blastomeres become enriched with ezrin and the PAR-aPKC complex (Louvet et al., 1996; 
Vinot et al., 2005) whilst the inner and contacting areas of the blastomeres display expression of 
E-cadherin, Jam-1 and Par-1 (Thomas et al., 2004; Vestweber et al., 1987; Vinot et al., 2005), 
thereby defining the emerge of basolateral cell-cell contacts. Interestingly, apical-basal polarity 
can be established in the absence of E-cadherin (Ziomek and Johnson, 1980). However, laser 
ablation of cadherin-depended filopodia (Fierro-Gonzalez et al., 2013) or knocking out 
E-cadherin all together cause embryos to fail compaction and are therefore unable to establish an 
epithelial structure (Larue et al., 1994; Ohsugi et al., 1997; Riethmacher et al., 1995; Stephenson 
et al., 2010). Taken together, compaction of the 8-cell embryo appears to be orchestrated by a 
combination of cadherin-mediated adhesion and pulsatile actomyosin contractility  
 
1.1.1.1.1 Adherens junctions  
Due to their importance in following chapters, I’ll insert an interlude regarding 
adherens junctions at this point, before continuing with early embryonic development and the 
first cell fate decision of the now compacted morula. Adhesion, whether it is cell-cell or 
Figure 1.2 | E-cadherin dependent filopodia formation during blastomere compaction. a, 8-cell stage chimeric 
embryo of wild type and E-cadherin-GFP expressing blastomeres. b, Extension and retraction of the E-cadherin rich 
filopodia in the blastomeres before compaction. Scale bar: 5 µm. Modified from Fierro-Gonzalez et al., 2013 
Figure 1.3 | Compaction via cadherin-mediated adhesion and pulsatile actomyosin contractility. At the 8-cell 
stage, blastomeres acquire apical-basal polarity. Apical domain markers such as ezrin, PAR3, PAR6 and aPKC are 
localized at the contact-free surface whereas the inner sides are enriched in E-cadherin, PAR1, JAM1 and 
Na+/K+ ATPase. Upon establishment of polarity, blastomeres compact via a combination of cadherin-mediated 




cell-matrix interactions, is one of the key components for morphogenesis, the association of 
individual cells into complex and highly ordered tissues in any multicellular life. Even though it 
is easy to imagine adhesion as a static property, it actually needs to be a dynamic process. One 
the one hand, cells must adhere to one another, whilst on the other hand, need to maintain the 
ability to constantly adjust their morphology. These properties can be achieved by the continuous 
formation, degradation and rearrangement of adherens junctions (AJ). AJs are multi-protein 
complexes in which cadherins and catenins play the central role (Figure 1.4). During early 
embryonic development, E-cadherin is the most prominent cadherin (Kemler, 1993). E-cadherin 
is a transmembrane protein with five (EC1-5), repeating, calcium dependent extracellular and 
several cytoplasmic domains (Hyafil et al., 1981). The extracellular domains interact solely with 
E-cadherin molecules from juxta-positioned cells (Gumbiner et al., 1988) through a 
trans-interaction of the EC1 domains and with E-cadherin molecules on the same cell through 
cis-interactions of the EC2 domains (Harrison et al., 2011). The cytoplasmic fraction of 
E-cadherin contains two catenin binding domains (CBD) including the juxta-membrane domain 
(JMD), which bind a whole array of proteins, collectively also known as the ‘cadhesome’(Zaidel-
Bar, 2013). The main group of binding proteins are called catenins (a-, b-, g- and d-catenin). 
p120-catenin (also known as d-catenin) binds to E-cadherin’s JMD (Jou et al., 1995; Ohkubo and 
Ozawa, 1999) and is crucial in the remodelling of AJs. When bound, p120 inhibits endocytosis 
and degradation of E-cadherin (Davis et al., 2003; Fujita et al., 2002; Ishiyama et al., 2010; Xiao 
et al., 2003) by blocking an, in cadherins conserved, peptide sequence (DEEGGGE) (Nanes et 
al., 2012). Over the last several years, additional functions regarding p120 were identified that 
differ from its classical role in cadherin trafficking and elucidate its role in stem cell 
differentiation (Lee et al., 2014a) and proper lineage specification of the primitive endoderm 
(Pieters et al., 2016). Unlike p120, b-catenin and plakoglobin (also known as g-catenin) bind to 
the C-terminal CBD (instead of the JMD) of E-cadherin, connecting it to the actomyosin-
cytoskeleton via a-catenin (Herrenknecht et al., 1991) and vinculin (Bertocchi et al., 2017). 
Binding of b-catenin/plakoglobin is indispensable for functioning adherens junctions mediated 
cell-cell adhesion (Fukunaga et al., 2005; Ozawa, 2002). b-catenin and plakoglobin are 
structurally similar proteins (Butz et al., 1992a; Mccrea et al., 1991a), and represent the vertebrate 
homologues of the Drosophila protein armadillo (Peifer et al., 1992b). Both proteins are involved 
in cell adhesion and several signalling cascades regarding embryonic development, in particular 
canonical WNT signalling (reviewed in (Aktary et al., 2017; MacDonald et al., 2009)). It is this 
similarity between these proteins and their dual functions in cell-cell adhesion and signal 
transduction that I shall devote more detailed description. However, at this point I postpone 
further discussion and will return to it in chapter 4 where I will have a closer look at the 




Whereas b-catenin, plakoglobin and p120 share considerable amount sequence identity, 
a-catenin differs significantly in its structural organization from the aforementioned proteins, but 
is similar to vinculin (Pokutta et al., 2008). a-catenin has generally been described as the link 
between adherens junctions and the cytoskeleton due to its ability to simultaneously bind to 
b-catenin and F-actin (Pokutta et al., 2002; Pokutta and Weis, 2000). Conclusively, cadherins and 
catenins play a vital role in the formation of adherens junctions at the plasma membrane and 
furthermore occupy roles in signal transduction in the nucleus. 
 
1.1.1.2 First cell fate decision 
I have now arrived back at the point where I left at the end of paragraph 1.1.1. After 
compaction, the individual blastomeres have become visually indistinguishable. At this stage, the 
embryo consists out of the newly formed, outer and polar trophectoderm (TE) and the apolar, 
inner cell mass (ICM). Both cell types display distinct expression of transcription factors such as 
OCT4, NANOG and SOX2 (Avilion et al., 2003; Mitsui et al., 2003; Nichols et al., 1998) in the 
ICM and CDX2 and EOMES in the TE (Niwa et al., 2005; Russ et al., 2000; Strumpf et al., 2005). 
The underlaying transcriptional programs of TE and ICM are reciprocally inhibitory and therefore 
mutually exclusive (Niwa et al., 2005). Initially it was unclear if and how the polarity differences 
between the inner and the outer cells were orchestrating differentiation towards trophectoderm. 
Eventually, the Hippo-signalling component angiomotin (AMOT), and its homologue 
angiomotin-like 2 (AMOTL2) had been identified as the missing link (Hirate et al., 2013; Leung 
and Zernicka-Goetz, 2013). Apolar ICM cells show homogeneous distribution of membrane 
associated AMOT which can directly tether the transcription factor YAP or cause its 
phosphorylation by Lats1/2, preventing it in both cases from entering the nucleus (Leung and 
Zernicka-Goetz, 2013; Nishioka et al., 2009; Paramasivam et al., 2011) (Figure 1.5). In contrast, 
Figure 1.4 | Schematic illustration of the composition of adherens junctions. The main component of adherens 
junctions are the cadherins. E-cadherin consists of 5 extracellular domains (EC1-5), a transmembrane domain (TM) 
and the intracellular juxtamembrane (JDM) and the catenin binding domain (CBD). Cadherins interact in a homophilic 
fashion with cadherins of surrounding cells via trans interactions of their EC1 domains. They also bind to cadherins on 
the same cell via trans-interactions of the EC2 domains. p120 (also known as d-catenin) binds to the JMD of E-cadherin 
and is heavily involved in its trafficking and recycling. b-catenin and its structurally similar plakoglobin (also known 




the outer cells (which eventually form the TE) show polarised AMOT localisation to their apical 
domain (Leung and Zernicka-Goetz, 2013). It is believed that components of the apical polarity 
complex, such as PAR6 and aPKC, deactivate AMOT as they are required for its apical 
localisation (Hirate et al., 2013). Due to inactive AMOT in the outer cells, YAP localises to the 
nucleus where it then binds to TEAD4 (Hirate et al., 2012; Nishioka et al., 2009). Subsequently, 
TEAD4 activates expression of CDX2 and EOMES, kickstarting the trophectodermal 
differentiation program through suppression of OCT4 and NANOG (Nishioka et al., 2008; Yagi 
et al., 2007). Consequently, knockout of AMOT or TEAD4 leads to TE gene expression within 
the ICM and failure to initiate the trophectodermal differentiation program in the outer cells 
(Leung and Zernicka-Goetz, 2013; Nishioka et al., 2008; Yagi et al., 2007). At this point, the first 
cell fate decision has been made and the hitherto equal blastomeres have differentiated towards 
TE, which forms the placenta, and ICM, which subsequently separates during the second cell fate 




Figure 1.5 | Polarity-mediated localisation of YAP to the nucleus initiates trophectodermal differentiation. In 
the outer cells of the compacted morula, apical domain proteins such as PAR6 and aPKC inhibit AMOT/AMOTL2. 
Consequently, YAP can translocate to the nucleus where, in combination with TEAD4, it activates CDX2 expression. 
Subsequently, CDX2 kickstarts the trophectodermal differentiation program via downregulation of OCT4. In contrast, 
the inner cells of the compacted morula inhibit nuclear translocation of YAP via sequestration by AMOT/AMOTL2 




1.1.1.3 Second cell fate decision and the establishment of pluripotency 
Simultaneously with the establishment of the trophectodermal epithelium around the 
apolar ICM, the embryo keeps proliferating and transitions from the compacted morula to the 
blastocyst stage (Figure 1.6). The formation of the blastocyst is coined by the expansion of a 
fluid-filled cavity, the blastocoel, and the second cell fate decision: the segregation of the ICM 
into epiblast (EPI) and primitive endoderm (PrE), respectively. Initially, the newly formed and 
polar TE cells ‘seals’ the embryo via extensive formation of desmosomes and ZO-1 enriched tight 
junctions (Fleming et al., 1991; Wang et al., 2008) (Figure 1.6 a). Subsequently, a multiplicity 
of intercellular micro lumens, originating from vesicles that had been secreted by the basal 
membrane of the trophectoderm, merge to form one central cavity: the blastocoel (Aziz and 
Alexandre, 1991). Active pumping of sodium ions into the blastocoel creates an osmotic gradient, 
which is then neutralised by the influx of fluid into the cavity, creating an ‘inside pressure’ within 
the sealed embryo (Barcroft et al., 2003; Benos et al., 1985) (Figure 1.6 b). In a recent set of 
elegant experiments, Chan and colleagues have demonstrated that the formation of the blastocoel 
is a highly dynamic process (Chan et al., 2019). Upon reaching a critical pressure threshold, tight 
junctions rupture and pressure is released. These oscillations are detected by the 
mechanosensitive adherens junction protein vinculin, which in turn activates a positive feedback 
loop strengthening the tight junctions (Chan et al., 2019). Taken together, this study nicely 
elucidated the relationship between embryonic morphology, tissue mechanics and luminal 
pressure. Concomitant with the expansion of the blastocysts, is the development of the PrE and 
EPI with mutually exclusive transcriptional programs (Chazaud et al., 2006) (Figure 1.6 c). 
Initially ICM cells are transcriptionally indistinguishable and co-express genes such as Pou5f1, 
Nanog and Gata6 (Ohnishi et al., 2014). Yet, as development continues NANOG becomes 
restricted to the EPI precursors whereas GATA6 marks the PrE (Chazaud et al., 2006). EPI and 
PrE cells are further defined by the expression of Nanog (Chambers et al., 2003; Mitsui et al., 
2003), Sox2 (Avilion et al., 2003) and Gata4/6 (Koutsourakis et al., 1999), platelet-derived 
growth factor receptor a (PDGFRa) (Plusa et al., 2008), Sox17 (Niakan et al., 2010), 
respectively. This lineage segregation has been shown to be driven by FGF4 signalling, such that 
cells receiving FGF4 signals will become PrE cells, whereas cells secreting FGF4 become the 
EPI (Guo et al., 2010; Krawchuk et al., 2013). How the decision between FGF4 secreting and 
receiving cells is made remains debated. Yet, it appears to be partially due to differential 
expression of FGFR1 and FGFR2 (Kang et al., 2017; Molotkov et al., 2017), a bias of early 
internalised cells to display higher FGF4 expression than cells that are internalised later (Morris 
et al., 2013), and variations in FGF4 expression caused by fluctuations in SOX2 levels (Mistri et 
al., 2018). Upon lineage allocation, EPI and PrE cells are randomly distributed within the ICM, 




having formed an epithelium lining the outside of the epiblast (Meilhac et al., 2009; Plusa et al., 
2008). Simultaneously, EPI cells acquire naïve pluripotency and have the capacity to readily 
differentiate to all germ layers and the germline but have lost the ability to contribute to 
extraembryonic lineages (Boroviak et al., 2014). The transcription factors Pou5f1 (OCT4) and 
Sox2 have been identified as the master regulators of the pluripotency gene regulatory network, 
yet very little is known about how the network is initiated (Avilion et al., 2003; Nichols et al., 
Figure 1.6 | Hallmark events during blastocyst formation. a, Establishment of a permeability barrier that ‘seals’ 
the embryo, a prerequisite for subsequent cavity formation. b, The cavity (blastocoel) is formed by the merging of 
several microlumens originating from the outer trophectodermal cells. Active pumping of sodium ions into the cavity 
results in osmotic pressure that is then equalised via influx of water, causing the cavity to expand. c, Concomitantly to 
blastocyst expansion, the ICM separates via an FGF4 driven process into the pluripotent epiblast and the primitive 
endoderm, expressing NANOG and GATA6, respectively. d, In the final step during pre-implantation development, 
the blastocyst hatches from its surrounding zona pelucida via proteolytic degradation and mechanical pressure. 




1998). The final steps of pre-implantation development is the hatching of the embryo from its 
surrounding zona pelucida, a process driven by proteolytic lysis originating from the mural 
trophectoderm (Perona and Wassarman, 1986) (Figure 1.6 d). With this last step, 
pre-implantation development is complete and the embryo begins its complex interaction with 
the maternal tissue in the form of implanting into the uterus.  
 
1.1.2 The peri- and post-implantation embryo 
At time of implantation, the embryo consists of three cell types: the two extraembryonic 
epithelia, the trophectoderm (TE) and the primitive endoderm (PrE) as well as the apolar 
aggregate of epiblast (EPI) cells, eventually forming the somatic lineages and the germ cells of 
the embryo proper. The TE mediates the initial interaction between embryo and uterus and 
subsequently proliferates and forms the extraembryonic ectoderm (ExE) and the ectoplacental 
cone, both progenitors of the placenta, whilst the PrE segregates into parietal and the visceral 
endoderm (VE). Simultaneously, the EPI cells undergo a radical change in their morphology, 
they become, an along the proximal-distal axis elongated, columnar epithelium which surrounds 
the pro-amniotic cavity. A process initiated by the actomyosin-driven polarisation of the epiblast 
into a rosette-like structure with a central apical domain (Bedzhov and Zernicka-Goetz, 2014) 
(Figure 1.7). As the embryo continues its development, the epiblast opens a lumen in the centre 
of the rosette-like structure, eventually forming the pro-amniotic cavity. Remarkably, the process 
of cavity formation does not depend on apoptosis but appears to be orchestrated by membrane 
separation due to charge repulsion by apical secretion of the sialomucin podocalyxin (PODXL) 
(Bedzhov and Zernicka-Goetz, 2014). However, two question remained: what signals initially 
induce the polarisation of the epiblast and why only at the stage of implantation? It is very likely, 
Figure 1.7 | Polarised rosette formation of the epiblast during implantation. a, Membrane-bound CAG-GFP in 
the epiblast reveals polarisation into a rosette-like structure during implantation. b, Percentage of rosette-like epiblast 





that EPI polarisation is induced by extracellular matrix (ECM) components, in particular laminin, 
and its interactions with b1-integrins. This assumption is based on the observation that Matrigel 
embedded embryonic stem cells (ESCs) undergo polarisation similar to the EPI, whereas ESCs 
in agarose, devoid of ECM components, or ESCs without b1-inegrins fail to polarise (Bedzhov 
and Zernicka-Goetz, 2014). This hypothesis is further supported by the evidence, that 
homozygous knockout of laminin in the embryo leads to peri-implantation lethality (Coucouvanis 
and Martin, 1995; Smyth et al., 1999). To answer the questing concerning the ‘when’, one has to 
look into the deposition of ECM by the different lineages. Albeit, the early ICM does express 
ECM genes such as Fn1, Lama5, Lamb1 and Lamc1, formation of a basal membrane is not 
observed (Boroviak et al., 2014). In contrast, due to their epithelial character, PrE and TE deposit 
high amounts of basal membranes (Li et al., 2004; Murray and Edgar, 2000). Therefore, it is 
possible, that the extraembryonic lineages have to develop and establish a proper basal lamina 
before polarisation of the EPI can be achieved. Taken together, polarisation and lumen formation 
of the peri-implantation EPI are prerequisites for subsequent formation of the egg cylinder and 
symmetry breaking of the embryo. 
 
1.1.2.1 Formation of the body axis 
At around E5.0, as the EPI becomes a polarised epithelium with a central lumen, it starts 
to elongate along the proximal-distal (P-D) axis and forms a structure termed the ‘egg cylinder’ 
(Figure 1.8). On its proximal end, the ExE simultaneously undergoes epithelialisation and rosette 
formation, similar to the epiblast, eventually leading to the formation of a single fused cavity 
between these two compartments (Christodoulou et al., 2018). On top of the ExE forms the 
ectoplacental cone whilst the VE monolayer epithelium envelops the complete EPI. A variety of 
signalling molecules, including the TGFb-family members nodal and bone morphogenetic 
proteins (BMP), as well as WNT and FGF, are involved in establishing distinct gene-expression 
patters along the EPI, finally resulting in is symmetry breaking. Initially, differential gene 
expression becomes apparent along the P-D axis. Reciprocal nodal signalling between EPI and 
ExE cells leads to the activation of BMP4 in the ExE, which in turn activates WNT3 in the EPI 
(Brennan et al., 2001; Guzman-Ayala et al., 2004; Norris and Robertson, 1999). Remarkably, it 
is in the distal part of the embryo, that nodal activates intracellular SMADs in the visceral 
endoderm and thereby creating a new signalling centre: the distal visceral endoderm (DVE) 
(Brennan et al., 2001). The DVE acts as a WNT and nodal signalling antagonist via the secretion 
of DKK1, CER1 and LEFTY1 (Perea-Gomez et al., 1999). Consistent with these findings, loss 
of SMAD2 or constitutive activation of the WNT/b-catenin pathway disrupt DVE formation and 
consequently cause upregulation of proximal-posterior markers such as brachyury and WNT 




physical removal of ExE and ectoplacental cone leads to the acquisition of a DVE-like phenotype 
in the entity of VE cells and the absence of proximal-posterior markers within the EPI (Rodriguez 
et al., 2005). Therefore, the proximal extraembryonic tissue prevents the majority of the VE from 
transitioning into DVE-like state by hitherto unidentified signals. At around E6.0, the newly 
formed DVE migrates ‘up’ along the prospective anterior side of the epiblast, becoming the 
anterior visceral endoderm (AVE) and thereby defining the anterior-posterior (A-P) axis of the 
embryo (Beddington and Robertson, 1999; Lu et al., 2001; Thomas and Beddington, 1996). The 
underlaying mechanisms of AVE formation are still debated (Rodriguez et al., 2005; Srinivas et 
al., 2004; Takaoka et al., 2011; Yamamoto et al., 2004). Once study hypothesised, that enhanced 
cell proliferation at the distal tip of the embryo and subsequent, passive shifting of the DVE 
towards the anterior side is the origin of the AVE (Yamamoto et al., 2004) whereas Takaoka and 
colleagues claim that DVE and AVE are actually two different and non-overlapping cell 
populations (Takaoka et al., 2011). In contrast, lineage-tracing via fluorescent real-time imaging 
has shown that DVE cells actively migrate via filopodia formation towards the anterior side of 
Figure 1.8 | Signalling in the pre-gastrulating embryo. At E5.0 the embryo is in the process of implanting into the 
uterus and has transitions from the blastocyst to the ‘egg cylinder’ stage. The proximal end of the embryo is defined 
by the ectoplacental cone which sits on the epithelial extraembryonic ectoderm (ExE). The epiblast (EPI) has become 
a polarised and columnar epithelium, surrounding the pro-amniotic cavity. The primitive endoderm has developed into 
embryonic and extraembryonic visceral endoderm (VE) as well as parietal endoderm. (a) Reciprocal nodal, BMP and 
WNT signalling between ExE and EPI initiate proximal-distal axis formation and establish a new signalling centre, 
the distal visceral endoderm (DVE) (b). The DVE subsequently secretes WNT and nodal antagonists and thereby 




the embryo (Srinivas et al., 2004), an observation further supported by the evidence that loss of 
NAP1, a protein important for cytoskeletal rearrangement, impairs DVE migration (Rakeman and 
Anderson, 2006). Additionally, expression of nodal and its co-receptor cripto (gene: Tdgf1) have 
been shown to be crucial for DVE migration (Ding et al., 1998; Lowe et al., 2001; Norris and 
Robertson, 1999), however, the exact signals controlling DVE and AVE formation remain to be 
fully understood. Taken together, these studies elucidate how reciprocal signalling between the 
ExE and EPI establish firstly the P-D axis and how subsequently DVE and AVE formation 
prepare the embryo for gastrulation. 
 
1.1.2.2 Gastrulation  
Once the P-D and A-P axis have been defined, the embryo is forming the primitive 
streak and subsequently initiates gastrulation at around E6.5 (Figure 1.9). Gastrulation is the 
process in which the hitherto pluripotent EPI continues its development by establishing the three 
germ layers: ecto-, meso-, and endoderm. At the anterior side, the newly formed AVE shields the 
EPI from WNT and nodal signals via the expression of antagonists (Perea-Gomez et al., 1999). 
In turn, anterior EPI cells give rise to the neuroectodermal lineage (Lawson, 1999). Since no 
additional activating signals are required for neuroectoderm induction, and the absence of nodal 
or BMP signalling results in upregulation of neuroectodermal markers in the complete EPI, it is 
often considered the ‘default’ path of differentiation (Camus et al., 2006; Di-Gregorio et al., 
Figure 1.9 | The gastrulating embryo. a, Around E6.0 the P-D and A-P axis have been established. On the posterior 
side, a combination of nodal, WNT and FGF signalling induce the formation of the primitive streak in which EPI cells 
undergo an epithelial-to-mesenchymal transition and subsequently migrate out of the epithelium and form the 
mesendoderm between EPI and VE. Antagonistic WNT and nodal signals secreted by the AVE prevent formation of 
an anterior primitive streak and enable neuroectodermal differentiation. b, In-situ hybridization show anterior 
localisation of Dkk1, Cer1, Otx2 and Foxa2 whereas Wnt3 and Bra are mostly localised to the posterior side. Modified 




2007). In contrast, primitive streak and subsequent mesendoderm (general precursors of 
meso- and endoderm) differentiation requires BMP signals from the ExE and nodal signals from 
the EPI (Conlon et al., 1994; Dunn et al., 2004; Mishina et al., 1995). Furthermore, WNT3 and 
its surface receptors, LRP5 and LRP6, as well as its intracellular signal transducer b-catenin, are 
crucial for successful gastrulation (Haegel et al., 1995; Huelsken et al., 2000b; Kelly et al., 2004; 
Liu et al., 1999). Albeit there is no known signalling function of b-catenin in the pre-implantation 
embryo, stabilisation of b-catenin signalling or the absence of its antagonists CER1 and LEFTY1 
at this stage, results in posterior gene activation and formation of multiple primitive streaks 
throughout the embryo (Kemler et al., 2004; Perea-Gomez et al., 2002; Zeng et al., 1997). 
Interestingly, gastrulation is not affected by the deletion of plakoglobin, a vertebrate homologue 
of b-catenin, however, its overexpression in Xenopus embryos leads to axis duplication similar 
to the phenotype of stabilised b-catenin in the mouse (Bierkamp et al., 1996; Karnovsky and 
Klymkowsky, 1995; Ruiz et al., 1996). During the formation of the primitive streak, EPI cells 
leave the monolayer epithelium via an epithelial-to-mesenchymal transition orchestrated by the 
upregulation of snail, a direct transcriptional repressor of the cell-cell adhesion molecule 
E-cadherin (Cano et al., 2000; Carver et al., 2001), and the progressive breakdown of the basal 
lamina (Williams et al., 2012). As the primitive streak elongates from its proximal-posterior 
origin to the distal-anterior endpoint, EPI cells become primed to different meso- and endoderm 
lineages depending on their time and location of egression within the streak (Lawson, 1999). EPI 
cell migrating through the more proximal primitive streak give rise to the paraxial and cardiac 
mesoderm, whereas cells leaving the primitive streak at its most anterior part become axial 
mesoderm and definite endoderm (Lawson, 1999). All things considered, it has been extensively 
demonstrated, that changes in embryonic morphology, symmetry breaking of the EPI and new 
signalling environments are of utmost importance for the initiation of gastrulation and the 
subsequent establishment of the three germ layers.  
 
1.2 Embryonic mouse cell lines – pluripotency in vitro 
In vivo, pluripotency is a transient feature of the developing embryo that arises in the ICM 
and quickly disappears after implantation. Embryonic stem cells, the in vitro counterpart of the 
pre-implantation epiblast, artificially keeping cells in a pluripotent and self-renewing time, 
hypothetically for indefinite time. In the next few paragraphs I will be briefly describing capturing 
the continuum of pluripotency in vitro.  
 
1.2.1 Embryonic stem cells (ES cells) 
The history of embryonic stem (ES) cells dates back to the early 50’s and their discovery 




develop testicular teratocarcinomas (Stevens and Little, 1954). Teratocarcinomas are a type of 
tumour consisting of a mixture of fully differentiated cells as well as highly proliferative and 
undifferentiated cells, termed embryonic carcinoma (EC) cells. Shortly after, it was shown that 
when injecting individual of these undifferentiated cells into adult mouse brains, they would go 
on and differentiate again to form multilineage tumours (Kleinsmith and Pierce, 1964). Therefore, 
these cells have a multipotent differentiation potential, a state similar to what has been previous 
described in the embryonic epiblast. Furthermore, it was possible to expand clonal EC cells in 
culture when supplemented with serum and grown on inactivated mouse embryonic 
fibroblasts (iMEF) (Kahan and Ephrussi, 1970). Remarkably, upon removal of iMEFs, EC cells 
could also be maintained on gelatin coated dishes, however, a part of the cell population would 
in this case differentiate to a feeder-like state and support the remaining EC cells in an 
undifferentiated state. However, albeit showing a multipotent differentiation potential, chimera 
contribution of EC cells remained poor. This challenge was finally overcome by the establishment 
of pluripotent cells directly from the epiblast of the pre-implantation embryo, termed embryonic 
stem cells (ESC) (Evans and Kaufman, 1981; Martin, 1981). Initially ESCs were also cultured 
under the same serum and feeder conditions, but in comparison to EC cells, ESCs showed higher 
chimeric contribution potential and their genetic material could be passed on through germline 
transmission (Bradley et al., 1984). Although gene regulatory networks of pluripotency in ESCs 
are now well established, the first in vitro cultures exhibited great heterogeneity across their 
phenotype, transcription and developmental potential (Chambers et al., 2007; Kolodziejczyk et 
al., 2015; Marks et al., 2012; Toyooka et al., 2008; Wray et al., 2010). However, culture 
conditions were far from ideal, serum batch variability and the unknown contribution of feeder 
cells appeared to be the main cause behind this metastability in ESC cultures (Robertson, 1997). 
In an effort to move towards more defined culture conditions, serum and feeder cells needed to 
be replaced. In this regard, one of the breakthrough discoveries was the identification of the 
protein ‘leukaemia inhibitory factor’ (LIF) which can substitute for the use of feeder cells in ESC 
cultures, a condition termed hereafter S+LIF (Smith et al., 1988; Williams et al., 1988). LIF was 
subsequently shown to act via pSTAT3, which translocates to the nucleus where it promotes the 
expression of pluripotency associated genes such as TFCP2L1 and the KLFs (Martello et al., 
2013; Niwa et al., 1998). With the identification of LIF, dependency on feeder cells had been 
eliminated, yet quality variations across batches of serum remained an issue. Over 15 years later, 
it was shown BMP signals from the serum were the major contributor in maintaining pluripotency 
(Ying et al., 2003a). Therefore, a combination of LIF and BMP enabled the first fully defined 
culture conditions for ESCs. Surprisingly, despite having eliminated the quality variations in 
serum and feeder cells, ESCs still exhibited heterogeneous expression of the transcription factors 
known to be associated with the pre-implantation epiblast (Boroviak et al., 2014; Wray et al., 




counterpart of the pluripotent epiblast. In particular the observation that ESCs could only be 
derived from embryos of the inbred mouse strain 129, further fuelled the argument that ESCs are 
an in vitro artefact and different from the EPI cells. In vivo, pluripotency is a transient feature of 
the EPI which last not even 48 hours (Boroviak et al., 2014). LIF and BMP signalling act by 
promoting pluripotency but do not inhibit the intrinsic drive towards developmental progression 
and somatic lineage differentiation. In 2008, Ying and colleagues addressed this issue by 
culturing ESCs in the presence of two small molecules PD0325901 (PD) and CHIR99021 (CH) 
inhibiting ERK (an FGF pathway kinase) and GSK3 (a WNT/b-catenin pathway kinase), 
respectively (Ying et al., 2008). Both of these pathways have previously been indicated to play 
crucial roles in ESCs differentiation (Doble et al., 2007; Sato et al., 2004; Wilder et al., 1997). 
This double inhibition of ERK and GSK with the optional addition of LIF, from here on termed 
2i+LIF, finally enabled ESC derivation from any mouse strain and even other rodents such as the 
rat (Buehr et al., 2008; Nichols et al., 2009a; Ying et al., 2008). Remarkably, unlike ESCs in 
S+LIF or BMP+LIF, 2i+LIF cultured ESCs show no heterogenous expression of genes known to 
be associated with the naïve EPI and are therefore considered to be anchored in a so called 
‘ground state’ (Silva and Smith, 2008) 
 
1.2.2 Epiblast stem cells (EpiSCs) 
The ability of the epiblast to give rise to ESCs disappears with quickly with implantation 
(Boroviak et al., 2014). However, pluripotent cell lines can be also derived from the 
post-implantation epiblast between E5.5 and E7.5 (Brons et al., 2007; Tesar et al., 2007). These 
cell lines, referred to as epiblast-derived stem cells (EpiSCs), have a distinct transcriptional 
signature from ESCs, require FGF and activin/nodal signalling and cannot be maintained in 
2i+LIF (Brons et al., 2007; Kojima et al., 2014; Tesar et al., 2007). Furthermore, EpiSCs do not 
readily contribute to the developing embryo, when injected into the blastocyst (Ohtsuka et al., 
2012) and show weak and heterogeneous expression of lineage-specific marker (Tsakiridis et al., 
2014). Hence, EpiSCs are considered to occupy the primed space of pluripotency (Nichols and 
Smith, 2009) 
 
Conclusively, it can be said, that ESCs and EpiSCs have been successfully employed as in vitro 
models for their respective in vivo counterparts, the naïve pre-implantation and the primed 







1.3 Pluripotency, a developmental continuum.  
To this end, I have described two methods of capturing pluripotency in vitro – through the 
use of ESCs and EpiSCs. Both of these cell types are self-renewing and can contribute to all germ 
layers of the developing embryo, they are therefore pluripotent. However, these are two distinct 
states of pluripotency that we are able to keep artificially from progressing in their developmental 
timeline. In the developing embryo, pluripotency arises and disappears as a developmental 
continuum in which cells are not arrested at a particular time point – with the exception of 
embryonic diapause (Renfree and Fenelon, 2017). ESCs and EpiSCs represent the early and late 
stages of pluripotency, respectively. ESCs can be derived from the pre-implantation epiblast 
between E3.5 and E4.5, transcriptionally cluster with the E4.5 epiblast and readily form blastocyst 
chimaeras and contribute to all germ layers and the germ line, therefore they are considered naïve 
pluripotent (Boroviak et al., 2014; Evans and Kaufman, 1981; Martin, 1981). Naïve ESCs require 
MEK/ERK and GSK3 inhibition and express a set of distinct naïve transcription factors such as 
Zfp42, Tfcp2l1, Esrrb, Klf2, Klf4 and Klf5 (Boroviak et al., 2014; Ying et al., 2008). Unlike 
differentiated cells, ESCs also have two active X chromosomes just like the pluripotent cells of 
the pre-implantation epiblast (Silva et al., 2009). In contrast to ESCs, EpiSCs are derived from 
the post-implantation epiblast, transcriptionally represent cells of the anterior primitive streak  
(Brons et al., 2007; Kojima et al., 2014; Tesar et al., 2007; Tsakiridis et al., 2014). Furthermore, 
EpiSCs require FGF/activin signalling and do not revert spontaneously to the naïve state when 
cultured in 2i+LIF but undergo rapid cell death (Guo et al., 2009). Furthermore, they do not 
contribute to blastocyst chimaeras but do integrate into the post-implantation epiblast (Huang et 
al., 2012). EpiSCs express the core pluripotency factors Pou5f1, Sox2 and Nanog, but do not 
express any members of the naïve transcription factor network. Interestingly, EpiSCs show 
heterogeneous expression of lineage priming markers such as T (Brachyury) and 
post-implantation markers including Fgf5 and Otx2, therefore EpiSCs are considered primed 
pluripotent. Remarkably, EpiSCs are not capable of differentiating into primordial germ cells 
(PGCs) despite their parental tissue, the E5.5 epiblast, being the origin of PGCs in vivo (Hayashi 
et al., 2011; Murakami et al., 2016; Ohinata et al., 2009). Similarly, ESCs cannot be directly 
differentiated into PGCs as they have to initially downregulate the naïve transcription factor 
network before becoming responsive to lineage inducing signals (Hayashi et al., 2011; Nakaki et 
al., 2013). Interestingly, when ESCs are transferred into medium containing FGF, activin and 
KSR, they start differentiating and, after 48 hours, transition into epiblast-like cells (EpiLCs) 
(Hayashi et al., 2011). EpiLCs are transcriptionally distinct from EpiSCs, can give rise to PGCs, 
but only exist transiently. Hence, another distinct state – the formative state – has been proposed 
in which the naïve pluripotency network has been completely downregulated, cells are responsive 




colleagues found that when culturing naïve ESCs in the presence of LIF, the WNT inhibitor IWP2 
and the MEK PD03, they upregulate the peri-implantation marker OTX2 (Neagu et al., 2020). 
However, these cells still express the naïve marker KLF4, readily revert back to the naïve state 
when exposed to WNT signals. Therefore, these cells are considered to correspond to the rosette 
stage but have not acquired the formative state. Subsequently, it was found that the culture of 
naïve ESCs in low levels of activin, with the WNT inhibitor XAV and retinoic acid receptor 
inhibitor BMS 493 or the direct derivation of cells from the E5.5 epiblast under these conditions, 
leads to cultures that have downregulated the naïve network and are responsive to PGC induction 
and are therefore bona fide formative cells (Kinoshita et al., 2020). 
 
Table 1 | Properties of naïve and primed pluripotency (Modified from (Nichols and Smith, 2009)) 
 Naïve Primed 
Expression of Oct4 Yes Yes 
Expression of naïve pluripotency TFs Yes No 
Expression of early post-implantation TFs No Yes 
X inactivation No Yes 
DNA methylation Low High 
Apicobasal polarity No Yes 
Homogeneity Yes No 
Dependence on FGF/ERK signalling No Yes 
Dependence on nodal/activin signalling No Yes 
Formation of blastocyst chimaeras Yes No 
Formation of post-implantation chimaeras No yes 
In vitro stem cell derivation Yes Yes 
 
Pluripotent cells have also been derived from human and non-human blastocysts (Sasaki et al., 
2005a; Thomson et al., 1998; Thomson et al., 1995; Thomson et al., 1996). However, these cells 
are, unlike mouse ESCs, transcriptionally and epigenetically different from their derived tissue – 
the primate pre-implantation epiblast (Guo et al., 2014; Yan et al., 2013). Furthermore, primate 
ESCs consistently failed to form chimaeras when injected into the respective embryo (Okano et 
al., 2012). They also share several features with mouse post-implantation EpiSCs including the 
requirement for FGF and activin/nodal signalling and transcriptionally cluster with the late 
post-implantation epiblast (Brons et al., 2007; Nakamura et al., 2016; Tesar et al., 2007). 
Eventually, through the use of derivations of the original mouse naïve medium 2i+LIF, it was 
possible to reset primate ESCs to a naïve state and also enables the derivation of naïve human 




Theunissen et al., 2014). Extensive single-cell sequencing studies have revealed that, although 
the majority of pluripotency-associated transcription factors match that of rodents, primate ESCs 
still differ in the expression of several distinct transcriptional regulators (e.g. the absence of KLF2 
and the upregulation of KLF17) and have therefore a primate-specific pluripotency network 
(Boroviak and Nichols, 2017; Boroviak et al., 2018). 
 
1.4 WNT/b-catenin signalling during pluripotency 
WNT/b-catenin signalling during pluripotency is complex, controversial and its role in 
pluripotency establishment, maintenance and execution remains debated. The outcome of 
WNT/b-catenin signalling in the early embryo heavily depends on the context, developmental 
stage and cell type (Munoz-Descalzo et al., 2015). The sheer amount of WNTs (19) and respective 
Frizzled receptors (12), in combination with the dual function of b-catenin as a cell adhesion 
molecule and signal transducer makes the deciphering of specific signalling pathways a 
non-trivial endeavour (Kemp et al., 2005; McCrea et al., 2015; van Amerongen and Berns, 2006). 
Mouse and human pre-implantation express many signalling components of the WNT/b-catenin 
pathway including several members of the WNT protein family and b-catenin (Lloyd et al., 2003; 
Yan et al., 2013). Historically speaking, the consensus was that there is no, or only marginal, 
requirement for WNT/b-catenin for embryonic pre-implantation development and the 
establishment of pluripotency. This hypothesis was based on the observation that b-catenin 
knockout mice develop normally until gastrulation. At time of gastrulation b-catenin null 
embryos fail to establish the anterior-posterior axis, cells start to detach from the embryonic 
ectoderm layer and no mesoderm formation was observed (Haegel et al., 1995; Huelsken et al., 
2000a). Similar observations were made when abrogating the secretion of all WNTs through the 
knockout the WNT chaperone Porcupine. Porcupine null embryos lack the formation of the 
primitive streak and do not develop an anterior-posterior axis (Biechele et al., 2013). These 
studies have established a strong base of evidence for the importance of WNT/b-catenin 
signalling during gastrulation. Indeed, when manually removing the in vivo source of WNT 
signalling, the extraembryonic ectoderm, the complete epiblast takes on an anterior fate without 
the formation of mesoderm and its associated markers such as T and AFP (Rodriguez et al., 2005). 
On the contrary, stabilisation of b-catenin leads to premature EMT and the expression of posterior 
markers throughout the complete epiblast (Chazaud and Rossant, 2006; Kemler et al., 2004). 
Interestingly, a recent study has found that, despite being dispensable for regular pre-implantation 
development, WNT/b-catenin is crucial for pluripotency maintenance during murine embryonic 
diapause (Fan et al., 2020). This finding and the evidence that WNT/b-catenin signalling prevents 




signalling pathways on pluripotency in embryonic stem cells (Neagu et al., 2020). Unlike in the 
embryo, the benefits of WNT/b-catenin signalling on the pluripotency network in ESCs are 
undisputed. Initially, it was observed that modulation of the WNT/b-catenin pathway by the 
GSK3 inhibitor BIO promotes pluripotency (Sato et al., 2004; Umehara et al., 2007). 
Subsequently, the inhibition of GSK3 by Chiron (CH) in combination with MEK inhibition and 
the optional addition of LIF, enabled the derivation and long-term culture of mouse embryonic 
stem cells from mice with varying genetic backgrounds (Ying et al., 2008). ESCs can also be 
maintained when activating the WNT signalling pathway through exogenous addition of WNT3A 
(ten Berge et al., 2011). In either case, exogeneous WNT or inhibition of GSK3, b-catenin 
becomes stabilised which leads to its nuclear accumulation where it interacts with the TCF/LEF 
transcription factor family (Behrens et al., 1996; Molenaar et al., 1996; van de Wetering et al., 
1997). The most dramatic effects on the pluripotency network appears to be b-catenin’s function 
in abrogating the repressive function of TCF3 on the pluripotency network, in particular the naïve 
transcription factor ESRRB (Lyashenko et al., 2011; Martello et al., 2012; Wray et al., 2011). 
However, there is further evidence that b-catenin also promotes pluripotency through 
TCF-independent mechanisms (Faunes et al., 2013; Kelly et al., 2011; Zhang et al., 2020). These 
TCF-independent mechanism have been suggested to act through a direct interaction of b-catenin 
with OCT4 (Kelly et al., 2011). b-catenin can promote OCT4 activity and also sequester it to 
regulate its pro-differentiation properties (Faunes et al., 2013; Kelly et al., 2011; Munoz Descalzo 
et al., 2013). Additionally, b-catenin has the ability to supply transcriptional coregulators to 
pluripotency loci and thereby stabilising the complete pluripotency network (Zhang et al., 2020) 
 
Remarkably, stabilisation of b-catenin in EpiSCs leads to rapid differentiation and loss of OCT4, 
rather than promotion of pluripotency like in ESCs (Kinoshita et al., 2020; Kurek et al., 2015; 
Sumi et al., 2013). On the contrary, inhibition of WNT/b-catenin signalling reduces spontaneous 
differentiation, promotes more homogeneous cultures and even improves reprogramming of 
EpiSCs back to the naïve state (Murayama et al., 2015; Sumi et al., 2013). Consistent with the 
WNT/b-catenin signalling response of mouse EpiSCs, human conventional stem cells also 
differentiate upon stabilisation of b-catenin (Davidson et al., 2012; Dravid et al., 2005; Kurek et 
al., 2015; Singh et al., 2012; Sun et al., 2017). However, some studies have also suggested 
beneficial effects of WNT/b-catenin signalling on the pluripotency network in conventional 
human ESCs and mouse EpiSCs (Cai et al., 2007; Kim et al., 2013; Sato et al., 2004). 
Interestingly, the signalling outcome, differentiation or maintenance of pluripotency, appears to 
depend on the localisation of b-catenin with nuclear accumulation causing differentiation (Kim 
et al., 2013). Extrapolating from the knowledge gained in mice, one might expect WNT/b-catenin 




elucidated that a precise titration of GSK3 inhibition was necessary to establish human naïve cells 
(Theunissen et al., 2014). A recent study found that actually WNT/b-catenin inhibition via 
XAV939 treatment is beneficial for pluripotency, suggesting that active WNT/b-catenin 
signalling to maintain pluripotency might be rodent specific pathway (Zimmerlin et al., 2016). 
Yet, another contradicting study found WNT/b-catenin to support the naïve state in human ECS 
by inhibiting the transition into primed pluripotency (Xu et al., 2016). Conclusively, it can be 








1.5 Aims of this study 
All higher organisms consist of a multiplicity of cell types with distinct functions and 
morphological features. Already during the first few days after the fertilization of the egg, the 
mammalian embryo undergoes complex morphological rearrangement, transcriptional rewiring 
and epigenetic changes. It has become eminent, that conventional two-dimensional tissue culture 
systems cannot fulfil the requirements to recapitulate all these processes in vitro. Therefore, the 
development of new technologies is crucial to complete our understanding of such events. Over 
the last decade the amount of publications regarding three-dimensional cell culture has undergone 
an exponential growth, thereby exposing benefits, and limitations of these systems. In particular, 
the advances in the derivation of tissue specific organoids and synthetic embryos have enabled 
us to ask (and answer) a complete new set of questions, that could have been only answered to a 
very limited extend by conventional tissue culture techniques. I have performed my doctoral 
studies in collaboration between the Department of Biochemistry and Cambridge Stem Cell 
Institute which reflects itself in the experimental set ups and techniques I have used throughout 
my research. Thus, over the last several years I have addressed the following questions and aims: 
 
o Are microgels are suitable format for culturing embryonic stem cells and does this microgels 
suspension culture represent a physiologically more relevant environment compared to cells 
grown on flat plastic surfaces? 
 
o How do such environmental changes (e.g. 2D vs 3D, adhesion, stiffness, pressure) affect cell 
morphology and behaviour? Can these biophysical properties modulate the pluripotency gene 
regulatory network? If yes, to which extend and what are the underlying mechanisms? 
 
o Will the co-encapsulate of cells of multiple embryonic lineages allow the synthetic 
reconstruction of spatiotemporal events of embryogenesis in vitro? 
 
o Finally, how versatile is the proposed system of microgel suspension culture? Can the set-up 
be adapted to suit cells of other species than rodents, e.g. human or non-human primate? Will 













2.1 Microfluidic chip fabrication 
I used a variety of different microfluidics chips throughout this study of which all were 
designed with the CAD software (DraftSight, Dassault Systems). Chip production followed the 
well-established soft-lithography protocols (Xia and Whitesides, 1998). Briefly, chip designs 
were cut out on a photo mask which is then used for the fabrication of a silicon wafer master 
mould in a clean room. Once fabricated, the silicon mould can be theoretically reused indefinitely. 
For the actual chip production, the master mould was placed in a petri dish and covered with a 
1:10 (w/w) ratio of curing reagent with a polydimethylsiloxane (PDMS) precursor. Subsequently, 
the PDMS covered petri dish was placed in a desiccator and degassed until no more air bubbles 
were visible. The PDMS was polymerized at 65 °C overnight. The next day, the cured PDMS 
was carefully cut out of the petri dish and the chip in- and outlets were punched with a 1 mm 
biopsy needle. The PDMS was then thoroughly washed with 2-propanol and dried with 
compressed air. At this point, the PDMS is ready to be bond to a microscopy slide to produce the 
final microfluidic chip. PDMS and microscopy slides were placed in a low-pressure oxygen 
plasma generator. The plasma chamber was evacuated of air (0 mbar) and refilled with pure 
oxygen. The plasma treatment lasted for 12 seconds, after which the PDMS was gently pressed 
onto the microscopy slide resulting in covalent binding of the two surfaces to each other. 
Immediately afterwards, the microfluidic channels were filled with 1% (v/v) 
Trichloro(1H,1H,2H,2H-perfluorooctyl)silane in HFE-7500 (Figure 2.1) and the chip was placed 
on a hot plate at 65 °C for 30 min. Subsequently, the chip was washed with filtered HFE-7500 
and stored sterile until use. 
 
 
2.2 Microgel production 
The in the literature previously described design (Anna et al., 2003) for a flow focusing 
device (FFD) was used for the production of microgels. The design contains two inlets, one for 
the HFE-7500 (oil phase) containing 0.3% PicoSurf-1 (Dolomite) surfactant and one for the 
agarose (aqueous phase). The channel intersection at which droplet formation (agarose in oil 
emulsion) occurs, has a width of 70 µm and a height of 75 µm unless stated otherwise. The 




polydimethylsiloxane (PDMS) FFDs were prepared according to section 2.1. Due to its physical 
properties (low melting temperature and clearness) SeaPrep® agarose (Loza) was used for 
microgel production. The desired amount of agarose was dissolved in PBS at 70 °C for 20 min. 
Subsequently, the melted agarose was cooled down to 37 °C. To inject the liquid agarose into the 
chip, a syringe (SGE, 100 µL) was connected with a disposable needle (BD microlance 1 mm ID) 
to 80 cm of tubing (Smiths Medical fine-bore polyethylene tubing: ID: 0.38 mm, OD: 1.09 mm). 
The syringe and tubing were filled with HFE-7500 to remove all air, the syringe was then almost 
emptied and the tubing was filled backwards with the liquid agarose and connected to the FFD’s 
aqueous inlet. A second syringe (SGE, 2.5 mL) was filled with HFE-7500 supplemented with 
0.3% PicoSurf-1 and connected to the oil inlet. Syringe pumps (neMESYS and Harvard 
Apparatus) were used to control the flow rates. If not stated otherwise, the agarose flow was set 
to 6 µL/min and the oil flow to 30 µL/min. Finally, the agarose in oil emulsion was collected 
through the exit channel in an ice cooled test tube (Eppendorf, 1.5 mL) where microgel 
polymerization occurred.  
 
2.2.1 Demulsification of microgels  
For long term culture of cells, the microgels needed to be transferred from the emulsion 
into a corresponding cell culture medium. To break the emulsion, the excess of oil underlying the 
emulsion was carefully aspirated. The emulsion was then covered with 200 µL PBS (or 
appropriate cell culture medium). Afterwards, 45 µL PFO (Alfa Aesar) were pipetted under the 
emulsion and the mixture was immediately vortexed for 5 s and subsequently briefly centrifuged 
(small table centrifuge) until the phases were separated. The aqueous phase (on top) contains the 
microgels and was transferred by pipette into an uncoated tissue culture vessel filled with 
pre-warmed medium. 
 
2.3 Cell culture 
2.3.1 Mouse embryonic stem cells (mESCs) 
The 129/Ola derived E14TG2a cells (Hooper et al., 1987) and Rex1:GFPd2 (Wray et al., 
2011) were generally cultured under 2i+LIF (Ying et al., 2008) conditions. Briefly, N2B27 (1:1 
DMEM/F-12 and Neurobasal media, N2 (Bottenstein and Harvey, 1985) [in-house] and B27 
(Brewer et al., 1993) [GIBCO] additives, 2 mM L-glutamine, and 100 µM β-mercaptoethanol) 
was supplemented with 1 µM PD0325901 (MEK inhibitor), 3 µM CHIR99021 (GSK3 inhibitor), 
and 10 ng/mL leukaemia inhibitor factor (LIF) (in-house). For a certain set of experiments, ES 
cells were cultured under serum+LIF (S+LIF) conditions. Briefly, GMEM (Sigma-Aldrich) was 
supplemented with 10% foetal calf serum (FCS) (Sigma-Aldrich), 1x non-essential amino acids 




L-Glutamine (Life Technologies). Cells were maintained on gelatin-coated (0.1%) culture dishes 
in a 7% CO2 humidified incubator at 37 °C and medium was replaced every other day. Cells were 
passaged every 2-3 days at a dilution of 1:10. Briefly, the medium was aspirated and cells were 
treated with accutase until cells detached from the dish. Colonies were dissociated into single 
cells by gentle pipetting the detached cells against the tissue culture dish. Afterwards, the accutase 
was diluted with 10x volume of wash medium (DMEM-F12 + BSA) and cell were centrifuged 
for 3 min. at 300 RCF. Finally, the supernatant was discarded, cells were resuspended and 
replated in the appropriate pre-warmed medium. 
 
2.3.1.1 In vitro differentiation assays 
2.3.1.1.1 EpiLC differentiation 
EpiLC induction from ESCs was as described by Hayashi and colleagues (Hayashi et 
al., 2011). Briefly, 2i+LIF cultured ESCs were plated at a density of 200.000 cells/6-well on 
10 µg/mL fibronectin coated 6-well plates. EpiLC induction medium consisted of N2B27 
medium supplemented with 12 ng/mL bFGF, 20 ng/mL activin A and 1% KSR. Cells were 
analysed after 48 hours in culture. Alternatively, ESCs were plated on fibronectin coated plates, 
cultured in N2B27 supplemented with 12 ng/mL bFGF, 20 ng/mL activin A, 2 µM XAV and 
passaged every 48 hours. 
 
2.3.1.1.2 Neuroectoderm differentiation 
For monolayer neuroectodermal differentiation of ESCs I applied the protocol as 
described by Ying and colleagues (Ying et al., 2003b). Briefly, tissue culture dishes were coated 
with ~10 µg/mL laminin in PBS for a minimum of 3 hours. Subsequently, laminin was aspirated, 
replaced with N2B27 and stored in the incubator for equilibration. After passaging, ESCs were 
resuspended in N2B27 and plated at a density of 1.0x104 cells/cm2. Medium was replaced with 
fresh N2B27 after 48 hours and every day thereafter. 
 
2.3.1.1.3 Mesendoderm differentiation 
There are several different protocols for definite endoderm and mesoderm 
differentiation. However, initial ‘mesendoderm’ induction always rely on the stimulation of the 
WNT and activin/nodal pathways (Mulas et al., 2017; Thomson et al., 2011). For monolayer 
mesendoderm differentiation plates were coated for a minimum of 3 hours with 10 µg/mL 
fibronectin (Millipore, FC010) in PBS at 37 °C. Subsequently, fibronectin was aspirated and 
replaced with fresh N2B27. After passaging, ESCs were resuspended in N2B27 and plated at a 
density of 1.5x104 cells/cm2. After 48 hours in N2B27, medium was replaced with fresh N2B27 




2.3.2 Hanging drop culture 
For the aggregation of ESCs in suspension I utilized the hanging drops method. Briefly, 
after accutase treatment, ESCs were resuspended in 2i+LIF medium at a concentration of 
10.000 cells/mL. Subsequently, 30 µL droplets (containing ~300 cells) were pipetted onto the 
inside lid of a 15 cm petri dish. Finally, the lid was placed on the petri dish, which was filled with 
PBS to mitigate evaporation. 
 
2.3.3 Mouse epiblast derived stem cells (EpiSC) 
Mouse epiblast-derived stem cells (EpiSCs) carrying the Oct4GiP transgene (Ying et al., 
2002), were originally established from E5.75 embryos by Dr. Ge Guo (Austin Smith’s lab, 
Cambridge Stem Cell Institute, University of Cambridge) (Guo et al., 2009). EpiSCs were 
cultured on 10 µg/ml fibronectin coated 6-well plates without feeder cells in serum-free N2B27 
medium supplemented with 12 ng/mL bFGF, 20 ng/mL activin A and 2 µM XAV (Kim et al., 
2013; Sumi et al., 2013). Cells were passaged every other day by accutase dissociation. 
 
2.3.4 Extraembryonic endoderm cells (XEN cells) 
XEN-EGFP cells were a gift from Magdalena Zernicka Goetz’s lab (Department of 
Physiology, Development and Neuroscience, University of Cambridge) and originally derived in 
Peter Rugg-Gunn’s lab (Babraham Institute) (Rugg-Gunn et al., 2010). XEN cells were routinely 
maintained in RPMI-1640, supplemented with 20% FBS, 1 mM sodium pyruvate, 50 U/mL 
penicillin, 50 µM 2-mercaptoethanol, 2 mM glutamine. 
 
2.3.5 Marmoset embryonic stem cells 
Common marmoset embryonic stem cells (cmESC) were established and maintained by 
Erin Slatery (Thorsten Boroviak’s lab, Department of Physiology, Development and 
Neuroscience, University of Cambridge). Conventional cmESCs were cultured on inactivated 
mouse embryonic fibroblast (iMEF) feeder cells in KSR/bFGF medium. Briefly, DMEM/F-12 
was supplemented with 20% KnockOut Serum Replacement (KSR), 10 ng/mL FGF2, 100 mM 
2-mercaptoethanol, 1xNEAA and 2 mM L-glutamine. For the resetting to naïve-like 
pluripotency, conventional cmESCs were plated on iMEFs and cultured for at least 10 days in a 
resetting medium termed PLAXA. Briefly, this medium is based on N2B27 and additionally 
supplemented with 1 µM PD0325901, 10 ng/mL hLIF, 50 µg/mL ascorbic acid, 2 µM XAV939 
and 20 ng/mL activin A. Optionally, PLAXA can be further supplemented with 5% chemically 
defined lipids. Conventional as well as reset naïve-like cmESCs were maintained at 37 °C, 




2.3.6 Human embryonic stem cell 
The conventional human pluripotent cell line H9 (Thomson et al., 1998) was propagated 
on Geltrex coated 6-well dishes in Essential 8 (E8) medium (Chen et al., 2011) made in-house. 
Briefly, DMEM/F12 was supplemented with 64 mg/L L-ascorbic acid-2-phosphate magnesium, 
100 µg/L FGF2, 19.4 mg/l insulin, 14 µg/L sodium selenium, 543 mg/L NaHCO3, 10.7 mg/L 
transferrin and 2 µg/L TGFβ1 or 100 µg/L Nodal. The human naïve derived ES cell line HNES1 
(Guo et al., 2016) was routinely maintained on inactivated mouse embryonic fibroblast (iMEF) 
feeder cells in PXGL medium (Bredenkamp et al., 2019; Guo et al., 2017). Briefly, N2B27 was 
supplemented with 1 µM PD0325901, 2 µM XAV939, 2 µM Gö6983 and 10 ng/mL human LIF. 
For immunofluorescent staining, HNES1 cells were plated on laminin coated dishes to 
circumvent the use of MEFs. Naïve and conventional human ES cells were fed every day and 
passaged via accutase treatment every 3 to 5 days and cultured in 5% O2 and 7% CO2 in a 
humidified incubator at 37 °C. After passaging, 10 µM ROCK inhibitor (Y-27632, 688000, 
Millipore) were added to the culture for 24 hours.  
 
2.3.7 Cryopreservation of cell stock 
Cells were dissociated and washed as described in section 2.3.1. After the centrifugation, 
cells were resuspended in freezing medium (2i+LIF+20% FCS+10% DMSO). Cells were then 
transferred into 1 mL cryo vials and cooled at -1°C/minute with a Mr. Frosty™ freezing container 
(Thermo Fisher) overnight at -80 °C, before being transferred into liquid nitrogen for long term 
storage.  
 
2.4 Cell encapsulation in microgels 
2.4.1 Preparation of cell suspension for subsequent cell encapsulation 
2i+LIF or S+LIF cultured ESCs were grown in 6-well plate and grown for two or three 
days. Medium was aspirated and cells were washed with 10 mL PBS. Afterwards, PBS was 
aspirated and cells were dissociated with 1.5 mL accutase for 3 min. at room temperature. 
Subsequently, 8.5 mL of BSA containing DMEM-F12 medium were added and cells were 
centrifuged for 3 min at 300 RCF. The supernatant was aspirated and cells were re-suspended in 
an appropriate amount of N2B27. 
 
2.4.2 Cell and colony recovery from microgels 
Cells can be recovered from the agarose microgels at any given time point by digestion 
of the hydrogel. For recovery, 0.3 U/mL agarase (Thermo Fisher) were added to the in-gel 
suspension culture, resulting in rapid digestion of the agarose. Cells were then transferred into a 




resuspended in 1 mL accutase for 3 min. at room temperature. If additional dissociation was 
needed, cells were mixed gently with a 1 mL pipette. Afterwards, 9 mL of BSA containing 
DMEM/F-12 were added and centrifuged again at 300 RCF for 3 min. Cells were then 
resuspended in appropriate medium and replated or used for downstream analysis. Colonies were 
recovered as describe before, but accutase treatment was omitted. 
 
2.5 Cell analysis 
2.5.1 Flow cytometry and cell sorting 
Flow cytometric analysis of the Rex1::GFPd2 and Jup-mCherry reporters were were analysed 
with the LSR Fortessa (BD Biosciences). 
2.5.1.1 Fluorescence activated cell sorting  
Fluorescence activated cell sorting (FACS) was performed at the Cambridge Stem Cell 
Institute Flow Facility on a MoFlow XDP cell sorter (Beckman Coulter) and the Gurdon Institute 
on a SH800S Cell Sorter (Sony). For single or bulk FACS, cells were accutase treated for 10 min. 
at 37 °C before resuspending in 10 ml washing buffer (DMEM/F-12 + 5% BSA). Cells were then 
centrifuged for 3 min. at 300 RCF. Subsequently, cells were resuspended in 500 µL wash buffer, 
filtered through a 100 µm cell strainer and stored on ice until sorting. Single cells were directly 
sorted into 96-well plates, whereas bulk sorted cells were collected in a 1.5 mL test tube and 
centrifuged after collection. The wash medium was then replaced with the appropriate culture 
medium before plating the cells.  
 
2.5.2 Immunocytochemistry 
Cells were fixed for 10 min. with 4% PFA in PBS. After washing with PBS, cells were 
permeabilised for 15 min. with 0.5% Triton X-100 in PBS. Subsequently, cells were blocked for 
at least 2 hours with 3% BSA in PBS blocking solution. Primary antibody incubation was 
performed at desired concentration at 4 °C, overnight (Table 3). Cells were then washed with 
blocking buffer and incubated with the secondary antibody for 2 hours at room temperature. 
Afterwards cells were washed with blocking buffer and stained with 1 µg/mL Hoechst. 
 
2.6 Molecular biology 
2.6.1 Cloning 
All polymerase chain reactions (PCR) were performed with the Q5 High-Fidelity 
2x Master Mix (NEB) and, if necessary, purified from 1% agarose gels using the Zymoclean Gel 
DNA Recovery Kit (Zymo Research). The plakoglobin (Gene name: Jup) overexpression plasmid 




restriction digest and subsequent Gibson assembly(Gibson et al., 2009) with the Jup and 
T2A-mCherry fragments. Jup was previously amplified from cDNA with the primers 
F_Jup_cDNA and R_Jup_cDNA (Table 2.1). The T2A-mCherry fragment was obtained by PCR 
amplification of pCSpyT_mCherry-HA plasmid (kindly provided by Dr. Laurens Lindenburg, 
Florian Hollfelder’s lab, Department of Biochemistry, University of Cambridge) using the 
primers F_T2A-mCherry and R_T2A-mCherry (Table 2.1). Alpha-select chemically competent 
cells (Bioline) were transformed with the Gibson assembly reaction mix and plated on selective 
LB-agar. Plasmid DNA was extracted from monoclonal E. coli using the GeneJET Plasmid 
Miniprep Kit (Thermo Fisher Scientific) and subsequently sequence-verified by Sanger 
sequencing at the Department of Biochemistry (University of Cambridge).  
 







2.6.2 Piggy-Bacc Transfection 
To generate the Jup overexpressing cell line, I used the PiggyBac transposon system. 
Briefly, 10 µL Lipofectamine 2000 were mixed with 300 µL 2i+LIF medium. Separately, 1.2 µL 
PB_Jup-T2A-mCherry (700 ng/mL, 0.8 µg) with 1.6 µL PBase (500 ng/mL, 0.75 µg) and 150 µL 
2i+LIF medium. Then, 150 µL diluted DNA were mixed with 300 µL diluted Lipofectamine 2000 
and incubated for 5 min. at room temperature. Subsequently, ~5x105 cells were resuspended in 
450 µL of DNA/Lipofectamine 2000 and incubated for 10 min. at 37 °C. Then, cells were plated 
and stably transfected cells FACS-sorted based on their mCherry signal. 
 
2.6.3 Gene knock-out via CRISPR Cas9 
b-catenin knockout cells were generated via transient transfection with a CRISPR/Cas9 
Ctnnb1 KO plasmid according to the manufacturer’s instructions (Santa Cruz, sc-419477).  









2.6.4 RNA-sequencing  
All library preparations, sequencing and bioinformatic pre-processing were performed 
by my collaborator Joachim de Jonghe (Florian Hollfelder’s lab, Department of Biochemistry, 
University of Cambridge).  
 
2.6.4.1 Smart-Seq2 (Bulk) 
For ‘bulk’ RNA sequencing of ESCs in 2i+LIF cultured on tissue culture plastic or 
encapsulated in microgels, cDNA sequencing libraries were generated according to the 
Smart-seq2 protocol (Picelli et al., 2014). The amount of PCR cycles for the initial enrichment 
was set 12 for bulk samples. Subsequently, libraries were quantified using a Qubit HS 
(Invitrogen) kit and size distribution was assessed on a Bioanalyzer 2100 DNA HS kit. Libraries 
were then pooled at equimolar ratios and final molarity was obtained using both the Qubit HS 
and the Bioanalyzer 2100 HS kits. 
 
For next-generation sequencing (NGS) reads processing, read quality was analysed via the fastQC 
tool. Low-quality reads (Q<25) and Nextera adapters were removed using the trimmomatic tool. 
The STAR aligner was further used to index a mm10 reference genome (downloaded via the FTP 
module from the USCS Genome browser server) using a GTF annotation file downloaded in 
Gencode. Reads from each sample were the mapped to the indexed reference using the STAR 
aligner in paired-end sequencing mode. FeatureCounts from the package subread was then used 
to count the mapped reads and multi-mapped reads were discarded. FeatureCounts were then 
imported as a matrix in DESeq2 for differential expression analysis.  
 
2.6.4.2 inDrop Single Cell Sequencing 
For inDrop single-cell sequencing (Klein et al., 2015), cells were diluted to a 
concentration of 120,000 cells/mL in PBS containing 15% (v/v) Optiprep® and processed 
according to the inDrop protocol (Zilionis et al., 2017) with the v3 barcoding design (Briggs et 
al., 2018). Diversity of barcodes for these experiments was 147,456, and polyacrylamide 
barcoded-bead batches were quality controlled using FISH on the extended primers. Additionally, 
species mixing experiments were carried out to measure cross-contamination levels and capture 
efficienc. Each of the collected fractions aimed to contain 2,949 cells, resulting in a theoretical 
barcode collision rate of 1%. Cell co-encapsulation with reverse transcription mix and barcoded 
beads and library preparation were carried out following published protocols (Zilionis et al., 
2017). Limited-cycle PCR was employed to amplify and barcode the libraries and the quality of 
the latter was inspected using a BioAnalyzer HS kit. Samples were pooled at equimolar ratios 




concentration. The final library was purified using AmpureXP beads (1.5x volumetric ratio) and 
molarity was measured using a BioAnalyzer HS kit and a Kapq NGS library quantification kit.  
 
The libraries were sequenced using a 75 bp Illumina Nextseq 400M High output kit. In addition, 
5% PhiX were used as a spike-in control. Illumina’s bcl2fastq script was used to generate the 
fastq files, which were subsequently quality controlled using FastQC . 
 
2.7 Image acquisition, processing and quantification 
Imaging was performed with inverted Leica TCS SP5 and SP8 confocal microscopes using 
40x and 20x objectives. Fluorophores were excited with a 405 nm diode laser (DAPI), a 488 nm 
argon laser (GFP), a 543 nm HeNe laser (Alexa Fluor 543/555) and a 633 nm HeNe laser (Alexa 
Fluor 633/647). Images were acquired with 1 µm z-steps at 400 Hz and a resolution of 
1024x1024. Raw data were analysed with the open source software Fiji (Schindelin et al., 2012) 
and subsequently assembled in Illustrator CC (Adobe) 
 
2.8 Embryo work 
2.8.1 Mouse embryo collection and culture 
All mice used in this dissertation were intercrosses of strain CD1 and obtained through 
natural mating. Embryonic staging was based on the assumption, that mating occurred at 
midnight. Hence, embryos were staged at E0.5 and noon of the following day. For analysis, 
pre-implantation embryos were flushed with M2 medium (Sigma) from the oviducts (8-cell stage 
embryos) or the uterine horns (blastocysts), respectively. Post-implantation E5.5 embryos were 
carefully dissected from the implantation sites within the uterus. This research has been regulated 
under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following 
ethical review by the University of Cambridge Animal Welfare and Ethical Review Body 
(AWERB). Use of animals in this project was approved by the ethical review committee for the 
University of Cambridge, and relevant Home Office licenses (Project license No. 80/2597 and 
No. P76777883) are in place. 
 
2.8.1.1 Embryo immunofluorescence staining  
Mouse embryos were fixed, permeabilized and stained according to Prof. Jenny 
Nichols’ protocol (Nichols et al., 2009b). Initially, the zona pellucida was removed using acid 
acid tyrode’s (TA) to avoid incompatibilities with the immunostaining protocol. In summary, 
embryos were then fixed with 4% PFA for 20 min. at room temperature. After one wash in PBS 
supplemented with 3 mg/mL polyvinylpyrolidone (PBS/PVP), embryos were permeabilised for 




containing 0.1% BSA, 0.01% Tween 20 and 2% donkey serum (blocking buffer). Primary 
antibodies were appropriately diluted in blocking buffer and incubated at 4 °C overnight (Table 
3). Subsequently, embryos were washed 3x in blocking buffer for at least 15 min. each time before 
incubation with the secondary antibodies for 2 hours at room temperature and in the dark. All 
secondary antibodies were labelled with Alexa fluorophores and diluted 1:500 in blocking buffer. 
Subsequently, embryos were then washed in blocking buffer. Imagining was performed by 
placing the embryos in 2 µL droplets of water in an microscopy dish covered with mineral oil or 
were incubated briefly in increasing concentrations of Vectashield (Vector Labs) before mounting 
on glass slides in a small drop of concentrated Vectashield. 
 
2.8.1.2 Embryo microinjection  
For (single) cell injections, ESCs grown in the appropriate conditions were dissociated 
by accutase (500 µL/6-well) treatment for 5 min. at 37 °C. Cells were the centrifuged for 3 min. 
at 300xg in washing buffer (9.5 mL). Then, cells were resuspended in their appropriate medium 
and stored on ice until injection. Embryos were injected at the 8-cell stage with single (or 
multiple) ES cells via laser-generated perforation of the zona pellucida using the XYClone® 
(Hamilton Thorne Biosciences). Subsequently, injected embryos were cultured in Blast medium 
at 37 °C and 5% CO2 for 48 hours, the equivalent of the E4.5 blastocysts.  
 
2.8.2 Human embryo collection and culture 
All human embryos were handled and processed by Prof. Jennifer Nichols (Wellcome – 
MRC Cambridge Stem Cell Institute). The human embryo research was licensed by the UK 
Human Fertilization and Embryology Authority under research licence RO178. Supernumerary 
embryos were donated from in vitro fertilization programs with informed consent. Liquid 
nitrogen stored embryos were thawed at day 6 post fertilisation and cultured for 24 hours in 
N2B27. Embryos were then fixed in 4% PFA and stained as described in section 2.8.1.1. 
 
 
2.9 Statistical analysis 
All experiments were performed with at least three biological or technical replicates unless 
otherwise stated. Samples were compared with individual or multiple T-test with the GraphPad 
PRISM software (v8.4.4). Error bars represent the standard deviations.  
Asterisks legend: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001. 
  
Characterisation of a microgel culture system for embryonic stem cells 
34 
 
3 Characterisation of a microgel culture 




























Droplet microfluidics allows the high-throughput and precisely controllable generation of 
monodisperse microcompartments – droplets. Microdroplets have been used for several decades 
across different disciplines and functions (Huebner et al., 2008; Theberge et al., 2010). Recently 
in cell biology, droplets microfluidics emerged as a valuable tool for single-cell sequencing 
(Klein et al., 2015; Macosko et al., 2015), or when turned into microgels, as a novel culturing 
method and an alternative to conventional tissue culture plastic. Cells encapsulated in microgels, 
are surrounded by a three-dimensional (3D) scaffold that, depending on the chosen gel, comes 
with a variety of properties mimicking the in vivo microenvironment – often better than plastic 
can. 3D polymers allow to control parameters such as stiffness, extracellular matrix components, 
degradability, nanotopography and cell adhesivity. Consequently, with the use of gels, 2D and 
3D, arises a complex toolbox to regulate cell fate and behaviour (Murphy et al., 2014). Microgels, 
compared to regular bulk gels, have the advantage of being scalable through high-throughput 
generation (Headen et al., 2018) and expansion in bioreactors (Tabata et al., 2014), and they are 
compatible with other microfluidics platforms (Kleine-Bruggeney et al., 2019; Shi et al., 2013). 
In stem cell biology these features become relevant, as it has been known for several years, that 
adult stem cells reside in tissue specific microenvironments, called “niches”, that regulate 
self-renewal and differentiation (Morrison and Spradling, 2008). In a ground breaking study, 
Engler and colleagues elucidated the capabilities of directing mesenchymal stem cells towards 
different fates by adjusting the stiffness of the substrate they were grown on (Engler et al., 2006). 
Shortly after, it was also shown, that mouse embryonic stem cells (ESCs) appear to be substrate 
sensitive, with softer substrates promoting pluripotency (Chowdhury et al., 2010a). Recently, 
Lutolf and colleagues used soft and defined 3D gels to improve the generation of induced 
pluripotent stem cells (iPSC) by accelerating the mesenchymal to epithelial transition and 
enhancing epigenetic plasticity (Caiazzo et al., 2016). Mouse ESCs are in a way special, as they 
can grow matrix-independent in suspension, allowing their culture in a variety of different 
hydrogels, even when biologically inert and not supplying any extracellular matrix (Allazetta et 
al., 2015; Kumachev et al., 2011; Siltanen et al., 2016; Wilson et al., 2014). Recently, our group 
has demonstrated the successful micro-encapsulation and several day long culture of naïve mouse 
embryonic stem cells in ultra-low melting agarose (Kleine-Bruggeney et al., 2019). However, 
microgel culture drastically changes the cells microenvironment and thus far little is known about 
any downstream signalling events and changes in cell behaviour. In this chapter, I will be 
characterising the effects of microgel culture on mouse embryonic stem cells, its implications on 
pluripotency, self-renewal and differentiation. 
  




3.2.1 Microfluidic encapsulation of mouse embryonic stem cells 
 At the beginning of this project, the first critical step was to establish a reliable and 
reproducible protocol for the microfluidic encapsulation of mouse embryonic stem cells (ESCs). 
All microfluidic cell encapsulations throughout this study were performed with so called flow-
focussing devices (FFD). The simplest microfluidic FFDs have one inlet for the aqueous phase 
and the another one for the non-miscible continuous oil phase (Figure 3.1 a&b). At the cross 
section of these channels, droplet formation occurs due to the non-miscibility of the two phases. 
The operation of such FFDs is relatively simple, briefly, inlet flows were controlled via precision 
pumps and droplet formation was observed by placing the chip on a microscope connected to a 
high-speed camera. In case of mammalian cell encapsulation, sterility was one of the greatest 
concerns. Initially, contaminations were circumvented by strict standard operating procedures 
and the use of antibiotics during encapsulation. Later on, I installed a microfluidic encapsulation 
rig under completely sterile conditions within a laminar flow hood. Droplets exit the chip via an 
exit channel and can then be handled and analysed off-chip. When introducing a hydrogel 
precursor as aqueous phase, droplets can be turned into microgels upon polymerisation. Our 
group has previously shown the use of ultra-low melting agarose for microgel production (Kleine-
Bruggeney et al., 2019). Ultra-low melting agarose stays liquid at 37 °C (after initial melting at 
50 °C) and polymerises quickly upon cooling through physical cross-linking (Lahaye and 
Rochas, 1991). Additional advantages are that agarose is biologically inert, chemically defined, 
visually clear, compatible with most molecular biology techniques and if needed can be degraded 
via agarase treatment. For all my experiments I exclusively used LONZA’s SeaPrep® agarose in 
which hydroxyethylation reduced the melting and gelling temperature as well as gel strength. To 
keep the microgels as soft as possible I had to use the lowest agarose percentage possible. 
According to the manufacturer’s data, SeaPrep® agarose melts at temperatures below 37 °C when 
at a lower percentage than 1.5% (Figure 3.1 c). Hence, to ensure stable hydrogels at 37 °C in the 
incubator, all encapsulations were performed with 1.5% SeaPrep® agarose unless stated 
otherwise. According to the product information sheet, at a concentration of 1.5%, gel strength 
lays around 100 g/cm2 (~10 kPa) and is therefore several magnitudes softer than conventional 
tissue culture plastic which is in the range of GPa (Saruwatari et al., 2005) (Figure 3.1 d). Besides 
changing the substrate stiffness, microgels also suddenly offer a 3D scaffold to the cells, rather 
than a flat 2D surface. Depending on the experiments, cells needed to be cultured for different 
lengths. Therefore, microgel volumes would need to be changed as well. This was achieved by 
adjusting the channel diameter of the cross section at which droplet formation occurs. The most 
commonly used FFDs had channel widths of 75, 100 and 200 µm. Also, as the encapsulation 
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procedure, normally taking between 20 and 30 minutes, was assumed to be harsher on the cells 
than regular cell maintenance, I had to ensure good cell viability past encapsulation. However, 
2i+LIF cultured ESCs survived the micro-encapsulation surprisingly well. At 24 hours past 
encapsulation, ~90% of encapsulated cells were alive as determined by calcein-AM assay (Figure 
3.1 f). As no further increase in cell death was observed after 48 hours in culture, I considered 
the effects of the microgel encapsulation procedure on the overall cell viability as negligible. 
Besides showing no cell-toxicity, another of the advantages of low-melting agarose is its simple 
enzymatic degradability via agarase treatment, allowing cell retrieval at any given timepoint 
which is, for example, necessary for single cell sequencing or blastocyst injections. To determine 
the effects of agarase treatment on cell viability, I dissolved individual microgels and re-plated 
Figure 3.1 | Microfluidic 
encapsulation of mouse embryonic 
stem cells into agarose micro gels with 
subsequent in-gel suspension culture.  
a, Schematic illustration of a 
microfluidic flow focussing device 
(FFD). b, Microfluidic chip (1 &2), 
sterile microfluidic control module (3) 
cells being encapsulated into 
microdroplets at cross-section of FFD 
(4). c&d, SeaPrep® ultra-low meting 
agarose melting/gelling points and gel 
strength as supplied by manufacturer 
(LONZA). e, representative images of 
agarose microgels produced with 100 
µm and 200 µm FFDs, respectively. f, 
Viability analysis of cells 24 hours and 
48 hours after encapsulation. g, 
Efficiency of colony recovery from 
microgels after 24 hours and 48 hours in 
culture. h, Representative images of 
microgel cultured ESCs cultured in 
2i+LIF for up to 120 hours. 
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the previously encapsulated colonies back onto tissue culture plastic. When recovered 24- or 
48-hours past encapsulation, >90% of the released colonies attached and continued to proliferate 
(Figure 3.1 g). I therefore concluded, that agarase treatment had no measurable negative effects 
on cell viability. At this point, I have demonstrated that ESCs can be successfully encapsulated 
into microgels and even when using a rather unsophisticated material such as agarose, there is no 
appearance of negative effects on cell viability. Therefore, microfluidic-based encapsulation is a 
suitable tool for the culture and expansion of ESCs and offers the opportunity to ask questions 
regarding the impact of microenvironmental changes on e.g. pluripotency, self-renewal and 
differentiation. 
 
3.2.2 Microgel suspension culture of mouse embryonic stem cells promote ground state 
pluripotency 
Little is known about the influence of the microenvironment on embryonic stem cells, 
however, some studies claim that softer materials and three-dimensional culture environments 
support the pluripotency network (Caiazzo et al., 2016; Chowdhury et al., 2010a). Yet, the 
underlaying mechanisms of how microenvironmental changes might influence gene regulatory 
networks, and overall cell behaviour, remain poorly understood. In this paragraph I will be 
describing how I have made use of the previously described REX1::GFPd2 (RGd2) reporter cell 
line to investigate pluripotency in microgel encapsulated ESCs (Kalkan et al., 2017; Wray et al., 
2011). REX1, encoded by the gene Zfp42, is known to be expressed in the epiblast of the pre-
implantation embryo but sharply downregulated upon implantation into the uterus (Boroviak et 
al., 2014; Pelton et al., 2002). REX1 is also expressed in undifferentiated ESCs and has been 
associated with naïve state pluripotency (Toyooka et al., 2008; Wray et al., 2010). Therefore, 
tracking expression levels of REX1 via the destabilised GFP (GFPd2) enables a near real-time 
readout for naïve pluripotency in ESCs (Kalkan et al., 2017) (Figure 3.2 a). In vitro, ES cells can 
be maintained in an undifferentiated and self-renewing, pluripotent state in 2i+LIF medium. 
Under these conditions, ESCs grew as tightly packed colonies with individually indistinguishable 
cells (Figure 3.2 b). In 2i+LIF, ESCs show homogeneous naïve-state associated gene expression 
as measured by single-cell RNA-seq (Kolodziejczyk et al., 2015). This trait reflects in the 
homogeneous single-peak Rex1::GFPd2 reporter signal when analysed via flow cytometry 
(Figure 3.2 c). Upon transfer to N2B27 medium ESCs exited pluripotency and started to 
differentiate, individual cells became visible as they morphologically changed to form a flat 
monolayer of spread out cells (Figure 3.2 b). Within the first 24 hours after 2i+LIF removal, cell 
shape changed but most cells remained GFP positive (Figure 3.2 c). However, after 48 hours the 
majority of cells had lost the GFP signal and successfully exited naïve pluripotency (Figure 
3.2 c). In contrast, cells cultured under S+LIF 




Figure 3.2 | The Rex1::GFPd2 reporter system. a, Schematic illustration of the Rex1::GFPd2 reporter system 
in mouse embryonic stem cells (ESC). REX1 is expressed during naive pluripotency and abruptly downregulated 
upon differentiation. Within 48 hours of culture in N2B27 medium, all cells have differentiated and lost the 
Rex1::GFPd2 reporter signal. b, Representative images of ESC cultured in 2i+LIF (pluripotent and self-renewal 
conditions) or in N2B27 (differentiation conditions). Pluripotent ESC form tight dome-shaped colonies in which 
individual cells are indistinguishable. Upon differentiation, cells start to spread and form a flat monolayer. c, 
Flow cytometric analysis of Rex1::GFPd2 ESC in 2i+LIF or after 24 hours and 48 hours differentiation in 
N2B27. d&e, representative images of 2i+LIF and S+LIF cultured ESCs on conventional tissue culture plastic 
(TCP) and after being microgel encapsulated. f, Schematic illustration of the dissociation of microgels and cells 
for subsequent flow-cytometric analysis. g, Flow-cytometric analysis of Rex1::GFPd2 cells in 2i+LIF and S+LIF 
on TCP and in microgels (N=3). h, Representative confocal images of S+LIF cultured ESCs on TCP and in 
microgels stained for the naïve transcription factors TFCP2L1 and KLF4. 
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conditions are morphologically and transcriptionally distinct from 2i+LIF cells (Kolodziejczyk 
et al., 2015). The attribute of homogeneity, transcriptionally as well as morphologically, is lost 
under S+LIF conditions (Chambers et al., 2007; Toyooka et al., 2008). ESCs in S+LIF are still 
pluripotent and self-renewing but show great heterogeneity across these properties, manifesting 
in a bimodal GFP distribution (Toyooka et al., 2008). Morphological heterogeneity became 
apparent as some cells still grew in the typical dome-shaped structure, whereas predominantly 
cells started to flatten out (Figure 3.2 d). In contrast to conventional tissue culture plastic, once 
microgel encapsulated, ESCs grew as morphologically homogeneous colonies regardless of their 
media conditions (Figure 3.2 e). I next investigated, whether this shift towards homogeneity also 
happened on transcriptional level and not just morphologically. Therefore, RGd2 cells were 
cultured in 2i+LIF and S+LIF medium, subsequently the GFP signal was analysed via flow 
cytometry to assess the level of pluripotency (Figure 3.2 f&g). As expected, all cells in 2i+LIF, 
whether cultured on plastic or microgel encapsulated, were GFP positive. Also, cells cultured in 
S+LIF exhibited the above described heterogeneity with about ~50% of cells being GFP positive 
when cultured on plastic. However, when these cells were transferred to S+LIF and their 
pluripotency was assessed after 48 hours of in-gel culture, I was surprised to see that this number 
had risen to ~70% of cells expressing GFP. As this 20% increase indicated a shift of the cell 
population towards naïve pluripotency I next investigated the expression levels of TFCP2L1 and 
KLF4, additional members of the naïve gene regulatory network (Boroviak et al., 2014; Martello 
et al., 2013), via immunofluorescence staining (Figure 3.2 h&i). Notably, TFCP2L1 displayed a 
heterogeneous expression pattern with only a fraction of the cells (~36%, n=478) being positive 
for TFCP2L1 when cultured on plastic in S+LIF medium (Figure 3.2 h). KLF4 positive cells 
appeared rarely (~26%, n=320) and as small clusters surrounded by KLF4 negative cells (Figure 
3.2 h). Consistent with the increased Rex1::GFP signal, I also observed the majority of cells being 
positive for TFCP2L1 and KLF4 when cultured in microgels (Figure 3.2 h). Taken together, 
these data show that microgel culture of ESCs in S+LIF medium leads to a higher degree of 
morphological and transcriptional homogeneity compared to regular tissue culture plastic. 
Finally, these effects appear to be converging on promoting the naïve pluripotency gene 
regulatory network, however, extensive single-cell RNA-seq analysis will be necessary to 
validate this claim. 
 
3.2.3 Systemic changes across the transcriptome stabilise the pluripotency network in 
microgel cultured embryonic stem cells 
The previously described observations regarding microgel induced promotion of ground 
state pluripotency, the increase in the expression of naïve transcription factors like TFCP2L1 and 
KLF4, led us to ask the question whether just a few individual (pluripotency) genes were affected  




Figure 3.3 | RNA-seq analysis of microgel encapsulated ESC vs conventionally cultured ESC in 2i+LIF. a, 
Experimental set-up for whole genome RNA-seq analysis. Embryonic stem cells were cultured under 2i+LIF 
conditions and sequenced either directly from conventional tissue culture plastic or after 48 h of in-gel suspension 
culture. b, Scatterplot of log2-fold differentially regulated genes c, STRING protein-protein interaction network 
analysis. After top 200 upregulated genes (according to log2(normalised counts)) were then sorted by significance 
(padj) and plotted with STRING. Each node represents a protein (splice isoforms and post-translational modifications 
collapsed). The network edges represent protein interactions based on text mining, experiments, databases, 
co-expression, neighbourhood, gene fusion and co-occurrence (line thickness indicates the strength of data support). 
Hence, edges represent but do not ineluctably mean that these proteins physically bind to each other. d&e, Gene 
ontology analysis for biological processes and cellular components. | All RNA-seq was performed in collaboration 
with Joachim de Jonghe, Department of Biochemistry, University of Cambridge. 
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or if there was a more global change in transcription. However, due to the inherent heterogeneity 
of S+LIF cultured cells (Kolodziejczyk et al., 2015), they were unsuitable for bulk RNA 
sequencing (RNA-seq) analysis as I would be averaging transcripts across different cells. I 
hypothesized, that microgel culture would affect cells cultured in 2i+LIF, which are more 
homogeneous in gene expression and therefore suitable for bulk RNA-seq, in a similar fashion as 
it does in S+LIF cultured cells – by promoting pluripotency. Consequently, I decided to perform 
RNA sequencing on ESCs cultured in 2i+LIF from regular tissue culture plastic (TCP) and 48 
hours past encapsulation (Figure 3.3 a). Indeed, on global level I have observed a >log2-fold 
change in 1449 up- and 927 downregulated genes when cultured in microgels compared to TCP 
(Figure 3.3 b). I then took the top 200 (by log2-fold change) upregulated genes and sorted them 
by their significance (adjusted p-value). Subsequently, I used the STRING software (von Mering 
et al., 2005) to analyse potential protein-protein interactions networks amongst the 100 most 
differentially regulated genes (Figure 3.3 c). I then used gene ontology (GO) analysis (Ashburner 
et al., 2000) to further investigate the protein functions and localisations of the upregulated genes 
(Figure 3.3 d&e). Upregulated genes were predominantly be clustered into pluripotency, 
chromatin structure/modifications and RNA metabolism associated groups. GO terms for 
biological processes include “negative regulation of WNT signalling pathway involved in 
dorsal/ventral axis specification”, “regulation of the canonical WNT signalling pathway” and 
“cellular response to leukaemia inhibitory factor” based on the upregulation of Sfrp1, Axin2 and 
the Klfs (Figure 3.3 d). GO terms for cellular components include the “spliceosomal complex”, 
“nuclear chromatin”, “integral components of membrane” and “nuclear transcription factor 
complex” (Figure 3.3 e). I also utilized the KEGG pathway enrichment tool (Kanehisa and Goto, 
2000), which highlighted the “Signalling pathways regulating pluripotency of stem cells” 
pathway, based on the upregulation of Axin2, Esrrb, Pou5f1, Sox2 and Klf4. Taken together, these 
data show transcriptomic adjustments on a global level. These adjustments originated from an 
accumulation of several small changes rather than a few individual genes that were drastically 
differentially regulated. Due to the extent of changes in gene expression I had to ensure next, that 
microgel cultured cells did not transit into an artificial state or have lost any of their original 
function. Therefore, I encapsulated H2B-turquoise (H2B-tq) tagged ESCs and cultured them for 
48 hours in 2i+LIF medium (Figure 3.4 a). Subsequently to in-gel culture, I released the colonies 
from the microgels and dissociated the colonies into single-cell suspension. I then injected several 
cells (~5 cells/embryo) into the developing 8-cell stage embryos (n=11) and cultured them in 
vitro until the blastocysts stage. Embryos were then fixed and immunostained for Lamin B1 
(nuclear envelop protein) and SOX2 (epiblast marker) (Figure 3.4 b). The injected cells 
integrated into the embryos, with about 70% of them being positive for H2B-tq signal within the 
epiblast (Figure 3.4 c). None of the chimeric embryos showed extraembryonic potential of the 
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microgel cultured ES cells. Now, after having confirmed that microgel encapsulated cells have 
not lost their potential to contribute to the developing embryo, even though they show a distinct 
gene expression pattern compared to TCP cultured cells, I had a closer look at the expression 
levels of general and naïve state associated transcription factors (Figure 3.5 a&b) as described 
by Boroviak and colleagues (Boroviak et al., 2014). Surprisingly, even amongst the core 
pluripotency genes Pou5f1 (OCT4), Nanog and Sox2 I detected changes. Pou5f1 and Sox2 were 
significantly upregulated whereas Nanog was slightly downregulated. Within the group of naïve 
transcription factors, Esrrb, Tbx3, Tfcp2l1 and the Klfs were upregulated, all of which are 
downstream targets of the LIF and WNT signalling pathways (Hall et al., 2009; Martello et al., 
Figure 3.4 | In-gel cultured embryonic stem cells readily integrate into the developing epiblast after injection 
into 8-cell embryos. a, Schematic illustration of the injection preparation and procedure. Several cells were injected 
per embryo. b, Confocal images of chimeric and non-chimeric blastocysts after cell injection and in vitro culture. 
Injected cells had a nuclear H2B-turquoise (H2B-tq) reporter and the embryos were additionally stained for Lamin B1 
and SOX2. c, Chimera contribution efficiency of cells injected during the 8-cell stage (n=11). | Injections were 
performed by Dr Ayaka Yanagida, Cambridge Stem Cell Institute. 
Figure 3.5 Microgel cultured embryonic stem cells display adjustments across their pluripotency gene 
regulatory network. a, Log2 normalised counts of general pluripotency transcription factors (N=3). b, Log2 
normalised counts of naïve pluripotency transcription factors. c, Confocal z-slice images of TCP and microgel cultured 
ESCs stained for OCT4, KLF4 and TFCP2L1. 
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2013; Martello et al., 2012; Qiu et al., 2015; Renard et al., 2007). One may note that Zfp42 
(REX1) expression levels slightly dropped, coinciding with the reduced GFP signal when 
analysed by flow cytometry (Figure 3.6 a&b). Taken together, these data show a global 
transcriptomic change that facilitated through cumulative changes across several groups of genes 
regulating chromatin structure, RNA metabolism and pluripotency. In particular, pluripotency 
appears to be re-wired to as genes changes across the general and naïve gene regulatory networks. 
Nevertheless, microgel cultured cells can readily incorporate into the developing embryo where 
they contribute exclusively to the epiblast.  
 
3.2.4 Microgel adjusted LIF and WNT signalling delays the exit from naïve pluripotency 
The upregulation of LIF and WNT signalling targets within the pluripotency network 
prompted us to investigate if encapsulated cells can readily exit the naïve state or if the exit is 
delayed. Therefore, I transferred microgel encapsulated and TCP cultured RGd2 cells from 
2i+LIF medium into differentiation permissive N2B27 medium and measured the GFP signal via 
flow cytometry at several time points over the course of 48 hours (Figure 3.6 a&b). The GFP 
signal consistently diminished at equal rates in encapsulated and TCP cultured cells. Consistent 
with previous studies (Kalkan et al., 2017), after 48 hours almost all cells (>99%) had lost their 
GFP signal and had therefore successfully exited the state of naïve pluripotency. Downregulation 
of the naïve network was additionally confirmed via immunostaining for OCT4, KLF4 and 
b-catenin (Figure 3.6 c) . In contrast to conventional culture on TCP, differentiating cells in 
agarose microgels did not change their morphology as seen by the b-catenin distribution. 
However, after 48 hours in N2B27 the naïve marker KLF4 was completely absent from these 
cells while OCT4 levels were only slightly decreased (Figure 3.6c&d). As any dual combination 
of the components of 2i+LIF is able to maintain naïve pluripotency (Wray et al., 2010; Ying et 
al., 2008), I tested the differentiation capacities of RGd2 cells in the presence of either just LIF, 
PD or CH. As expected, in all three conditions maintenance of the pluripotency network was 
prevented and cells initiated the exit from naïve pluripotency, however differentiation kinetics 
were delayed compared to differentiation in N2B27 (Figure 3.7 a-c). LIF and CH appeared to be 
the more potent signals to maintain the naïve state as ~80% and ~70% respectively were still GFP 
positive 48 hours after removal of 2i. Initially, there was no change between TCP and microgel 
cultured cells after 48 hours of LIF only, however, after 72 hours microgel cultured cells were 
still ~60% GFP-positive whereas TCP cultured cells were reduced to ~23%. This finding 
indicates, that indeed the WNT signalling pathways appeared to be partially activated by microgel 
culture even in the absence of CH. The differences between TCP and microgel culture were less 
striking in the case of CH only culture. This might be due to the effect, that CH alone is already  
  





Figure 3.6 | Microgel culture does not inhibit the exit from naive pluripotency. a&b, 
Flow cytometric analysis of the Rex1::GFP reporter as cells exit naive pluripotency in 
differentiation permissive N2B27 medium. c, Confocal images (single z-slice) of microgel 
encapsulated embryonic stem cells in 2i+LIF medium and after 48 h in N2B27. Cells were 
stained for OCT4 (general pluripotency), KLF4 (naïve pluripotency) and b-catenin. d, 
Fluorescence intensity measurements of OCT4 and KLF4 in 2i+LIF (n=359) and N2B27 
(n=458) medium. 
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a strong signal and maintains half of the cell population in a GFP-positive state when cultured on 
TCP. However, I still detected a ~15% increased GFP signal in the microgel cultured cells 
compared to TCP after 48 hours. Hence, microgels appears to be supporting the LIF signalling 
pathway even though not to the extend as they do support the WNT signalling pathway. I did not 
further focus on PD only, as the majority of cells had exited naïve pluripotency after 48 hours. 
Due to these findings and our earlier GO-term analysis (Figure 3.3 d) that highlighted the 
responsiveness of the LIF and the WNT signalling pathways to microgel culture, I further 
scrutinised the expression of their signalling components and targets (Figure 3.7 d-i). Indeed 
both, the target and negative feedback regulator of LIF signalling Socs3 (Nicholson et al., 1999) 
and of WNT signalling Axin2 (Jho et al., 2002) were significantly upregulated in 2i+LIF cultured 
cells when encapsulated in microgels (Figure 3.7 d). Interestingly, I did not observe any drastic 
transcriptional changes in the components of the LIF and WNT signalling pathways (Figure 
3.7 f&h). However, exclusively all LIF signalling targets as defined by Martello and colleagues 
(Martello et al., 2013) as well as the known WNT targets Esrrb, Sp5, Tbx3 and Cdx1 (Boroviak 
et al., 2014; Renard et al., 2007; Wray et al., 2011; Ye et al., 2016) were upregulated (Figure 3.7 
g&i). Concluding, these data show that microgel encapsulated ESCs can readily exit naïve state 
pluripotency with similar kinetics as TCP cultured cells. However, slowed differentiation kinetics 
became apparent in response to single activation of the LIF or WNT signalling pathways, 
Figure 3.7 | Microgel encapsulated ESCs display enhanced activation of WNT/b-catenin and LIF/STAT3 targets 
under naïve culture conditions. a, b & c, Rex1::GFPd2 positive cells as measured by flow cytometry after 48 and 72 
hours of culture in N2B27 with either LIF, CH or PD (N=3). d, Log2 normalised count for the LIF/STAT3 signalling 
target Socs3 and the WNT/b-catenin signalling target Axin2 under naïve conditions (N=3). e, Confocal z-slice images 
of TCP and microgel cultured ESC stained for SOCS3. f&g, Log2 normalised counts for LIF/STAT3 signalling 
members and targets. h&i, Log2 normalised counts for WNT/b-catenin signalling members and targets. 
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potentially explained by a partial compensatory activation of the pluripotency network by the 
microgel culture.  
 
3.2.5 Microgel culture leads to structural rearrangement of adherens junctions  
Intrigued by the enhanced activity of the WNT and LIF signalling pathways, I was 
wondering if these observations were independent events or have been potentially co-activated 
by an upstream regulator. b-catenin (Ctnnb1) is an integral component of the canonical WNT 
signalling pathway (Rudloff and Kemler, 2012) and E-cadherin (Cdh1) is crucial for the proper 
activation of the LIF signalling cascade (del Valle et al., 2013). Both proteins are also core 
components of the membrane localised adherens junctions (Harris and Tepass, 2010). Therefore, 
I went back to our RNA-seq data set and had a closer look at the expression levels of the 
individual components of adherens junctions. To our surprise, neither Cdh1 or Ctnnb1 were 
differentially expressed (Figure 3.8 a). a-catenin, which acts as the linker protein between 
adherens junctions and the cytoskeleton, appeared to be slightly reduced in its expression when 
cultured in microgels. However, I then found the b-catenin homologue plakoglobin (Jup 
[Junctional plakoglobin]) and another armadillo protein, p120-catenin (Ctnnd1), to be 
significantly upregulated. Interestingly, plakoglobin was overall one of the most differentially 
regulated proteins between plastic and microgel culture. To confirm that the transcriptional 
Figure 3.8 | Microgel encapsulated embryonic stem cells upregulate plakoglobin under naïve culture conditions. 
a, Log2 normalised expression levels as measured by RNA-seq for the adherens junction components E-cadherin 
(Cdh1), b-catenin (Ctnnb1), a-catenin (Ctnna1), p120 (Ctnnd1) and plakoglobin (Jup) (N=3). b-f, confocal images of 
TCP and microgel cultured cells immunostained for (b) E-cadherin, (c) b-catenin, (d) a-catenin, (e) p120 and (f) 
plakoglobin. Nuclei were stained with Hoechst. g, Plakoglobin staining intensity measured across a single cell as 
indicated in (f) with a red line. 
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changes actually had influence on the protein level, I immunostained RGd2 cells in 2i+LIF 
medium, cultured on TCP or in microgels, for the different adherens junction proteins – 
E-cadherin, a-catenin, b-catenin, p120 and plakoglobin (Figure 3.8 b-f). In general, protein 
levels were corresponding precisely to the measured transcript levels, however on a closer look 
some deviation became apparent. E-cadherin levels remained stable in both conditions whereas 
b-catenin, even though no differences were detectable on transcriptional level, showed 
heterogeneity in its protein level. This heterogeneity was obvious between different colonies, but 
not within the same colony. Equally, a-catenin displayed a similar heterogeneity across different 
colonies with some being high and other low in expression. Now, for p120, which showed a clear 
increase on transcriptional level, I could not detect a clearly quantifiable increase in protein via 
immunofluorescence. Yet, all the previously mentioned fluctuations become negligible when 
considering the dramatic changes of plakoglobin. On conventional TCP, embryonic stem cells 
exhibited extremely low levels of plakoglobin, whereas encapsulated cells showed strong 
plakoglobin signal (>2-fold increase intensity compared to TCP), mostly in association with the 
cell membrane (Figure 3.8 f&g). As I had observed drastic morphological changes of S+LIF 
ESCs when cultured in microgels, I was wondering if these changes were concomitant with 
adjustments in the adherens junction’s structure, similar to the upregulation of plakoglobin under 
Figure 3.9 | Microgel suspension culture of embryonic stem cells leads to structural 
reorganisation of adherens junctions in S+LIF medium. a, S+LIF cultured cells on TCP 
or microgel encapsulated were stained for E-cadherin. b, E-cadherin immunostaining 
intensity and diameter at the cell membrane. d&d, S+LIF cultured cells on TCP or microgel 
encapsulated were stained for b-catenin or plakoglobin and OCT4. 
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2i+LIF conditions. Therefore, I immunostained RGd2 cells cultured in S+LIF for E-cadherin, 
b-catenin and plakoglobin (Figure 3.9 a-d). The previously observed changes in the cells’ 
phenotype indeed coincided with a rearrangement of adherens junction components. ESCs in 
S+LIF show E-cadherin along their membrane but not in their cytoplasm (Figure 3.9 a). In 
contrast, upon encapsulation E-cadherin signal became increasingly diffuse, instead of detecting 
a clear membrane localisation, now E-cadherin was also located in the cytoplasm (Figure 
3.9 a&b). If E-cadherin can be found in the cytoplasm in encapsulated cells, the E-cadherin 
associated protein b-catenin and plakoglobin should display a similar distribution. Indeed, both 
proteins were found to have dissociated from the membrane as shown by strong cytoplasmic 
signal (Figure 3.9 c&d). Conclusively, microgel culture of ESCs triggered an upregulation of 




In this chapter I have introduced and explained the microfluidic-based encapsulation of 
mouse embryonic stem cells (ESCs) into microgels. The relatively humble needs of ESCs on their 
microenvironment, when maintained as self-renewing and pluripotent cells, enabled the use of 
such a simple hydrogel as agarose for the scaffold material. Agarose is perfectly compatible with 
microfluidics and most techniques used in molecular biology, it is also chemically defined, 
biologically inert and easy to work with. These are all clear advantages of agarose. On the other 
hand, because biologically inert, agarose does not supply any extra cellular matrix and is also not 
degradable by the cells on their own. Nonetheless, it appears to be a suitable material for the 
culture of ESCs under pluripotent conditions, as they can proliferate over several days without 
any observable negative implications. Yet, initially we knew very little about the effects of 
microgel culture on pluripotency and these cells in general. When culturing heterogeneous S+LIF 
ESCs in microgels, the most prominent change was their adjusted morphology. Suddenly these 
cells had lost the typical, spread out morphology and turned into something, resembling what we 
normally associate with the dome-shaped colonies in 2i+LIF medium. I then confirmed this 
observation of morphological homogeneity on transcriptional and protein level via the 
Rex1::GFP transcriptional reporter and immunostainings. The naïve-state associated 
transcription factors REX1, TFCP2L1 and KLF4 (Boroviak et al., 2014; Martello et al., 2013), 
all appeared to be upregulated when S+LIF cells were cultured in microgels. Postulating that this 
‘boost’ towards naïve pluripotency was inherent to microgel culture, and should therefore also 
act on 2i+LIF cultured cells, I performed RNA-seq analysis of these cells and compared them to 
cell grown on conventional tissue culture plastic. This approach allowed me to elucidate changes 
on a global level – because so far, I had little knowledge of what could potentially regulate 
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pluripotency upstream when cells were microencapsulated. Indeed, even in 2i+LIF I was able to 
detect the hypothesised microgel induced ‘boost’ of pluripotency. Most naïve state associated 
transcription factors, including Tfcp2l1, Esrrb, Klf2, Klf4 and Klf5, were expressed at higher 
levels than on plastic whilst simultaneously detecting differential regulation of the core 
pluripotency genes Pou5f1, Sox2 and Nanog. Unbiased gene ontology analysis of the top 100 
differentially regulated genes elucidated the microgels influence on the regulation of the WNT 
and LIF signalling pathways as well as spliceosomal regulation and chromatin modifications. 
Because ESCs in 2i+LIF are considered to be naïve and closely resemble the E4.5 epiblast 
(Boroviak et al., 2014; Plusa and Hadjantonakis, 2014), I was concerned that the extend of 
transcriptional changes would be an artificial state with unwanted cell properties – e.g. losing the 
ability to integrate into the developing embryo. However, when injecting microgel cultured ESCs 
into the 8-cell embryo, no integration disabilities were observed. Pleased to see that microgel 
cultured cells did not display any obvious disadvantages in chimera contribution in comparison 
to the wild type cells, I was then investigating the encapsulated cells ability to exit naïve 
pluripotency. When microgel cultured cells were transferred to differentiation permissive N2B27 
medium, the Rex1::GFP reporter was downregulated at similar kinetics as in the conventionally 
cultured cells. This finding and the absence of the naïve transcription factor KLF4, as confirmed 
via immunostaining, indicated the cells ability to exit the naïve state despite the differentially 
regulated pluripotency network. However, when N2B27 was supplemented with LIF or CH, the 
exit from pluripotency was significantly prolonged in microgel cultured cells, suggesting a partial 
activation of the pluripotency maintenance pathways by the microgel. The LIF and WNT 
signalling pathways converge at the adherens junctions. E-cadherin, crucial for LIF signalling 
(del Valle et al., 2013), and b-catenin, an essential component of canonical WNT signalling, both 
are key components of the adherens junction complex. The enhanced activation of both of these 
signalling pathways prompted me to further investigate the adherens junction complex. In S+LIF 
conditions, microgels cultured cells underwent a structural reorganization of their adherens 
junctions, with E-cadherin and b-catenin being found not just at the membrane, but also in the 
cytoplasm. Interestingly, in 2i+LIF the reorganisation of adherens junctions was mainly due to 
the dramatic upregulation of plakoglobin. Plakoglobin is a homologue of b-catenin and has been 
implicated to be potentially involved in WNT signalling. However, it’s signalling functions and 
how they differ from b-catenin remain elusive. In the next chapter I will be investigating 
plakoglobin’s role in mouse embryonic stem cells, its potential role in pluripotency and how it 
might differ from the known b-catenin signalling cascade.  
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In the last chapter I have introduced a microgel culture system for mouse embryonic stem 
cells and elucidated the microenvironmentally induced changes in cell morphology, pluripotency 
and transcription. Amongst the differentially regulated genes between conventional 2D tissue 
culture and 3D microgel culture, I identified Jup, a gene encoding a protein named ‘junctional 
plakoglobin’, as one of the most upregulated genes upon cell encapsulation. Plakoglobin (also 
known as g-catenin) is a ~82 kDa protein, that has originally been identified in desmosomes 
(Cowin et al., 1986; Franke et al., 1983), where it connects the cell membrane to intermediate 
filaments via linkage of desmocollin and desmoglein to desmoplakin (Kowalczyk et al., 1997; 
Troyanovsky et al., 1994a; Troyanovsky et al., 1994b). Plakoglobin, like most catenins, belongs 
to the group of armadillo proteins and is a closely related homologue of b-catenin, the mammalian 
homologue of armadillo in Drosophila (Butz et al., 1992b; McCrea et al., 1991b; Peifer et al., 
1992a). Plakoglobin and b-catenin have an overall high sequence similarity (~69%), especially 
their central regions, which in both proteins consist of 13 armadillo repeats (Butz et al., 1992b; 
Hatzfeld, 1999). Albeit preferentially localised at desmosomal plaques, plakoglobin, just like 
b-catenin, can also bind to E-cadherin and be incorporated into cell-cell adherens junctions (Butz 
and Kemler, 1994; Knudsen and Wheelock, 1992). The formation of this cadherin-catenin-
complex (CCC) is facilitated through the cytoplasmic catenin-binding domain (CBD) 
encompassing amino acid positions 832-862 (Ozawa et al., 1990). Interestingly, interaction 
between the CBD acts in a mutually exclusive fashion, resulting in either E-cadherin/b-catenin 
or E-cadherin/plakoglobin CCC formation (Butz and Kemler, 1994; Hinck et al., 1994; Nathke 
et al., 1994). In addition to their interaction with E-cadherin, plakoglobin and b-catenin also bind 
directly to a-catenin and vinculin, which in turn bind to a-actinin and thereby connect the cell 
membrane with the cytoskeleton (Huber et al., 1997). So far, no differential function has been 
observed between these different types of CCCs, suggesting that plakoglobin and b-catenin have 
similar or identical function in the formation of adherens junctions. All the above studies have 
focussed on adhesion properties but largely omitted signalling functions of catenins. Yet, just like 
b-catenin, plakoglobin has a dual functionality in cell-cell adhesion whilst simultaneously acting 
as a signalling molecule. Especially in cancer biology, b-catenin and plakoglobin have gained 
special interest since both proteins, despite their structural similarity, have opposing signalling 
functions. On the one site, hyperactive b-catenin signalling has been shown to have powerful 
oncogenic potential (Korinek et al., 1997), whereas plakoglobin has been implicated in 
functioning as a tumour suppressor (Alaee et al., 2018; Charpentier et al., 2000; Sechler et al., 
2015; Simcha et al., 1996). During embryonic development, formation of the CCCs is of crucial 
importance for maintaining structural integrity of the embryo. Any single homozygous knockout 
of the components of the CCCs is embryonically lethal. Whilst E-cadherin and a-catenin 
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knockout embryos fail to undergo compaction (Larue et al., 1994; Riethmacher et al., 1995; 
Torres et al., 1997), p120 (d-catenin) knockout embryos arrest only around E8.5 showing distinct 
abnormalities in axis formation (Hernandez-Martinez et al., 2019). Both, plakoglobin and 
b-catenin null embryos, show no defects during pre-implantation development but die at different 
stages post-implantation. b-catenin null embryo development arrests ~E7.0 due to the lack of 
mesodermal differentiation whilst plakoglobin null embryos develop until ~E10.5 at which they 
die due to severe failure in heart and skin formation (Bierkamp et al., 1996; Haegel et al., 1995; 
Huelsken et al., 2000b; Ruiz et al., 1996). Consequently, plakoglobin and b-catenin can substitute 
for one another in the adherens junctions during compaction, but fail to take on more specific 
roles during gastrulation and desmosome formation, respectively. When inducing hyperactive 
b-catenin mediated transcription via its stabilisation, embryos undergo premature 
epithelial-to-mesenchymal transition and display T(Bra)-positive cells in their anterior site 
(Kemler et al., 2004). To my knowledge, there are no studies investigating the overexpression of 
plakoglobin in mammalian embryos, however, injection of plakoglobin mRNA into fertilized 
Xenopus eggs leads to axis duplication reminiscent to ectopic expression of int-1 (WNT1), 
b-catenin or treatment with an antibody against b-catenin antibody (Karnovsky and 
Klymkowsky, 1995; McCrea et al., 1993; McMahon and Moon, 1989). These were some of the 
first experiments indicating plakoglobin’s potential involvement during developmental 
signalling, however, no follow-up studies have been performed regarding mammalian 
embryogenesis. Despite the embryos ability to develop without b-catenin until implantation, 
WNT/b-catenin signalling has been shown to be extremely beneficial for the maintenance of 
mouse embryonic stem cells during naïve pluripotency (Ying et al., 2008). An observation that 
can be mostly attributed to the alleviating effect of b-catenin on the repressive function of TCF3 
(Tcf7l1) on the pluripotency network (Lyashenko et al., 2011; Wray et al., 2011). Interestingly, 
Mahendram and colleagues have shown that plakoglobin can, albeit at lower efficiency, rescue 
TCF/LEF mediated transcription in b-catenin knockout cells (Mahendram et al., 2013). However, 
plakoglobin’s contribution to WNT induced signalling has still to be fully deciphered. 
Remarkably, upon transition from naïve ESCs to primed pluripotency in EpiSCs, the role of 
b-catenin mediated transcription switches from maintaining pluripotency to induce 
differentiation (Kim et al., 2013; Sumi et al., 2013). Consistent with these findings, 
overexpression of b-catenin in conventional hPSCs, also leads to differentiation (Sun et al., 2017). 
However, contrary to naïve mouse ESCs, b-catenin signalling does not show naïve pluripotency 
promoting effects when reset to naïve-like pluripotency. Hence, its inhibition rather than its 
activation supports the naïve pluripotency network (Zimmerlin et al., 2016). Neither b-catenin 
nor plakoglobin are necessary for self-renewal in conventional hPSCs, however, plakoglobin’s 
effects on pluripotency have not yet been studied (Sun et al., 2017). Generally speaking, due to 
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the complex interactions between plakoglobin and b-catenin, and their dual functionality as 
adhesion-mediating and signal-transducing proteins, the underlaying mechanisms remain largely 
unclear. In this chapter I will be elucidating plakoglobin’s role in the establishment of naïve 
pluripotency in mouse embryonic stem cells and embryonic development. Further, I will be 
investigating plakoglobin in human pluripotent stem cells, naïve and primed, as well as during 
embryonic pre-implantation development. Finally, I shall explore plakoglobin expression in a 
new model system, the common marmoset.  
 
  




4.2.1 Generation and characterisation of a plakoglobin overexpressing mouse embryonic stem 
cell line 
Due to the microgel induced upregulation of plakoglobin and its accompanied 
upregulation of pluripotency transcription factors, I hypothesised that plakoglobin might play a 
role in the maintenance and establishment of naïve state pluripotency. Therefore, I used the RGd2 
cell line as my starting material to generate a plakoglobin (Gene name: Jup) overexpressing cell 
line (PG OE). I assembled a plasmid containing mouse Jup under the control of the CAG 
promotor (Niwa et al., 1991). The Jup gene was followed by a T2A self-cleaving peptide (Ahier 
and Jarriault, 2014; Daniels et al., 2014) which itself was followed by an mCherry reporter 
(Figure 4.1 a). With this construct, I was able to have a fluorescent readout of the transcriptional 
level of the Jup transgene in addition to the Rex1::GFPd2 reporter for naïve state pluripotency. I 
used the PiggyBac transposon system (Li et al., 2013) for stable cell line generation. After 
transfecting the RGd2 cells with the Jup-T2A-mCherry and the PiggyBac plasmid, I expanded 
the cells for several days before than sorting the mCherry-GFP double positive cells via FACS 
(Figure 4.1 b). To ensure that mCherry positive cells overexpress plakoglobin, I then confirmed 
the actual plakoglobin protein levels by immunofluorescence staining (Figure 4.1 c). The “wt” 
RGd2 cells showed very little plakoglobin, irrespectively of their media conditions (S+LIF or 
2i+LIF). In contrast, the PG OE cells displayed a tremendous increase of plakoglobin protein 
level, and as expected, the mCherry reporter signal positively correlated with the amount of 
plakoglobin. As I did not start from a single clone, but sorted a bulk population of mCherry/GFP 
double positive cells, I was not surprised to find a heterogeneous mixture of mCherry, and 
therefore plakoglobin expression (Figure 4.1 c). However, I did not expect its differential cellular 
localisation, depending on the plakoglobin expression level. Plakoglobin seems to initially 
saturate the cell membrane, and only when passing a certain threshold, it started to accumulate in 
the cytoplasm and the nucleus (Figure 4.1 c). This phenomenon was observed in S+LIF and 
2i+LIF. When investigating cell morphology, RGd2 and PG OE cells were indistinguishable 
when cultured in 2i+LIF (Figure 4.1 d). Yet, when cultured under S+LIF conditions, PG OE cells 
acquired a tighter and dome-shape appearance, normally associated with naïve pluripotency in 
2i+LIF medium. I then quantified this change in cell shape by measuring the aspect ratio of 
individual cells (Figure 4.1 e). RGd2 cells in 2i+LIF showed a mean aspect ratio of 1.4 (n=15) 
and of 2.8 (n=17) S+LIF, reflecting the previously described differences in morphology. 
Interestingly, PG OE cells in S+LIF exhibited a mean aspect ratio of 1.2 (n=17) confirming our 
observation of being more similar to 2i+LIF associated morphology (Figure 4.1 d&e). It has 
previously been shown, that the knockout of b-catenin (Ctnnb1) leads to a compensatory 
upregulation of plakoglobin (Sun et al., 2017). In return, I was intrigued if the upregulation of 
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plakoglobin leads to a decrease in b-catenin levels. Thus, I also immunostained the RGd2 and 
PG OE cells for b-catenin, and additionally p120 (d-catenin) (Figure 4.1 f&h). In 2i+LIF 
medium, RGd2 and PG OE cells both show similar levels of b-catenin with a slight reduction in 
the PG OE cells (Figure 4.1 f). However, under S+LIF conditions, in which GSK3 is not inhibited 
by CH, b-catenin levels drop to almost undetectable levels in the PG OE cells, whereas the RGd2 
cells show strong expression of b-catenin. PG OE cell behaviour was therefore consistent with 
the previous studies showing a reciprocal protein level between b-catenin and plakoglobin (Sun 
et al., 2017) (Figure 4.1 g). One may note that p120 (d-catenin) remained largely unaffected by 
plakoglobin overexpression (Figure 4.1 h), most likely due to an E-cadherin binding epitope 
Figure 4.1| Generation and characterisation of a mouse embryonic stem cell line overexpressing plakoglobin. 
a, Schematic illustration of the PiggyBac transfection of the RGd2 (Rex1::GFPd2 reporter) cell line with the 
plakoglobin overexpression construct (Jup-T2A-mCherry). b, Subsequently to PiggyBac transfection, cells were 
sorting according to their GFP and mCherry signals. Double positive cells were bulk sorted (sorting gate as indicated) 
and were expanded in 2i+LIF medium to generate the PG OE cell line. c, Confocal images of RGd2 and PG OE cells 
stained for Plakoglobin in 2i+LIF and S+LIF medium. d, Phase contrast images of RGd2 and PG OE cells in 2i+LIF 
and S+LIF. e, Aspect ratio measurements of RGd2 and PG OE cells. f, Confocal images of RGd2 and PG OE cells 
stained for b-catenin in 2i+LIF and S+LIF medium. g, Schematic illustration of plakoglobin and b-catenin protein 
levels in the RGd2 and PG OE cells. h, Confocal images of RGd2 and PG OE cells stained for p120 in 2i+LIF and 
S+LIF medium. 
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separate of b-catenin and plakoglobin (Daniel and Reynolds, 1995; Shibamoto et al., 1995). Once 
I had confirmed the successful generation of a plakoglobin overexpressing ES cell line, I next 
had to investigate if there were any downstream effects regarding the state of pluripotency. As I 
had previously observed an upregulation of the REX1::GFPd2 reporter when S+LIF cultured cells 
were microgel encapsulated, I was wondering if the forced expression of plakoglobin also 
facilitated a shift towards naïve state pluripotency. Under 2i+LIF conditions, no differences were 
detectable between RGd2 and PG OE cells with ~100% of the cells being GFP positive (Figure 
4.2 a). Surprisingly, I also found that in S+LIF almost all cells of the PG OE cell line were GFP 
positive, indicating a re-establishment of ground state pluripotency (Figure 4.2.a). I therefore 
immunostained for the general pluripotency markers OCT4 and SOX2 as well as the naïve 
pluripotency markers NANOG and ESRRB (Figure 4.2 b&c). SOX2 and OCT4 were 
homogeneously expressed across all cells with PG OE cells showing slightly elevated protein 
levels. However, NANOG and ESRRB showed low and heterogeneous expression in the RGd2 
cells, but in PG OE cells homogeneity was regained and all cells showed strong signals for both 
transcription factors (Figure 4.2 c). Morphology and homogeneous expression of naïve 
pluripotency transcription factors in the PG OE cells supported the hypothesis of plakoglobin 
being involved in the establishment of naïve pluripotency. Since PG OE cells constitutively 
express plakoglobin, I was wondering if these cells still have the ability to exit pluripotency. 
Figure 4.2 | Plakoglobin overexpression promotes naïve pluripotency and slows differentiation kinetics of 
embryonic stem cells. a, Rex1::GFPd2 reporter analysis via flow cytometry of RGd2 and PG OE cells in 2i+LIF and 
S+LIF conditions (N=3). b, Epifluorescence images of RGd2 and PG OE cells stained for the general pluripotency 
makers SOX2 and OCT4. c, Epifluorescence images of RGd2 and PG OE cells stained for the naive pluripotency 
makers ESRRB and NANOG. d, Flow cytometric analysis of the differentiation kinetics of RGd2 and PG OE cells as 
measured by Rex1::GFPd2 signal in 2i+LIF and several time points in N2B27 medium (N=3). 
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When PG OE cells were transferred into N2B27 medium they readily exited the naïve state, 
however, with slowed kinetics compared to RGd2 cell (Figure 4.2 d). In summary, I have 
generated a plakoglobin overexpression cell line. These cells were morphologically distinct from 
wild type cells in S+LIF and displayed homogeneous expression of the transcription factors 
SOX2, OCT4, ESSRB and NANOG. Taken together, these data support my hypothesis of 
plakoglobin being involved in the establishment of naïve pluripotency. However, one main 
drawback was the heterogeneity of plakoglobin expression across the PG OE cells. In the next 
paragraph, I will be addressing this issue and proposed solutions. 
 
4.2.2 A certain plakoglobin threshold needs to be passed before re-establishment of ground 
state pluripotency 
The initial PG OE cell line displayed a great degree of plakoglobin heterogeneity, making 
it hard to draw conclusive results on its influence on pluripotency. To elucidate the effect of 
different levels of plakoglobin, I used the parental PG OE cell line to sub-clone cells expressing 
high and low levels of plakoglobin, respectively. Therefore, single PG OE cells were FACS sorted 
into 96-well plates based on their mCherry reporter signal (Figure 4.3 a). After several days of 
growth, I chose three plakoglobin high (PGHIGH [2, 4 and 5]) and three plakoglobin low (PGLOW 
[1, 2 and 4]) clones for further expansion (Figure 4.3 b&c). All PGHIGH clones displayed the same 
mCherry intensity, the PGLOW clones were about one magnitude lower in mCherry intensity and 
also showed a greater variance between the three clones. PGLOW#1 showed the strongest mCherry 
signal and PGLOW#2 the weakest of the three PGLOW clones. Nevertheless, in 2i+LIF medium all 
clones, regardless of their mCherry intensity, displayed homogeneous Rex1::GFPd2 expression 
across all cells (Figure 4.3 b). Therefore, high and low PG overexpression do not inhibit naïve 
state pluripotency. Furthermore, all clones were morphologically indistinguishable, exhibiting 
the tight, dome-shaped colonies associated with 2i+LIF conditions. When transferred into S+LIF 
medium, the PGLOW clones reverted to a flat, spread out monolayer of cells, whereas the PGHIGH 
clones retained the dome-shape morphology (Figure 4.3 c). When analysing the GFP signal, one 
may note that the PGLOW clones re-acquired a bimodal REX1 distribution, while exclusively all 
PGHIGH clones maintained their unimodal, positive GFP signal. Now, after having established 
several PGHIGH and PGLOW clones, I was wondering if I could detect differences between the 
clones on protein level. All further experiments were done with the PGLOW clone #2 (PGLOW#2) 
and PGHIGH clone #5 (PGHIGH#5), as representatives for the two different plakoglobin expression 
levels. I therefore immunostained RGd2, PGLOW#2 and PGHIGH#5 in S+LIF for plakoglobin. 
Consistent with our previous observations (see 4.2.1), RGd2 cells showed minimal levels of 
plakoglobin, all of which was associated to the membrane (Figure 4.3 d). The PGLOW#2 cells 
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exhibited a substantial increase in plakoglobin levels over the RGd2 cells. However, plakoglobin 
was again mostly found attached to the membrane and only negligible cytoplasmic levels were 
observed. In contrast, PGHIGH#5 cells still exhibited plakoglobin signal at the membrane, but 
additionally also showed abundant cytoplasmic and nuclear localisation (Figure 4.3 d). As I had 
already observed a negative correlation between plakoglobin and b-catenin in the parental PG 
OE cell line, I next stained the clonal lines for b-catenin (Figure 4.3 e). Indeed, I was able to 
confirm the previous findings, increased levels of plakoglobin caused degradation of b-catenin in 
S+LIF. Notably, the PGHIGH#5 cells appeared to have lost completely all b-catenin, potentially 
having been made redundant by abundant amounts of plakoglobin. As I had already observed the 
homogeneous expression of NANOG and ESRRB in the parental PG OE cells, I also wanted to 
confirm naïve transcription factor expression under S+LIF conditions in the PGHIGH#5 clone. 
Indeed, all PGHIGH#5 cells were positive for KLF4, TFCP2L1 and OCT4 whereas RGd2 cells 
showed homogeneous, even though weaker, OCT4 expression but heterogeneous expression for 
KLF4 and TFCP2L1 (Figure 4.3 f&g).  
 
4.2.3 Single-cell sequencing confirms re-establishment of naïve state-like pluripotency in 
plakoglobin overexpressing cells 
To confirm the existence of bona fide naïve state pluripotency upon expression of 
plakoglobin and to fully capture the inherent transcriptional heterogeneity in serum-based media, 
I used the inDrop (Klein et al., 2015) technology to single-cell sequence ESCs from five different 
conditions: RGd2 cells cultured on tissue culture plastic (TCP) in 2i+LIF (1) and S+LIF (2), 
microgel encapsulated RGd2 cells in S+LIF (3), and PGHIGH#5 (4) and PGLOW#2 (5) cells on TCP 
in S+LIF. After quality-control I obtained in total 4154 transcriptomes across the five different 
conditions. I then used principal component analysis to investigate relationship between 
populations and heterogeneity across the different samples (Figure 4.4 a). The RGd2 cells in 
2i+LIF and PGHIGH5 in S+LIF displayed a smaller degree of gene expression heterogeneity 
compared to all other S+LIF cultured. Furthermore, PGHIGH#5 cells clustered between the naïve 
RGd2 cells in 2i+LIF and the remaining S+LIF sample, further supporting the shift towards naïve 
pluripotency. I then used the nonlinear dimensionality reduction technique T-distributed 
stochastic neighbour embedding (t-SNE) (van der Maaten and Hinton, 2008), to visualise gene  
  
Figure 4.3| Plakoglobin acts in a concentration-dependent manner to promote naïve pluripotency. a, FACS 
profile of the parental plakoglobin (PG) overexpression cells. Sorting gates for high and low expression are indicated 
with rectangles. b, Images of clonal PG cell lines in 2i+LIF and corresponding flow cytometry profiles for Rex1::GFP 
and JUP-mCherry. c, Images of clonal PG cell lines in S+LIF and corresponding flow cytometry profiles for 
Rex1::GFP and JUP-mCherry. d, Confocal z-slice and maximum projection images of RGd2, PGLOW#2 and PGHIGH#2 
cells in S+LIF stained for plakoglobin. e, Confocal z-slice and maximum projection images of RGd2, PGLOW#2 and 
PGHIGH#2 cells in S+LIF stained for b-catenin. f, Epifluorescence images of PGHIGH#5 cells stained for OCT4, 
TFCP2L1 and KLF4. g, Epifluorescence images of RGd2 cells stained for OCT4, TFCP2L1 and KLF4. 
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expression amongst individual cells (Figure 4.4 b). As expected, the core pluripotency genes 
Pouf51 and Sox2 were homogeneously expressed across all cells in all samples. However, naïve 
transcription factors are known to be heterogeneously and lower expressed in serum-based 
medium (Chambers et al., 2007; Kolodziejczyk et al., 2015; Toyooka et al., 2008; Wray et al., 
2010). Yet, I had previously observed the homogeneous expression of KLF4 and TFCP2L1 in 
PGHIGH#5 cells despite being cultured in S+LIF. Hence, I asked how these, and other naïve 
transcription factors, would appear on transcriptional level. Remarkably, I found that the 
complete naïve gene regulatory network, including Klf2, Klf4, Tfcp2l1, Zfp42, Esrrb and Fgf4, 
was homogeneously upregulated in PGHIGH#5 cells (Figure 4.4 c-e). When comparing the 2i+LIF 
control and PGHIGH#5 cells against all other serum-based culture conditions, I found 49 
upregulated genes (log2-fold change > 0.4 and -log10P > 50) including the above-mentioned naïve 
transcription factors. In contrast, I found 98 upregulated genes in serum-based conditions, mostly 
connected to differentiation and the cytoskeleton (Figure 4.4 e). When applying KEGG pathway 
analysis on these genes, pathways regarding focal adhesion and tight junction as well as the 
regulation of actin cytoskeleton were detected. Interestingly, early post-implantation associated 
genes such as Pou3f1 and Otx2 as well as genes marking background differentiation of cells in 
S+LIF (Kolodziejczyk et al., 2015), such as Tubb6, Anxa2 and Krt19, were completely absent 
from 2i+LIF RGd2 and PGHIGH#5 cells in S+LIF (Figure 4.4 f). Furthermore, I did not see any 
changes in transcription concerning the adherens junction proteins Cdh1, and Ctnnb1 (b-catenin) 
and Ctnnd1 (Figure 4.4 g). Interestingly, despite cultured in serum containing BMPs, 
downstream signalling targets such as Id1 and Id2 normally involved in maintaining pluripotency 
in S+LIF (Ying et al., 2003a) were not expressed in PGHIGH#5 cells, indicating changes in the 
maintenance of pluripotency in these cells (Figure 4.4 h). To decipher in detail how PGHIGH#5 
cells differed from the other populations, I then compared them against all other S+LIF samples 
and subsequently against the 2i+LIF control cells (Figure 4.5). In comparison to the other 
serum-based samples, PGHIGH#5 cells are distinct in their upregulation of the naïve transcription 
factors and the threonine dehydrogenase (Tdh), a metabolic enzyme converting threonine into 
acetyl co-A and glycine as part of a unique threonine-depended catabolism during pluripotency 
and known to be downregulated upon differentiation (Kalkan et al., 2017; Wang et al., 2009) 
(Figure 4.5 a,b &d). When performing gene ontology (GO) analysis on this subset of genes, GO  
  
Figure 4.4 | Single-cell sequencing confirms re-establishment of naïve pluripotency. a, Principal component 
analysis including all samples. b, t-SNE non-linear dimensionality reduction visualisation of all sequenced samples. c, 
t-SNE visualisation of the core pluripotency factors Pou5f1, Sox2 and Nanog. d, t-SNE visualisation of naïve state 
associated transcription factors. e, Scatter plot of genes with log2-fold change > 0.4 and -log10P > 50, comparing 2i+LIF 
control and PGHIGH#5 cells against all other serum-based culture conditions. f, t-SNE visualisation of genes associated 
with early post-implantation (Pou3f1 and Otx2) or background differentiation in serum-based ESCs (Tubb6, Anxa2 and 
Krt18). g, t-SNE visualisation of genes associated with formation of adherens junctions. h, t-SNE visualisation the 
BMP signalling targets Id1 and Id2. | All single cell RNA-seq was performed in collaboration with Joachim de Jonghe, 
Department of Biochemistry, University of Cambridge. 
 
 




Figure 4.5 | Strong plakoglobin expression is concomitant with a distinct transcriptomic signature. a, Scatter plot of 
genes with log2-fold change > 0.4 and -log10P > 50, comparing PGHIGH#5 cells against all other serum-based culture 
conditions. b, STRING protein network analysis including genes upregulated in PGHIGH#5 cells. c, STRING protein network 
analysis including genes upregulated in all serum-based samples (except PGHIGH#5 cells). d, t-SNE plot for Tdh. e, t-SNE plot 
for Actg1. f-h, Gene Ontology (GO) analysis concerning biological processes and cellular components. i, Scatter plot of genes 
with log2-fold change > 0.4 and -log10P > 60, comparing 2i+LIF cells against PGHIGH#5 cells in S+LIF. j, t-SNE plots for 
Tms4bx, Mycn and Ldha. k, t-SNE plots for Scd2, Vim and Ldhb. 
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terms for biological processes such as “threonine catabolic process”, “multicellular organism 
development”, “cell dedifferentiation”, “positive regulation of transcription” and “regulation of 
stem cell division” were detected (Figure 4.5 f-h). In contrast, all other S+LIF samples were 
defined by a distinct upregulation of cytoskeletal genes such as Actg1, Myl12a, Tuba1a and 
Tubb6 which also reflected in the associated GO biological processes including “cytoskeleton 
organization” and GO cellular components “stress fibres” and “filamentous actin” (Figure 4.5 a, 
c, e, g&h). When comparing PGHIGH#5 cells with the 2i+LIF control, no such clustered gene 
regulatory networks were immediately obvious and differences were defined by a few and distinct 
genes (Figure 4.5 i-k). The 2i+LIF control cells were defined by expression of Vim (Vimentin), 
a component of intermediate filaments, and Scd2, a stearoyl-CoA desaturase connected to lipid 
metabolism and has been implied to play a role in regulating pluripotency (Hailesellasse Sene et 
al., 2007; Kaestner et al., 1989). On the other side, PGHIGH#5 cells were defined by the 
upregulation of Tmsb4x, encoding b4-thymosin, a protein with the ability of sequestering actin 
monomers and that has been shown to improve reprogramming cardiac fibroblasts to iPSCs (Qian 
et al., 2012; Safer et al., 1990). Furthermore, I detected the expression of Mycn, consistent with 
higher expression of Myc proteins in serum-based media compared to 2i+LIF (Scognamiglio et 
al., 2016). Additionally, PGHIGH#5 cells were defined by Mkrn1 expression, a gene encoding 
Makorin-1 which is part of the pluripotency gene regulatory network in S+LIF cultured ESCs 
(Cassar et al., 2015; Walker et al., 2007). Pluripotency is further denoted by a distinct metabolism 
– where somatic cells mainly use oxidative phosphorylation for energy production, pluripotent 
cells rely heavily on a glycolytic metabolism (Zhang et al., 2012). Lactate dehydrogenase (LDH), 
Figure 4.6 | Plakoglobin overexpressing cells display changes in the transcription of 
epigenetic regulators. t-SNE plots for the epigenetic regulator genes Dnmt3l, Jarid2, Tet1, 
Tet2, Dnmt3a and Dnmt3b.  
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a key component of glycolysis, was expressed in both cell populations, curiously, Ldha marking 
PGHIGH#5 and Ldhb marking the 2i+LIF control cells. As the change in metabolism between 
S+LIF and 2i+LIF cultured ESCs contributes to the epigenetic state of the respective cells (Carey 
et al., 2015) and PGHIGH#5 cells displayed upregulation of Dnmt3l, a catalytically inactive DNA 
methyltransferase that interacts with Jarid2 (Neri et al., 2013), also upregulated and part of the 
Polycomb-Repressive Complex 2 (PRC2) (Li et al., 2010), I was prompted to also investigate Tet 
and Dnmt expression, regulating DNA methylation and demethylation, respectively (Lyko, 2018; 
Rasmussen and Helin, 2016). I found Tet1 and Tet2 to be upregulated in the 2i+LIF control and 
PGHIGH#5 cells, whereas Dnmt3a and Dnmt3b were downregulated, suggesting changes in overall 
Figure 4.7 | Single plakoglobin overexpressing cells contribute twice as efficiently to the epiblast when injected 
into 8-cell embryos in comparison to wild type cells. a, Schematic illustration of the experimental set-up for a 
clonogenicity assay. b, Quantification of the clonogenicity assay 3 days after re-plating in 2i+LIF (N=3). c, Schematic 
illustration of single-cell injections into 8-cell stage embryos and representative confocal image of a blastocysts that 
had previously been injected with a single JupHIGH#5 cell. The cell had successfully integrated and proliferated within 
the developing epiblast of the embryo (mCherry-positive cells are indicated with a white arrow head). None of the 
contributing cells showed extraembryonic contribution potential (see max. proj. image). d, Quantification of chimera 
efficiency of injected single-cells from either wt (2i+LIF, n=15), wt (S+LIF, n=28) or JupHIGH#5 (S+LIF, n=26) cells. 
All single cell injections were performed by Dr Ayaka Yanagida, Cambridge Stem Cell Institute. 
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DNA methylation (Figure 4.6). However, additional experiments are required to fully decipher 
the epigenetic profile of the plakoglobin overexpressing cells. Now, after having elucidated the 
plakoglobin induced transcriptional re-establishment of naïve-like pluripotency in S+LIF 
cultured cells, I wanted to confirm this finding also on a functional level. Therefore, I determined 
the clonogenicity potential and chimera contribution efficiency of the PGHIGH#5 cells in 
comparison to the RGd2 control cells (Figure 4.7 a-d). No significant differences between RGd2 
and PGHIGH#5 cells were detectable in 2i+LIF, however when previously cultured in S+LIF, 
RGd2 cells were greatly reduced in their clonogenicity potential whereas PGHIGH#5 cells, in 
alignment with the upregulation of the naïve gene regulatory network, showed no difference to 
the 2i+LIF control cells (Figure 4.7 b). Finally, single S+LIF and 2i+LIF cultured RGd2 and 
S+LIF cultured PGHIGH#5 cells were injected into 8-cell embryos to investigate their potential to 
integrate into the developing embryo (Figure 4.7 c). Chimera contribution efficiency was scored 
after in vitro culture of the embryos to the blastocyst state (~E4.5). Remarkably, PGHIGH#5 
(S+LIF) cells contributed about twice as efficiently (~70%) as RGd2 (S+LIF and 2i+LIF) cells 
to the contributing embryo (Figure 4.7 d). Collectively, the extensive single-cell transcriptional 
analysis in combination with functional studies have confirmed the original hypothesis of the 
re-establishment of naïve-like pluripotency in ESCs expressing high levels of plakoglobin, 
despite being cultured under serum-based conditions.  
 
4.2.4 Plakoglobin expression impedes the exit from pluripotency  
After having extensively elucidated plakoglobin’s role in promoting naïve state 
pluripotency in mouse embryonic stem cells, I sought to investigate how constitutive plakoglobin 
expression effects their exit from pluripotency. Therefore, I initially differentiated the PGHIGH#5 
and PGLOW#2 clonal cell lines in the presence of serum, after removal of LIF, and followed their 
REX1::GFP signal over time (Figure 4.8 a). In S+LIF, just below 80% of the PGLOW#2 cells 
were GFP-positive. This number steadily declined upon removal of LIF to less than 5% 
GFP-positive cells after 96 hours of differentiation. The PGHIGH#5 cells, previously shown to be 
in a naïve-like state, even in S+LIF conditions, presented a stark contrast to the PGLOW#2 cells. 
All PGHIGH#5 cells were GFP-positive in S+LIF. Remarkably, these cells were unable to properly 
exit pluripotency according to their GFP signal. After 48 hours of LIF removal, the number of 
GFP-positive cells had initially dropped to ~80%, yet, no further decline was observed over the 
next several days. Despite maintaining high levels of REX1, PGHIGH#5 cells could not be kept in 
culture for extended amount of time without the support LIF, due to extensive cell death upon 
passaging (data not shown). Interestingly, even after LIF removal PGHIGH#5 cells maintained the 
dome-shaped morphology caused by plakoglobin overexpression, whereas RGd2 cells displayed 
the flat monolayer structure, irrespectively of LIF (Figure 4.8 b). The unexpectedly high levels 






Figure 4.8 | Plakoglobin impedes the exit from pluripotency in the presence of serum. a, Flow-cytometric 
analysis of Rex1::GFPd2 in PGHIGH#5 and PGLOW#2 cells in S+LIF and after LIF removal (N=3). b, Brightfield 
images of PGHIGH#5 and RGd2 cells in S+LIF and 72 hours after LIF removal. c, Confocal z-slice images of 
PGHIGH#5 and RGd2 cells in S+LIF and 72 hours after LIF removal stained for KLF4. d, Nuclear KLF4 intensities 
of PGHIGH#5 and RGd2 cells in S+LIF and 72 hours after LIF removal. e, Confocal z-slice images of PGHIGH#5 
and RGd2 cells in S+LIF and 72 hours after LIF removal stained for OCT4. f, Nuclear OCT4 intensities of 
PGHIGH#5 and RGd2 cells in S+LIF and 72 hours after LIF removal. 
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of GFP-positive PGHIGH#5 cells after LIF removal, prompted me to further investigate additional 
transcription factors of the pluripotency network. KLF4, downstream target of the LIF signalling 
pathway, naïve state transcription factor and enhanced by plakoglobin overexpression, was 
homogeneously expressed in all PGHIGH#5 cells in S+LIF, whereas KLF4 expression was 
heterogeneous in the parental RGd2 cells (Figure 4.8 c&d). After 72 hours of LIF removal, none 
of the RGd2 cells were positive for KLF4, yet strikingly, individual PGHIGH#5 cells maintained 
KLF4 expression despite the absence of LIF (Figure 4.8 c). Remarkably, PGHIGH#5 cells 
displayed a similar KLF4 intensity distribution, without the support of LIF, as RGd2 cells 
exhibited in S+LIF (Figure 4.8 d). This observation supports the hypothesis of plakoglobin’s role 
in the maintenance of naïve state pluripotency, especially because it has been shown that naïve-
state pluripotency is normally disassembled within 48 hours, unless extrinsically stabilised 
(Kalkan et al., 2017). Since OCT4 belongs to the group of general pluripotency transcription 
factors, protein levels should not change dramatically throughout the initial stages of 
differentiation (Boroviak et al., 2014; Kalkan et al., 2017). Indeed, OCT4 was expressed in all 
cells regardless of their background or culture condition (Figure 4.8 e). Simultaneously, OCT4 
displayed similar intensities in RGd2 and PGHIGH#5 cells, only in S+LIF, PGHIGH#5 showed 
slightly elevated OCT4 intensities, as would be expected with the naïve state-like transcriptional 
Figure 4.9 | Plakoglobin and b-catenin display differential protein levels upon 
differentiation. Confocal images of plakoglobin (a) and b-catenin (b) expression in 
PGHIGH#5 and RGd2 cells in S+LIF and 72 hours after LIF removal. 
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profile of these cells (Figure 4.8 f). As plakoglobin overexpression severely impeded the exit 
from pluripotency when kept in serum, I next investigated how the removal of LIF would affect 
protein levels of plakoglobin and b-catenin in RGd2 and PGHIGH#5 cells. Interestingly, 
immunostainings for both proteins elucidated a differential expression of plakoglobin and 
b-catenin upon the removal of LIF in the RGd2 cells. The low levels of plakoglobin under S+LIF 
conditions disappeared after dismantling the pluripotency network via removal of LIF, (Figure 
4.9 a), whereas b-catenin expression remained stable even after the exit from pluripotency 
(Figure 4.9 b). Contrary, in PGHIGH#5 cells, plakoglobin levels remained high, unaffected by the 
removal of LIF causing simultaneously the degradation of b-catenin. As I have observed an 
impeded exit from pluripotency when overexpressing plakoglobin, I was intrigued if these cells 
also have lost their ability to enter lineage specific differentiation. Therefore, RGd2 and PGHIGH#5 
cells were differentiated for 72 hours in the presence of serum and immunostained for the 
neuroectodermal precursor protein SOX1 and the mesendodermal protein T (Brachyury). 
PGHIGH#5 cells failed to upregulate SOX1 and RGd2 cells exhibited only sparsely (<1%), very 
low levels of SOX1 (Figure 4.10 a). However, this was to be expected as BMP signals, 
originating from the serum, are known to suppress neural differentiation. (Di-Gregorio et al., 
2007; Finley et al., 1999). In contrast, both cell lines were able to enter mesendodermal lineage 
specification as determined by the upregulation of T (Brachyury). About 39% (n=961, T-positive 
when intensity >30 a.u.) of RGd2 cells showed T expression after 72 hours without LIF and 
T-intensity analysis showed a population wide trend in T upregulation (Figure 4.10 b&c). 
PGHIGH#5 cells also upregulated T, but the efficiency had dropped to ~16% (n=285, T-positive 
when intensity >30 a.u.). Yet, one may note that, even though the overall percentage of T-positive 
PGHIGH#5 was lower than in RGd2 cells, T-intensities of individual cells were often higher 
(Figure 4.10 c). Overall, plakoglobin expression suppressed the exit from pluripotency in the 
Figure 4.10 | Plakoglobin overexpressing cells display severe differentiation defects in the presence of serum.  
RGd2 and PGHIGH#5 cells in S+LIF and 72 hours after LIF removal were immunostained for the neuroectodermal 
precursor protein SOX1 (a) and the mesendodermal precursor protein T (Brachyury) (b). c, Nuclear intensity 
distribution of T (Brachyury) as measured via confocal microscopy. 
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presence of serum whilst simultaneously inhibiting the upregulation of lineage specific proteins 
such as SOX1 and T (Brachyury). 
 
4.2.5 Plakoglobin overexpression allows maintenance of naïve pluripotency in the presence of 
just LIF or PD but not CH 
As it has become evident, that plakoglobin expression impedes the disassembly of the 
pluripotency network when maintained in serum, I next investigated plakoglobins ability to 
sustain pluripotency in serum-free conditions. Therefore, I cultured RGd2, PGLOW#2 and 
PGHIGH#5 cells over several passages in N2B27 medium supplemented with the individual 
components of 2i+LIF — LIF for activating STAT3 mediated transcription, the ERK inhibitor 
PD to disable FGF signalling and the GSK3 inhibitor CH to activate b-catenin mediated 
transcription. The state of pluripotency was then assessed by flow cytometric analysis of the 
REX1::GFP reporter. Remarkably, when transferred into LIF alone, 100% of PGHIGH#5 cells 
stayed GFP-positive, indicating that overexpression of plakoglobin with the only support of LIF 
is enough to sustain the naïve-pluripotency network (Figure 4.11 a,d&e). In contrast, RGd2 and 
PGLOW#2 cells behaved similarly in a manner of GFP decrease to ~50% of the cells after 6 days 
of LIF alone treatment (Figure 4.11 a,d&e). However, PGLOW#2 cells were able to be maintained 
in culture, albeit with the GFP signal fluctuating between 50% and 60%, for extended periods of 
time (over 20 days). This observation was not the case for the RGd2 cells, although GFP signals 
were similar to the PGLOW#2 clone, RGd2 cells started to detach after 6 days. When culturing in 
the presence of the small molecule ERK inhibitor PD, PGHIGH#5 cells initially dropped in GFP 
signal to ~70% after 3 days, however, quickly recovered to ~90% at day 6 (Figure 4.11 b,d&e).. 
Contrary, PGLOW#2 and RGd2 cells quickly exited naïve pluripotency and were completely 
GFP-negative after 3 days (Figure 4.11 b,d&e). These cells could not be kept in culture due to 
extensive cell death after 4 days in PD alone (Figure 4.11 e). Intriguingly, when cultured in the 
presence of the small molecule GSK3 inhibitor CH, the previous observation of high plakoglobin 
levels coinciding with stable pluripotency were inverted. When supplemented with CH, PGHIGH#5 
cells dropped in GFP signal to ~50% and could not be kept in culture for more than 6 days (Figure 
4.11 c-e). RGd2 cells, despite remaining to ~60% GFP-positive, were lost due to cell death on 
day 6. Remarkably, PGLOW#2 cells survived when supplemented with CH with the GFP signal 
fluctuating between 80% and 90% (Figure 4.11 c-e). This observation was surprising as any one 
of the components of 2i+LIF is not alone to maintain naïve pluripotency on its own (Wray et al., 
2010). Therefore, plakoglobin might promote pluripotency differently than b-catenin. 
Hypothetically, in PGLOW#2 cells enough b-catenin remains to act in concert with plakoglobin, 
whereas the high levels of plakoglobin in the PGHIGH#5 clone reduced b-catenin to an extend 
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where pluripotency cannot be maintained even with the addition of CH. To elucidate if 
plakoglobin acts independently of b-catenin, I supplemented all the above described surviving 
conditions with the tankyrase inhibitor XAV to (Huang et al., 2009) to abrogate b-catenin 
mediated transcription (Figure 4.11 f). Unexpectedly, neither PGHIGH#5 cells supplemented with 
LIF or PD, nor PGLOW#2 cells supplemented with LIF were affected by XAV treatment as their 
corresponding GFP signals remained largely constant (Figure 4.11 f). Contrary, PGLOW#2 cells 
supplemented with CH were not able to maintain the naïve pluripotency network upon addition 
of XAV. After 5 days, the GFP signal had decreased from ~90% to ~30% and cells could not be 
kept in culture due to detachment from the surface. Taken together, these data suggest that 
plakoglobin acts independently of b-catenin in promoting naïve state pluripotency. To eliminate 
Figure 4.11 | Plakoglobin overexpressing cells maintain naïve pluripotency when supplemented with LIF or PD 
but not CH. a-c, Percentage of Rex1::GFPd2-positive RGd2, PGLOW#2 and PGHIGH#5 cells that were cultured for in 
N2B27 supplemented with just LIF (a), just PD (b) or just CH (c) (N=3). d&e, Phase contrast and epifluorescent 
images of PGHIGH#5 and PGLOW#2 cells after 96 hours in the aforementioned conditions. f, Percentage of 
Rex1::GFPd2-positive cells upon WNT signalling inhibition via XAV treatment (N=1).  
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any ambiguity over potential b-catenin signalling I used the CRISPR/Cas9 system to knockout 
b-catenin in the RGd2 and PGHIGH#5 cells (Figure 4.12 a). The commercially available knockout 
plasmids contained three CRISPR gRNAs against Ctnnb1 and additionally a GFP-transfection 
control. Since both, RGd2 and PGHIGH#5 cells, already expressed GFP, I exclusively sorted cells 
they displayed GFP levels above the baseline expression (Figure 4.12 b). Subsequent 
immunostaining against b-catenin revealed that the CRISPR-mediated knockout resulted in a 
mixed population of hetero- and homozygous knockouts (Figure 4.12 c). Hence, in ongoing 
experiments I apply single-cell sorting to generate clonal homozygous knockouts. 
 
Figure 4.12 | CRISPR mediated knockout of Ctnnb1 (b-catenin) in RGd2 and PGHIGH#5 cells. a, Schematic 
illustration of the CRISPR mediated knockout of Ctnnb1 in RGd2 and PGHIGH#5 cells. b, Histogram of FACS-sorted 
RGd2 cells based on high GFP expression. c, Representative confocal z-slice images of wt RGd2 and Ctnnb1-KO 
RGd2 and PGHIGH#5 cells stained for b-catenin. 
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4.2.6 Plakoglobin does not inhibit the exit from naïve pluripotency in serum-free conditions 
but blocks neuroectodermal differentiation. 
After having observed plakoglobin mediated maintenance of naïve pluripotency in 
serum-free conditions, I next asked if these cells could readily exit pluripotency and enter lineage 
specific differentiation. Upon release from 2i+LIF and culture in differentiation permissive 
N2B27 medium, ESCs enter neuroectodermal differentiation as measured by the upregulation of 
neuroectoderm associated gens such as Sox1, Nestin and Tuj1 (Ying et al., 2003b). As no 
additional exogeneous signals are required for the neuroectodermal differentiation of ESCs, it has 
often been regarded as the “default” path of differentiation (Munoz-Sanjuan and Brivanlou, 
2002). In contrast, to induce mesendodermal differentiation, WNT/b-catenin and activin 
signalling is required (Turner et al., 2014). To investigate lineage specific differentiation 
potential, neuroectodermal and mesendodermal, I exposed RGd2, PGLOW#2 and PGHIGH#5 cells 
to both respective culture conditions (Figure 4.13 a&d). Consistent, with the differentiation in 
serum-supplemented medium, PGHIGH#5 cells also displayed delayed differentiation kinetics 
when cultured in serum-free N2B27 as measured by the REX1::GFP signal, whereas PGLOW#2 
cells behaved similar to the RGd2 wild type cells (Figure 4.13 b). To confirm neuroectodermal 
lineage specification, cells were stained for SOX1, a protein known to be associated with nascent 
neuroectoderm formation in the developing embryo (Pevny et al., 1998; Wood and Episkopou, 
1999), after 72 hours in N2B27 (Figure 4.13 c). RGd2 and PGLOW#2 cells efficiently upregulated 
SOX1, whereas its expression was complete disrupted in the PGHIGH#5 clone, suggesting that 
strong plakoglobin expression inhibits neuroectodermal differentiation. In contrast, 
mesendodermal differentiation initially appeared to be unaffected by plakoglobin overexpression, 
as determined by the consistent expression of the primitive streak associated T-box transcription 
factor brachyury across all samples (Wilkinson et al., 1990) (Figure 4.13 e). However, on closer 
inspection morphological differences became visible between the different cell lines. It has been 
reported that mesendodermal differentiation of ESCs in activin and CH is accompanied by events 
resembling the epithelial to mesenchymal transition (EMT) in the primitive streak of the 
gastrulating embryo — e.g. upregulation of brachyury, downregulation of E-cadherin and an 
increase in cell motility (Turner et al., 2014). After the 24 hours pulse of activin and CH, RGd2 
cells had started to detach from their originating colonies, however, freely moving cells were rare 
(Figure 4.13 e). This observation became more frequent with an increase in plakoglobin 
overexpression levels, suggesting a potential increase in EMT dynamics (Figure 4.13 e). Since 
the EMT precedes the differentiation between mesoderm and definite endoderm (DE), I was 
intrigued if the proposed acceleration in EMT kinetics biased the lineage between meso- and 
endoderm. Therefore, I extended the activin and CH pulse to 48 hours (48 h N2B27 + 48 h activin 
& CH) and immunostained for FOXA2, a member of the forkhead transcription factor family that  





Figure 4.13 | Plakoglobin overexpression suppresses neuroectodermal but not mesendodermal differentiation of 
ESC. a, Neuroectodermal differentiation strategy. b, Flow cytometric analysis of Rex1::GFPd2 signal in PGLOW# and 
PGHIGH#5 cells upon transfer from 2i+LIF to N2B27 (N=3). c, Representative epifluorescence images of RGd2, 
PGLOW#2 and PGHIGH#5 cells after 72 hours of neuroectodermal differentiation. Cells were then stained for the 
neuroectoderm marker SOX1 and nuclei were stained with Hoechst. d, Mesendodermal differentiation strategy. e, 
Representative epifluorescence images of RGd2, PGLOW#2 and PGHIGH#5 cells after 72 hours of mesendodermal 
differentiation. Cells were then stained for the primitive streak marker T (Bra) and nuclei were stained with Hoechst. 
f, Epifluorescence images of RGd2 and PGHIGH#5 cells in mesendodermal differentiation conditions stained for the 
definite endoderm marker FOXA2. g, Confocal z-slice images of RGd2 and PGHIGH#5 cells after 48 hours in N2B27 
or N2B27+activin+CH stained for plakoglobin.  
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is crucial for DE formation (Dufort et al., 1998). Consistent with published protocols for DE 
induction (Mfopou et al., 2014), treatment with activin and CH alone is inefficient in upregulating 
DE markers, such as FOXA2, in RGd2 cells (Figure 4.13 f). Competence for DE differentiation 
was further more reduced in PGHIGH#5 clone as judged by the number of FOXA-positive cells. 
Due to the lack of FOXA2, it suggests a primarily mesodermal differentiation path, however, 
additional experiments are required to fully elucidate the lineage specific potential of plakoglobin 
overexpressing cells. As I have previously observed an increase in cell-cell adhesion upon 
overexpression of plakoglobin, under pluripotent conditions in S+LIF as well as in the absence 
of LIF, I was surprised to see the described increase in cell motility of the PGHIGH#5 clone upon 
stimulation by activin and CH. To elucidate this phenomenon, I stained RGd2 and PGHIGH#5 cells 
in N2B27, and N2B27 supplemented with activin and CH, for plakoglobin and analysed its 
expression and distribution via confocal microscopy. Consistent with my previous data of 
differentiation in the presence of serum, RGd2 cells also downregulated plakoglobin in 
serum-free medium, regardless of the supplementation with activin and CH (Figure 4.13 g). In 
contrast, the PGHIGH#5 cells maintained high levels plakoglobin in N2B27, however remarkably, 
when supplemented with activin and CH, plakoglobin was released from the membrane, 
potentially due to EMT induced rearrangement of cell-cell adhesion. Now, after having observed 
differentiation defects in plakoglobin overexpressing cells I was prompted to investigate if the 
downstream pathways would also affect the transition from naïve to primed pluripotency. 
Therefore, I applied the protocol by Hayashi and colleagues (Hayashi et al., 2011), that allows 
the transition of ESCs to epiblast-like cell (EpiLCs), which are remarkably similar to the 
post-implantation epiblast-derived stem cells and reconstitute the state of primed pluripotency 
(Brons et al., 2007; Tesar et al., 2007). Briefly, 2i+LIF cultured RGd2 and PGHIGH#5 cells were 
transferred to N2B27 medium supplemented with FGF, activin and 1% KSR, termed FAK, and 
cultured for 48 hours before further analysis (Figure 4.14 a). Both, RGd2 and PGHIGH#5 cells 
changed their morphology from tightly packed, round and dome-shaped colonies in 2i+LIF to a 
flat monolayer, reminiscent to EpiSCs (Figure 4.14 b). To assess pluripotency and transcriptional 
levels of plakoglobin overexpression, I measured the REX1::GFP and Jup-mCherry signals via 
flow cytometry. Both cell lines readily downregulated the naïve state pluripotency transcription 
factor REX1 as seen by decrease in GFP signal (Figure 4.14 c). As expected, overexpression of 
plakoglobin was not affected by the differentiation to EpiLCs, according to the mCherry signal 
(Figure 4.14 c). To confirm the transition from naïve to primed pluripotency, I analysed 
expression of the naïve pluripotency factor KLF4 and the general pluripotency factor OCT4 via 
immunostainings (Figure 4.14 e-f). After 48 hours of culture in FAK, all cells had successfully 
exited the naïve state of pluripotency, regardless of the expression of plakoglobin. OCT4 
expression was maintained under naïve and primed conditions, though fluorescent intensities 
were reduced upon transfer to FAK (Figure 4.14 e&f). Next, I investigated the expression of 
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b-catenin and plakoglobin in RGd2 and PGHIGH#5 cells upon differentiation to EpiLCs. After 48 
hours in FAK medium, RGd2 cells had lost plakoglobin expression, whereas b-catenin levels 
remained largely the same (Figure 4.14 g). Remarkably, even the plakoglobin overexpressing 
PGHIGH#5 cells show a clear downregulation of plakoglobin protein despite transcription 
remained unchanged (Figure 4.14 h). In contrast to RGd2 cells, the PGHIGH#5 clone also loses 
b-catenin when maintained under primed conditions.  
 
Figure 4.14 | EpiLC differentiation of ESC. a, Schematic illustration of the differentiation of ESC to EpiLC by 
transfer from 2i+LIF to FGF+activin+KSR. b, Representative images of RGd2, PGLOW#2 and PGHIGH#5 cells in 2i+LIF 
and after 48 hours of EpiLC differentiation. c, Flow cytometric analysis of the Rex1::GFPd2 and Jup-mCherry reporter 
signals. d, Epifluorescence images of RGd2 cells in 2i+LIF and RGd2 and PGHIGH#5 cells in FAK stained for KLF4. 
e, Confocal z-slice images of RGd2 and PGHIGH#5 cells in 2i+LIF or FAK, stained for OCT4. f, Nuclear OCT4 intensity 
distribution. g&h, Confocal z-slice images of RGd2 and PGHIGH#5 cells in 2i+LIF or FAK, respectively. Cells were 
stained for plakoglobin and b-catenin. 
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4.2.7 Plakoglobin and b-catenin expression diverge upon implantation 
Hitherto, I have shown that plakoglobin appears to have similar function to b-catenin in 
mouse ES cells. This shall not be surprising as plakoglobin and b-catenin are closely related 
homologues and several studies have shown their partially compensatory effects for one another. 
Depending on the cellular context, b-catenin takes on different signalling roles. Stabilisation of 
b-catenin is known to promote pluripotency through elevating the repressive effects to TCF3 
(TCF7L1) in mouse ES cells (Wray et al., 2011), however, stabilisation of b-catenin in 
epiblast-derived stem cells (EpiSCs) leads to rapid differentiation (Kim et al., 2013; Sumi et al., 
2013). These findings prompted me to investigate plakoglobin expression during these two 
respective stages of pluripotency – naïve and primed. Therefore, I used EpiSCs carrying the 
Oct4GiP transgene (Ying et al., 2002), that were originally established from E5.75 embryos by 
Dr. Ge Guo (Austin Smith’s lab, Cambridge Stem Cell Institute, University of Cambridge) (Guo 
et al., 2009), as a model for the primed (post-implantation) stages of pluripotency. I cultivated 
EpiSCs in N2B27 supplemented with the originally described growth factors FGF and Activin A 
(Brons et al., 2007) and the addition of the small molecule tankyrase inhibitor XAV939 (Huang 
et al., 2009), which inhibits b-catenin facilitated transcription via stabilising axin. I then assessed 
b-catenin and plakoglobin levels via immunostainings (Figure 4.15 a). Under these conditions, 
the majority of cells displayed b-catenin either in their cytoplasm, or when in larger colonies, 
additionally in association with E-cadherin at the membrane. Surprisingly, I was not able to detect 
any plakoglobin, neither cytoplasmic nor, as observed before, in colocalization with E-cadherin. 
Next, I examined Jup (Plakoglobin) and Ctnnb1 (b-catenin) transcript levels of EpiSCs, ES cells 
and reprogrammed EpiSCs (Single-cell RNA-seq data kindly provided by Hannah Stuart, Jose 
Silva’s lab, Cambridge Stem Cell Institute, University of Cambridge). Ctnnb1 showed 
homogeneous and equal expression levels across all samples. In contrast, Jup is also 
homogeneously expressed in all reprogrammed samples and the ES cells, but displayed great 
heterogeneity in EpiSCs (Figure 4.15 b). Notably, several EpiSCs still showed similar or even 
higher Jup transcript levels than the ES cells. Therefore, not detecting any plakoglobin via 
immunostaining suggests that regulation occurred on protein level rather than on transcriptional 
level. The unexpected degradation of plakoglobin in EpiSCs encouraged us to investigate 
b-catenin and plakoglobin throughout early embryonic development. Thus, I immunostained 
mouse embryos at E2.5, E3.5, E4.5 and post-implantation at E5.5 for b-catenin and plakoglobin 
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(Figure 4.15 c&e). To discern between the embryonic and extraembryonic lineages, I also stained 
for SOX2 (epiblast marker) and SOX17 (primitive endoderm marker). I found that b-catenin was 
expressed throughout all stages of early embryonic development as well as all lineages (Figure 
4.15 e). At E2.5 most b-catenin appeared to have localized between adjacent blastomeres with 
only very little b-catenin protein on the side facing the exterior of the embryo. b-catenin was then 
also found throughout the inner cell mass and the trophectoderm, at E3.5. Upon formation of the 
Figure 4.15 | Differential expression of b-catenin and plakoglobin during naïve and primed pluripotency.  
a, Confocal z-slice and maximum projection images of EpiSCs stained for b-catenin, plakoglobin and E-cadherin. b, 
Jup  (plakoglobin) and Ctnnb1 (b-catenin) transcripts as measured by single-cell RNAseq in EpiSCs, Epi-iPSCs and 
ESCs. RNAseq data sets were taken from Stuart et al., 2019. c, Representative confocal images of pre-implantation 
embryos (E2.5, E3.5 and E4.5) and post-implantation (E5.5) stained for plakoglobin, SOX2 and SOX17. Nuclei were 
stained with Hoechst. d, RNAseq data for Jup transcription in the epiblast and primitive endoderm during pre- and 
post-implantation embryos. Data taken from Boroviak et al., 2015. e, Representative confocal images of 
pre-implantation embryos (E2.5, E3.5 and E4.5) and post-implantation (E5.5) stained for b-catenin, SOX2 and SOX17. 
Nuclei were stained with Hoechst. f, RNAseq data for Ctnnb1 transcription in the epiblast and primitive endoderm 
during pre- and post-implantation embryos. Data taken from Boroviak et al., 2015. 
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primitive endoderm at E4.5, b-catenin levels dropped in the SOX17-positve cells and was 
particularly strong in the SOX2-positive epiblast. Once the embryo had implanted into the uterus, 
b-catenin was found throughout the egg cylinder in all lineages. In contrast to b-catenin, 
plakoglobin expression varied greatly throughout the different developmental stages. At E2.5 
none of the blastomeres displayed any plakoglobin expression. However, at E3.5 strong 
plakoglobin expression became apparent in the trophectoderm and lower levels were detectable 
within the inner cell mass (Figure 4.15 c). At 4.5, SOX2-positive epiblast cells, also showed 
strong expression of plakoglobin, whereas SOX17-positive primitive endoderm cells displayed a 
complete lack thereof. Astonishingly, upon implantation exclusively all cells of the embryo had 
rapidly downregulated plakoglobin which stands in stark contrast to the expression of b-catenin 
at this stage. Intrigued by this finding, I then analysed a previously published RNA-seq data set 
of pre- and post-implantation embryos, for the transcript levels of Jup and Ctnnb1 (Boroviak et 
al., 2015) (Figure 4.15 d&f). Consistent with the observed protein level of b-catenin, Ctnnb1 
transcripts were relatively constant throughout pre-implantation development, whereas Jup 
transcripts clearly rose, peaking with the highest transcript levels at E4.5. Consistent with our 
observations, primitive endoderm cells showed decreased transcript levels of Jup but similar 
levels of Ctnnb1 with the E4.5 epiblast cells. Substantiating our finding of diverging protein 
levels of plakoglobin and b-catenin, transcript levels of Jup dropped at implantation, whereas 
Ctnnb1 transcript levels were even higher than at any stage during pre-implantation development. 
 
4.2.8 Overexpression of plakoglobin does not revert epiblast stem cells to a naïve-pluripotent 
state 
The abrupt disappearance of plakoglobin in the embryo upon implantation, the absence 
of it in post-implantation epiblast derived stem cells (EpiSCs) and its ability to stabilise the naïve 
pluripotency gene regulatory network in embryonic stem cells, encouraged me to ectopically 
express plakoglobin in EpiSCs. Could the forced expression of plakoglobin potentially revert 
EpiSCs back to a naïve-like state of pluripotency or will it facilitate differentiation in synergy 
with b-catenin? To elucidate this question this question, I used the previously described (see 
4.2.1) Jup-T2A-mCherry plasmid in combination with the PiggyBac transposase system to 
generate an EpiSC line that was constitutively expressing plakoglobin (Figure 4.16 a). As the 
parental EpiSC line (Guo et al., 2009) was already carrying an OCT4-GFP reporter (Ying et al., 
2002), I was able to simultaneously investigate plakoglobin transcription (mCherry) as well as 
having a fluorescent read-out pluripotency and differentiation (GFP). Several days after the 
transfection of the EpiSCs with the plakoglobin overexpression plasmid, double-positive 
(mCherry/GFP) cells were FACS-sorted and subsequently expanded to generate the EpiSC-PG 
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cell line (Figure 4.16 b&c). In FGF+Activin+XAV supplemented medium (FAX, the standard 
EpiSC maintenance medium), wild type EpiSC grew as a flat monolayer, whereas EpiSC-PG 
adopted a heterogeneous mixture of cell morphologies. The majority of cells maintained the flat 
Figure 4.16 | Generation of plakoglobin overexpressing epiblast-derived stem cells (EpiSCs). a, Schematic 
illustration of the transfection procedure and design of the plakoglobin overexpression plasmid. EpiSCs carrying an 
Oct4-GFP reporter were transfected with the plakoglobin overexpression plasmid enabling simultaneous fluorescent 
read-out for pluripotency (GFP) and transcriptional levels of plakoglobin (mCherry). b, FACS plot of control and 
transfected EpiSCs. Sorted cell population as indicated. c&d, Phase contrast and epifluorescence images of EpiSC, 
EpiSC-PG and EpiSC-PC1. e, phase contrast images of EpiSC, EpiSC-PG and EpiSC-PC1 after several passages in 
culture. f, Oct4-GFP and Jup-mCherry histograms of EpiSC, EpiSC-PG and EpiSC-PC1 in FAX medium. g, 
Representative confocal z-slice images of ESCs in 2i+LIF and EpiSC, EpiSC-PG and EpiSC PC1 in FAX, stained for 
plakoglobin and b-catenin. 
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cell shape, however, scattered round and dome-shaped colonies, resembling the morphology of 
naïve ESCs, started to appear throughout the culture (Figure 4.16 c). As these colonies also 
displayed a stronger GFP and mCherry signal than the rest of the culture, implying a higher 
expression of plakoglobin and OCT4, I subsequently picked one of these colonies and further 
expanded it to generate a pseudo-clonal EpiSC-PG line with high plakoglobin expression, from 
here on called pseudo-clone #1 (PC#1) (Figure 4.16 d). Directly after picking, PC#1 grew as a 
flat colony, however, individual cell boundaries were already indistinguishable. Remarkably, 
within the next several passages the EpiSC-PG cells reacquired the typical flat monolayer 
morphology, whereas PC#1 cells started to round up and grow as tight, dome-shaped colonies, a 
feature associated with naïve-state pluripotency in ESCs (Figure 4.16 e). Next, I investigated the 
Oct4-GFP and Jup-mCherry reporters via flow cytometry. EpiSCs and EpiSC-PG cells did not 
differ in their Oct4-GFP signal, whereas the PC#1 cells displayed slightly elevated levels (Figure 
4.16 f). This rise in GFP levels was simultaneously accompanied by an increase in mCherry, 
supporting the theory, that even in primed pluripotency and in contrast to b-catenin, plakoglobin 
promotes pluripotency (Figure 4.16 f). As EpiSC-PG and PC#1 cells both showed high mCherry 
signals as measured my flow cytometry fluorescence microscopy, I then confirmed plakoglobin 
overexpression levels, and corresponding b-catenin levels, via immunostainings (Figure 4.16 g). 
As observed before (see section 4.2.7), wild type EpiSC did not exhibit any plakoglobin 
expression, yet b-catenin was detected in association with the cell membrane. Surprisingly, even 
the plakoglobin overexpression cell lines, EpiSC-PG and PC#1, displayed low amount of 
plakoglobin, all of which was membrane-bound (Figure 4.16 g). When compared to RGd2 cells 
in 2i+LIF, plakoglobin levels in EpiSC-PG and PC#1 cells, seemed to be even lower than 
plakoglobin levels in wild type ESCs, suggesting the active degradation of plakoglobin protein, 
despite strong transcriptional expression. However, simultaneously these low expression levels 
of plakoglobin were enough to completely degrade b-catenin, which was not detectable anymore 
in EpiSC-PG and PC#1 cells. Furthermore, since the PC#1 cells had acquired a dome-shaped and 
tight colony morphology, similar to ESCs in 2i+LIF, despite the primed culture conditions (FAX 
medium), I immunostained the cells for the naïve pluripotency factors KLF4 and TFCP2L1 
(Figure 4.17). As expected, 2i+LIF cultured ESCs showed homogeneous expression of both 
proteins, whereas none, neither the wild type EpiSCs nor the plakoglobin overexpressing EpiSCs, 
exhibited any fluorescent signal for these transcription factors. Hence, plakoglobin 
overexpression in EpiSCs caused a change in morphology resembling similarity to the naïve-state 
but cannot activate the naïve transcription factor network in primed culture conditions. Next, I 
investigated whether plakoglobin expression with simultaneous change in culture conditions 
could activate the naïve gene regulatory network and reprogram EpiSCs to an induced pluripotent 
state (Epi-iPSCs). Generally, EpiSCs do not spontaneously revert to an ESC-like state when 
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transferred into 2i+LIF medium (Brons et al., 2007; Guo et al., 2009; Tesar et al., 2007). Yet, the 
ectopic expression of a single naïve-pluripotency factor (e.g. KLF4) is enough to overcome this 
reprogramming barrier and, even though at low efficiency (less than 1%), EpiSCs turn into 
Epi-iPSCs (Guo et al., 2009; Stuart et al., 2019). Therefore, I tried to reprogram wild type EpiSCs, 
EpiSC-PG and PC#1 cells in 2i+LIF. Since it has been shown, that the absence of b-catenin 
signalling is important for the maintenance of the EpiSCs (Sumi et al., 2013), and I have shown 
that plakoglobin can most likely substitute for b-catenin in ESCs, I have also tried reprogramming 
with the addition of the WNT signalling inhibitor XAV (2i+LIF+XAV). Furthermore, I tested the 
absence of CH in PD, LIF, XAV (PLX), and the addition of activin (PLAX). Due to the shift 
towards naïve pluripotency in ESCs under S+LIF conditions when overexpressing plakoglobin, 
we finally tried to reprogram EpiSCs in S+LIF. To initiate reprogramming, cells were plated in 
FAX medium and cultured for 24 hours before then switching to the corresponding media as 
described above (Figure 4.18 a). After four days exposure to reprogramming conditions, cells 
Figure 4.17 | Plakoglobin expression in EpiSCs does not upregulate the naïve-state 
associated transcription factors KLF4 and TFCP2L1. Confocal fluorescent images of 
embryonic stem cells (ESC) in 2i+LIF medium, epiblast-derived stem cells (EpiSC) and 
plakoglobin overexpressing EpiSCs (EpiSC-PG & PC#1) in FAX medium, immunostained 
for the naïve-state associated transcription factors KLF4 and TFCP2L1. Nuclei were stained 
with Hoechst. 
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were analysed for their Oct4-GFP signal via flow cytometry. Only when the primed pluripotent 
state of EpiSCs was maintained or when cells successfully reprogrammed to Epi-iPSCs, GFP 
signal was to be expected. Wild type EpiSCs, EpiSC-PG and PC#1 cells all lost their GFP signal 
upon the transfer to 2i+LIF, 2i+LIF+XAV and PLX, and have therefore differentiated or died 
(Figure 4.18 b). In both, PLAX and S+LIF, GFP signal was partially maintained. However, since 
the majority of the cells were still GFP-positive four days after change in media conditions, these 
cells most likely just slowly differentiated and did not reprogram. Remarkably, in 2i+LIF and 
also with the addition of XAV, PC#1 cells did expand as individual dome-shaped colonies as I 
would have expected when successfully reprogramed to Epi-iPSCs (Figure 4.18 c). However, 
the absence of Oct4-GFP and the inability to passage these cells indicates that these cells too have 
Figure 4.18 | Plakoglobin overexpression does not mitigate the reprogramming barrier from 
primed to naïve pluripotency. a, Schematic illustration of the reprogramming strategy for 
EpiSCs. b, Histograms of Oct4-GFP levels in EpiSC, EpiSC-PG and EpiSC PC#1 after four days 
in reprogramming conditions. c, Phase contrast images of EpiSC PC#1 after four days in 
reprogramming conditions.  
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differentiated. As b-catenin knockout embryos fail to successfully undergo gastrulation (Haegel 
et al., 1995) and b-catenin was shown to be pivotal for mesendodermal and neuroectodermal 
differentiation of EpiSCs (Sumi et al., 2013), I was curious to see if the plakoglobin induced 
reduction of b-catenin in EpiSC-PG and PC#1 cells would impede the exit from primed 
pluripotency. Therefore, wild type EpiSCs and the plakoglobin overexpressing EpiSC-PG and 
PC#1 cells were cultured for 48 hours in N2B27 and N2B27 + CH, respectively (Figure 4.19 a). 
In non-inductive N2B27, the majority of cells, regardless of plakoglobin overexpression, died. 
Yet, scattered and small GFP-negative colonies emerged across all cell lines, indicating a 
complete downregulation of the pluripotency network (Figure 4.19 a&b). When supplemented 
with CH, no widespread cell death was observed and EpiSCs as well as EpiSC-PG cell continued 
to grow as a flat monolayer of cells. In contrast, PC#1 cells maintained the previously acquired 
dome-shaped structure. However, in all conditions, GFP signal was lost and therefore consistent 
with the assumption that plakoglobin overexpression alone does not hinder the exit from primed 
pluripotency (Figure 4.19 c). Still, additional experiments are required to confirm the complete 
downregulation of the pluripotency network the ability to upregulate lineage specific markers. As 
Figure 4.19 | Forced plakoglobin expression does not inhibit the exit from primed pluripotency in EpiSC. 
a, Phase contrast images of EpiSC, EpiSC-PG and EpiSC PC#1 after 48 hours in N2B27 or N2B27+CH, respectively. 
b&c, Oct4-GFP histograms of EpiSC, EpiSC-PG and EpiSC PC#1 after 48 hours in N2B27 or N2B27+CH, 
respectively. 
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I have previously shown a differential expression of plakoglobin and b-catenin in the 
post-implantation epiblast, in which plakoglobin was rapidly degraded, and because of 
b-catenin’s dual function in promoting pluripotency and in mesendodermal differentiation, I 
asked if forced plakoglobin expression in EpiSC would activate b-catenin signalling targets and 
lead to differentiation. Therefore, wild type EpiSCs and PC#1 cells, normally maintained in FGF 
and activin supplemented with the WNT signalling antagonist XAV, were transferred for 
48 hours into FGF+activin+CH and FGF+activin, respectively (Figure 4.20 a). Upon the removal 
of XAV and simultaneous stabilisation of b-catenin via CH treatment, EpiSCs quickly lost their 
Oct4-GFP signal which was accompanied by prominent morphological changes (Figure 4.20 
b&c). EpiSCs downregulated cell-cell adhesion, whilst detaching from one another and 
simultaneous formation of membrane protrusions. Remarkably, PC#1 plakoglobin 
overexpressing EpiSCs retained their GFP signal after removing XAV and no change in 
morphology was observed. One may note, that regardless of the removal of XAV, plakoglobin 
overexpressing cells exhibit elevated levels of GFP in comparison to wild type EpiSCs (Figure 
4.20 c). Concluding, in this paragraph I have described the generation of the plakoglobin 
overexpressing EpiSC lines EpiSC-PG and PC#1. Due to an unknown mechanism, specific to 
primed state pluripotency, resulting in the fast degradation of plakoglobin protein, overexpression 
levels as achieved in ESCs (see 4.2.1) were never reached. Nonetheless, even though only 
Figure 4.20 | Plakoglobin, unlike b-catenin, does not promote differentiation of EpiSCs. a, Schematic illustration 
of experimental set up. b, Phase contrast images of EpiSC and EpiSC PC#1 in FAX maintenance medium and after 
removal of the WNT signalling inhibitor XAV with the addition of CH to the wt EpiSCs. c, Oct4-GFP Histogram after 
48 hours past change of medium.  
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marginally elevated, the rise of plakoglobin levels lead to the degradation of b-catenin whilst 
accompanied by morphological changes resulting in tightly packed and dome-shaped colonies, 
both traits which had been also observed in plakoglobin overexpressing ESCs (see 4.2.1). The 
low levels of plakoglobin expression did not yield in the expression of naïve pluripotency factors 
and EpiSC-PG and PC#1 cells stayed refractory to reprogramming towards naïve state 
pluripotency, a barrier that might be overcome once higher plakoglobin levels can be reached 
during primed pluripotency. Most importantly, these data elucidate not just transcriptional and 
post-transcriptional differences in regulation between b-catenin and plakoglobin during naïve and 
primed pluripotency, but moreover a differential signalling function — In the presence of 
stabilised b-catenin, EpiSCs rapidly differentiated whereas plakoglobin overexpression enhanced 
the Oct4-GFP reporter signal even in the absence of XAV. 
 
4.2.9 Plakoglobin in primates 
After having extensively elucidated the role of plakoglobin in mouse embryonic stem 
cells (see 4.2.1), epiblast-derived stem cells (see 4.2.8), the developing embryo (see 4.2.7) and 
due to the high degree of evolutionary conservation of the WNT/b-catenin signalling pathway, I 
was intrigued to investigate plakoglobin in other mammals. In the next several paragraphs, I will 
be describing plakoglobin expression and localisation during the different stages of pluripotency 
in human, and finally, give an outlook on the role of plakoglobin in the common marmoset, a 
model system located between human and mouse.  
 
4.2.9.1 Naïve human embryonic stem cells and the pre-implantation embryos  
In this paragraph, I will be elucidating plakoglobin expression and localisation during 
human embryonic development. Therefore, I utilized two previously established human 
pluripotent stem cell (hPSCs) lines – H9 (Thomson et al., 1998) and HNES1 (Guo et al., 2016) 
(Figure 4.21 a). The H9 hPSCs, one of the first hPSC lines, corresponds approximately to the 
stage of primitive streak in the post-implantation epiblast (Davidson et al., 2015; Nakamura et 
al., 2016; Wu et al., 2015) and mouse EpiSCs. Hence, these conventional hPSCs are generally 
considered to inhabit in the primed state of pluripotency. In contrast, HNES1 have been shown 
to resemble, transcriptionally and epigenetically, a more accurate representation of the 
pre-implantation epiblast and can therefore be considered naïve (Guo et al., 2016). Originally 
HNES1 cells were derived from the pre-implantation embryo in t2iLGö, including the small 
molecule GSK3 inhibitor CH, which enhances b-catenin mediated transcription. However, since 
it has been shown that WNT inhibition, via the small molecule tankyrase inhibitor XAV, 
improves resetting from primed to naïve pluripotency (Guo et al., 2017) as well as improving the 
maintenance of the naïve state (Zimmerlin et al., 2016), it has become common practice to culture  













naïve hPSCs in N2B27 supplemented with PD, XAV, GÖ, and LIF (PXGL) (Bredenkamp et al., 
2019; Guo et al., 2017). Based on the observation of plakoglobin levels in mouse ESC, EpiSCs, 
primed and naïve-like marmoset ESCs, I hypothesized that plakoglobin should be expressed 
highly in naïve HNES1, but not in primed H9 cells, whereas b-catenin should be detectable in 
both cell lines. To test my hypothesis, primed H9 in E8 medium and naïve HNES1 hPSCs in 
PXGL medium were immunostained for b-catenin and plakoglobin (Figure 4.21 b). Consistent 
with my previous data, b-catenin was indeed equally expressed in both cell lines and always 
colocalised with the cell membrane. In contrast, H9 cells only displayed low amounts of 
plakoglobin whereas HNES1 cells exhibited a distinct upregulation. Interestingly, distinguishing 
from b-catenin, plakoglobin was also detected in the nucleus, indicating that XAV treatment 
cannot disrupt plakoglobin mediated transcription. I then used previously published single-cell 
RNA-seq data sets of human embryos (Blakeley et al., 2015; Petropoulos et al., 2016; Yan et al., 
2013) that had been stage- and lineage-specifically aligned (Stirparo et al., 2018) to investigate 
Ctnnb1 and Jup expression in vivo (Figure 4.21 c). Consistent with the RNA-seq data of the 
mouse embryo, Jup expression levels rise at a later point during embryonic development than 
Ctnnb1. The highest Jup levels were detected in the early inner cell mass (ICM) and, in contrast 
to mouse, also in the primitive endoderm (PrE). Ultimately, I questioned whether plakoglobin 
was also to be found in vivo. To answer this question, I collaborated with Prof.  Jennifer Nichols 
(Wellcome MRC Cambridge Stem Cell Institute) to elucidate plakoglobin expression and 
localisation within the human embryo. We therefore thawed four supernumerary embryos that 
were donated from three different patients of in vitro fertilisation programs. Liquid nitrogen 
stored embryos were thawed at day 7 post fertilisation and subsequently prepared for 
immunofluorescent analysis. The embryos were then stained for plakoglobin as well as SOX2 
and SOX17, markers for the epiblast and PrE, respectively (Figure 4.21 d). Since the human 
pre-implantation embryo contains a high degree of desmosomal intercellular junctions in its 
trophectoderm (Hardy et al., 1996), it was not surprising to find it enriched with plakoglobin. Yet, 
consistent with the mouse embryo, human embryos do not form desmosomes within the inner 
cell mass but plakoglobin, albeit to a lesser extent, was still found in all SOX2-positive epiblast 
cells. One may note, that only embryo 1 displayed SOX17-positive cells that had differentiated 
towards PrE, the remaining embryos had weak SOX17 signal within the ICM (in a different 
z-plane than displayed in the figure, data not shown), indicating a potentially earlier 
Figure 4.21 | Human naïve embryonic stem cells as well as the pre-implantation epiblast express plakoglobin. 
a, Schematic illustration of human ESC lines and media conditions used in this chapter. The conventional human ESC 
line H9 was cultured in E8. The human naïve cell line HNES1 was cultured in N2B27 supplemented with PD, XAV, 
GÖ and LIF (PXGL). b, Confocal z-slice images of H9 and HNES1 cells stained for plakoglobin and b-catenin. c, 
Single-cell RNA-seq data for b-catenin (Ctnnb1) and plakoglobin (Jup) at different stages of pre-implantation 
embryonic human development. d, Confocal z-slice images of four human embryos collected from three different IVF 
patients. The embryos were stained for plakoglobin, SOX2 (epiblast marker), SOX17 (primitive endoderm marker) 
and nuclei were labelled with DAPI. | All human embryos were processed by Prof. Jennifer Nichols, Cambridge Stem 
Cell Institute. 
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developmental time point. However, consistent with the RNA-seq data, PrE cells of embryo 1 
were positive for plakoglobin. Together, these data reveal an expression pattern of b-catenin and 
plakoglobin in primed and naïve hPSCs which corresponds to plakoglobin levels I have observed 
in mouse EpiSCs and ESCs. Additionally, the expression of plakoglobin in the human 
pre-implantation epiblast indicates also a high degree of conservation across mouse and human 
in vivo.  
 
4.2.9.2 Marmoset stem cells show plakoglobin expression when reset to a naïve-like state 
Over the last several years, in vitro models of human development have become 
increasingly sophisticated. The in vitro culture of human embryos mimicking peri-implantation 
stages (Shahbazi et al., 2016), the generation of endometrial and trophoblast organoids (Boretto 
et al., 2017; Turco et al., 2017; Turco et al., 2018), that have exhibit traits similar to their in vivo 
counter parts, the maternal endometrium and the placenta respectively, have allowed preliminary 
insights into human development. Yet, human research must succumb to strict ethical guidelines 
and can therefore not offer in vivo reference for post-implantation stages. Non-human primate 
model organisms have been shown to be a middle-ground, featuring many chracteristics of human 
development whilst simultaneously allowing the options for in vivo post-implantation reference 
material. Common marmoset (Callithrix jacchus) embryonic stem cells (cmESC) have been used 
as an in vitro model for primate development (Boroviak et al., 2018; Sasaki et al., 2005b; 
Thomson et al., 1996). Albeit derived from the pre-implantation epiblast, cmESCs have 
consistently failed to form chimeras (Okano et al., 2012) and resemble transcriptionally the 
post-implantation embryo. However, recent data from the Boroviak lab has indicated that 
conventional cmESCs can be reset to a naïve-like state of pluripotency (Personal communication 
with Erin Slatery, unpublished data), when transferring cells into medium supplemented with, 
PD, hLIF, activin XAV and ascorbic acid, termed PLAXA (Figure 4.22 a). These cells show a 
loss in polarity, upregulate primate-specific naïve pluripotency associated transcription factors 
and cluster transcriptionally with the pre-implantation epiblast (Nakamura et al., 2016). Upon 
resetting, cmESCs lose the clear colony outline by the apical polarity marker ezrin (Berryman et 
al., 1993) and upregulate the primate-specific naïve pluripotency transcription factor KLF17 
(Figure 4.22 b&c). I next questioned if cmESCs expressed plakoglobin and if expression was 
consistent with my previous findings of its association with naïve pluripotency (Figure 4.22 d). 
In contrast to mouse EpiSCs, but consistent with primed human cells, conventional cmESCs show 
weak expression of plakoglobin (Figure 4.22 d). Yet, consistent with naïve-state pluripotency in 
mouse ESCs and human PSCs, upon resetting of cmESCs, plakoglobin levels dramatically 
increased (Figure 4.22 d). This differential expression was not observed for b-catenin, 
conventional and naïve-like cmESCs both exhibited similar amount of membrane associated 
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b-catenin whereas nuclear b-catenin was not detectable regardless of the pluripotent state (Figure 
4.22 e). Coherent with the data on hPSCs, cmESCs exhibit an ~2-fold increase of nuclear 
plakoglobin when maintained under naïve-like pluripotent conditions (Figure 4.22 f). Finally, 
when analysing single-cell transcripts (Single-cell RNAseq data of pre-implantation marmoset 
embryos taken from Boroviak et al., 2018) of Ctnnb1 (b-catenin) and Jup (plakoglobin), I found 
Figure 4.22 | Resetting of conventional cmESCs towards naïve-like pluripotency is accompanied by upregulation 
of plakoglobin. a, Schematic illustration of the resetting of conventional cmESCs towards naïve-like pluripotency. 
b-d, Confocal z-slice images of conventional and naïve-like cmESCs stained for (b) OCT4, KLF17, actin (phalloidin),  
(c) ezrin, b-catenin, and (d) plakoglobin. Nuclei were stained with Hoechst. e, Comparison and b-catenin and 
plakoglobin in primed and naïve-like cmESCs via confocal microscopy. f, Nuclear plakoglobin intensity distribution 
of conventional (KSR/bFGF) and naïve-like (PLAXA) cmESCs. g, Averaged single-cell transcript levels of Ctnnb1 
(b-catenin) and Jup (plakoglobin) during pre-implantation marmoset embryonic development. | cmESCs were cultured 
by Erin Slatery and Clara Munger, PDN, University of Cambridge. 
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low expression levels of plakoglobin throughout pre-implantation development with a sudden 
spike during the formation of the pluripotent epiblast, whereas Ctnnb1 remained rather stable 
after initial reduction in comparison to the zygote (Figure 4.22 g). In an effort to further expand 
the previously described microgel culture system, I worked in collaboration with the Boroviak 
lab to adapt the encapsulation procedure and culture conditions to enable cmESCs to grow in 
agarose microgels. Due to the more complex needs of cmESCs on their media, we initially tested 
Figure 4.23 | Microgel culture of conventional and naïve-like cmESCs in different media conditions. a, Schematic 
illustration of the media screening for cmESCs in agarose microgels. b&c, Phase contrast images of encapsulated 
conventional cmESCs cultured for 6 days under different media conditions. Efficiency was determined by counting all 
gels containing at least 1 colony divided by the total number of gels after 4 and 6 days (N=1) . d&e, Phase contrast 
images of encapsulated naïve-like cmESCs cultured for 6 days under different media conditions. Efficiency was 
determined by counting all gels containing at least 1 colony divided by the total number of gels after 4 and 6 days 
(N=1).   
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12 different media compositions on conventional and naïve-like cmESCs (Figure 4.23 a) to 
ensure cell viability after encapsulation into the biologically inert agarose microgels. Briefly, we 
used E8, KSR/bFGF, N2B27 and PLAXA as starting media and supplemented them with 
extracellular matrix (ECM) components in the form of laminin and fibronectin (Ln+Fn) or 1% 
Matrigel (MG). Microgel encapsulated cmESCs were then cultured in-gel suspension, and all 
media conditions were further supplemented with 2.5% chemically defined lipids and the 
culture-wells were coated with mitomycin-c inactivated mouse embryonic fibroblasts. 
Subsequently, microgel encapsulated cells were cultured in a low-oxygen incubator and imaged 
after 4 and 6 days in culture. Efficiency was assayed by counting microgels containing at least 
one cell colony and dividing it by the total number of microgels. Concluding from this screen, 
we achieved cell proliferation and colony formation in all conditions, however, efficiency varied 
greatly with the state of pluripotency, the base medium and the amount of ECM (Figure 
4.23 b-e). In summary, conventional cmESCs survived better than naïve-like cmESCs and the 
addition of ECM components increased the overall cell viability. Efficiencies ranged between 
~40% (PLAXA, no ECM) to ~80 % (E8, 1% MG) on day 4 and ~20% (PLAXA, no ECM) to 
~80% (E8, 1% MG) on day 6 for conventional EpiSCs (Figure 4.23 b&c). Whereas efficiencies 
for naïve-like cmESCs lay between ~20% (KSR/bFGF, no ECM) and ~40% (N2B27, 1%MG) 
on day 4 and ~5% (PLAXA, Ln+Fn) and ~40% (N2B27, 1%MG) on day 6 (Figure 4.23 d&e). 
 
4.3 Conclusions 
This chapter was devoted to elucidating plakoglobin’s role in the establishment and 
maintenance of naïve pluripotency in embryonic stem cells and their in vivo counterparts, the 
epiblast. Therefore, I have generated an ESC line constitutively expressing 
plakoglobin-T2A-mCherry (termed PG-OE). The previously described REX1::GFPd2 reporter 
allowed the near real-time analysis of naïve pluripotency whilst the mCherry signal indicated 
plakoglobin transcript levels. Under naïve conditions, in 2i+LIF, no morphological differences 
were apparent, however, PG-OE cells in serum-supplemented medium acquired the round and 
dome-shaped morphology associated with naïve-state pluripotency. Consistent with other studies 
(Mahendram et al., 2013; Salomon et al., 1997), forced expression of plakoglobin was 
accompanied by the degradation of b-catenin, however, this effect was mitigated in the presence 
of the GSK3 inhibitor CH. Due to the morphological changes, I was encouraged to further 
investigate the state of pluripotency. Remarkably, PG-OE cells showed in S+LIF homogeneous 
REX1::GFP signal, indistinguishable from 2i+LIF. As this observation indicated naïve-state 
pluripotency in all cells, I also immunostained for the naïve pluripotency associated transcription 
factor ESRRB and NANOG. Consistent with the GFP signal, all PG-OE cells were positive for 
both proteins, whereas RGd2 cells showed heterogeneous expression in S+LIF. However, since 
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PG-OE cells were originally not established as a clonal cell line, plakoglobin overexpression 
levels varied. To completely understand how different levels of plakoglobin would influence 
pluripotency, I next generated clonal PG-OE cell lines. Therefore, the parental PG-OE cell line 
was single cell sorted based on the mCherry signal into PGHIGH and PGLOW cells that were 
subsequently expanded into several clonal cell lines. Interestingly, only PGHIGH cells displayed 
the described changes in morphology, round and dome-shaped, whereas PGLOW cells were mostly 
indistinguishable from the RGd2 ‘wild type’ cells. Also, only PGHIGH cells showed homogeneous 
REX1::GFP signal in S+LIF, in contrast to PGLOW and RGd2 cells which had a bimodal GFP 
distribution. Taken together, these data indicated that a certain plakoglobin threshold had to be 
passed before being transcriptionally active. I then confirmed actual plakoglobin levels and 
distribution via fluorescent microscopy. Upon overexpression, plakoglobin was firstly localised 
to the cell membrane as seen in PGLOW cells. Only when plakoglobin levels were further 
increased, it was found also cytoplasmic and nuclear, further consolidating the hypothesis that a 
plakoglobin acts in a dosage-depended manner. The homogeneous REX1::GFP signal as well as 
the homogeneous expression of a variety of naïve-state associated transcription factors (e.g. 
ESRRB, NANOG, TFCP2L1 and KLF4) in PGHIGH cells prompted me to comprehensively 
compare the different cell lines transcriptionally via inDrop single-cell sequencing (Klein et al., 
2015) to determine if plakoglobin overexpression indeed lead to the re-establishment of bona fide 
naïve pluripotency. Remarkably, PGHIGH cells in S+LIF clustered separately from all other cells 
and have shifted towards the naïve control cells, RGd2 in 2i+LIF. This shift was mostly due to 
the re-establishment of the naïve gene regulatory network and the absence of any 
post-implantation and early differentiation genes (e.g. Otx2, Pou3f1, Tubb6 and Krt18) known to 
be normally expressed in a subset of cells when cultured in S+LIF. If indeed bona fide naïve 
ESCs, these cells should functionally behave like RGd2 cells in 2i+LIF. Consistent with this 
hypothesis, PGHIGH in S+LIF performed just as good as RGd2 cells in 2i+LIF during a 
clonogenicity assay and moreover, exhibited a 2-fold increase in chimera contribution efficiency 
when injected as single cells into 8-cell embryos. After having established that upregulation of 
plakoglobin leads to a state of naïve-like pluripotency, I next investigated how the forced 
expression affects the ability to exit pluripotency and enter lineage specific differentiation. When 
cultured in serum-based medium, PGHIGH cells failed to properly exit naïve pluripotency as 
indicated by prolonged REX1::GFP and KLF4 signal in the absence of LIF. Having observed 
plakoglobin’s abilities of promoting naïve-like pluripotency in serum-based medium, I next 
investigated its potential in sustaining naïve pluripotency in serum-free conditions. Remarkably, 
PGHIGH, unlike RGd2 cells, were able to maintain a unimodal and positive REX1::GFP signal 
when solely supplemented with LIF or the ERK inhibitor PD but not with the GSK3 inhibitor 
CH. However, CH supplementation of the PGLOW cells also resulted in stable maintenance of 
naïve pluripotency, suggesting that plakoglobin might act differently in promoting pluripotency 
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than b-catenin as normally a dual combination of LIF, PD or CH is necessary to maintain naïve 
pluripotency (Wray et al., 2010). This argument was further solidified with the observation that 
XAV treatment, a known inhibitor of b-catenin mediated transcription had no effect on 
plakoglobin mediated stabilisation of naïve pluripotency. To circumvent any ambiguity caused 
by residual b-catenin, I am in the process of using CRISPR technology to generate RGd2 and 
PGHIGH b-catenin knockout cells, however, this project is still ongoing. After having elucidated 
plakoglobins ability to maintain naïve pluripotency in serum-free medium in the combination 
with LIF, PD or CH, I then asked how its forced expression would affect the exit from naïve 
pluripotency and differentiation in serum-free conditions. In contrast to serum-based medium, 
ectopic expression of plakoglobin did not impede the exit from naïve pluripotency but did disturb 
lineage specification. Thus far, these data support the hypothesis of plakoglobin’s involvement 
in the regulation of naïve pluripotency. Yet hitherto, plakoglobin mostly appeared to be 
phenocopying the effects of stabilised b-catenin, despite the differences regarding its regulation 
(e.g. plakoglobin’s unresponsiveness to XAV treatment). Of particular interest is, that b-catenin 
takes on different signalling functions in naïve ESCs and primed EpiSCs by promoting 
pluripotency and differentiation, respectively (Kim et al., 2013; Wray et al., 2011) . Hence, I was 
intrigued to investigate plakoglobin’s role during primed pluripotency. Therefore, I initially 
converted RGd2 and PGHIGH ESCs to EpiLCs via FGF and activin (Hayashi et al., 2011). The 
absence of REX1::GFP and KLF4, but expression of the core pluripotency factor OCT4 
confirmed the transition into primed pluripotency. Unexpectedly, albeit being constitutively 
expressed, plakoglobin levels had dropped in the PGHIGH cells suggesting the acute activation of 
its degradation mechanism. I then checked wild type post-implantation epiblast-derived stem 
cells, that are known to occupy the primed space of pluripotency (Brons et al., 2007; Tesar et al., 
2007), for plakoglobin expression and found its complete absence in these cells. In contrast, 
b-catenin expression remained stable throughout naïve and primed pluripotency. The exclusive 
expression of plakoglobin during naïve pluripotency and its abrupt disappearance of upon 
transition into the primed state prompted me to examine plakoglobin during the respective states 
in vivo – the pre- and post-implantation embryo. Remarkably, b-catenin was found throughout 
all stages of development in embryonic and extraembryonic lineages whereas plakoglobin 
emerged only around E3.5, peaked at E4.5 and was absent from the implanted embryo at E5.5. 
This tight associated of plakoglobin with naïve pluripotency raised the question if forced 
expression of plakoglobin during primed state pluripotency would promote reprogramming to 
naïve pluripotency or act in synergy with b-catenin and support the regular developmental 
trajectory towards differentiation. To answer this question, I generated an EpiSC line 
exogenously expressing plakoglobin. Albeit having used the same overexpression construct as in 
the ESCs, EpiSC plakoglobin levels were more comparable to wild type ESCs, indicating an 
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intrinsically active degradation pathway of plakoglobin in EpiSCs. Nonetheless, the low levels 
of expressed plakoglobin were enough to cause the degradation of membrane associated 
b-catenin, change EpiSC morphology and increase OCT4 levels. However, I did not observe 
expression of naïve pluripotency associated transcription factors (e.g. KLF4 and TFCP2L1) and 
these cells were not able to survive under naïve culturing conditions. Finally, I investigated 
plakoglobin during pluripotency in human and marmoset using hPSCs, pre-implantation embryos 
and cmESCs, respectively. Remarkably, human and marmoset cells displayed similar expression 
pattern of plakoglobin as previously seen in the mouse – low levels of plakoglobin in primed cells 
and high levels during naïve pluripotency. In an ongoing project, I am now further expanding the 
microgel culture system to cmESCSs. How this culture format affects pluripotency in primate 
cells remains to be investigated. Taken together, these data elucidated an across different species 
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5 Microgel co-culture of embryonic and 























Embryonic stem cells’(ESC) potential to indefinitely self-renew and to differentiate to all 
germ layers and the germ cells have been proven to be an excellent model for pluripotency and 
lineage specification (Thomson et al., 2011; Ying et al., 2003b). However, two-dimensional (2D), 
conventional tissue culture has come to its limits when, for example, trying to emulate the 
complex spatiotemporal events of in vivo embryogenesis. To tackle such challenges, the move 
towards three-dimensional (3D) culture system was just a matter of time. Some of the earliest 
studies date back to the early 20th century when Ross G. Harrison cultured fragments of 
embryonic nerve cord in hanging drops (Harrison, 1906). The same methodology was later used 
to aggregate ESCs into little structures, that in the absence of the pluripotency stabilising 
leukaemia inhibitory factor (LIF), spontaneously differentiated into the three germ layers when 
cultured in serum-based medium (Boxman et al., 2016). These aggregates, generally referred to 
as ‘embryoid bodies’, can be considered as some of the first attempts of modelling embryonic 
development in vitro as EBs show, albeit very poor, self-organisation, extracellular matrix 
deposition (Goh et al., 2013) and axis formation upon activation of the WNT/b-catenin pathway 
(ten Berge et al., 2008). Despite the possibility of manipulating EB composition, the ratio of 
endo-, meso- and ectoderm, via the use of different methodologies and media compositions, 
precise control over spatiotemporal events remains modest. EBs have been used for several 
decades, in more recent studies ESCs have been aggregated, in a similar fashion as EBs, but 
differentiated in chemically defined, serum-free medium (Baillie-Johnson et al., 2015; van den 
Brink et al., 2014). When mimicking extraembryonic WNT signals through the addition of the 
GSK3 inhibitor Chiron (CH), these aggregates displayed features of the developing embryo, 
including symmetry breaking, elongation and cell migration resembling the epithelial to 
mesenchymal transition during primitive streak formation (Baillie-Johnson et al., 2015; Turner 
et al., 2017). Hence, these structures have been termed ‘gastruloids’. In their latest work, Beccari 
and colleagues have shown that, given enough time, gastruloids also display patterned Hox gene 
expression along their anterior-posterior axis, thereby acquiring another key hallmark of 
development (Beccari et al., 2018). Gastruloids show a major improvement in control over the 
spatiotemporal events compared to the mostly heterogeneous differentiation in EBs. Nonetheless, 
a major drawback remains the complete absence of the extraembryonic lineages – the primitive 
endoderm and trophectoderm, respectively. Recently, the laboratory of Magdalena 
Zernicka-Goetz has used the in vitro counterparts of these extraembryonic tissues, 
extraembryonic endoderm (XEN) cells (Kunath et al., 2005) and trophectoderm stem cells (TSC) 
(Tanaka et al., 1998), to generate composite cell aggregates containing embryonic and 
extraembryonic cells (Harrison et al., 2017; Sozen et al., 2018). In their first study, ESCs were 
aggregated with TSCs which subsequently self-organised into an embryonic and extraembryonic 
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compartment (Harrison et al., 2017). Furthermore, these aggregates which were then termed 
ETS-embryos, displayed the formation of polarised epithelia surrounding and inner cavity, 
reminiscent of the pro-amniotic cavity in the embryo. Based on the ETS-embryos, Sozen and 
colleagues advanced the approach by the addition of XEN cells during aggregate formation which 
led to self-organisation into two adjacent central compartments, an embryonic (ESC) and an 
extraembryonic (TSC) compartment, both of which were surrounded by a single layer of XEN 
cells (Sozen et al., 2018). These so called ETX-embryos indeed show many hallmarks of natural 
in vivo embryogenesis. In addition to closely rambling the natural embryo morphologically, 
ETX-embryos also undergo gastrulation-like events, show mesoderm as well as definite 
endoderm differentiation and display primordial germ cell-like specification (Sozen et al., 2018; 
Zhang et al., 2019). Although these model systems have increased in complexity and 
sophistication, EBs, gastruloids, ETS- and ETX-embryos all have one feature in common: they 
mimic peri/post-implantation development. In an attempt to model pre-implantation 
development, Rivron and colleagues co-cultured pre-aggregated ESCs with TSCs, which in 
combination with tankyrase and protein kinase A inhibition lead to the formation of structures 
resembling the pre-implantation blastocyst (Rivron et al., 2018). When injecting these ‘blastoids’ 
into the uterus, they induce decidualization but subsequently fail to develop into bona fide 
embryos (Li et al., 2019; Rivron et al., 2018). Finally, in one of the most recent studies, synthetic 
embryogenesis has been applied to model human embryonic development (Zheng et al., 2019). 
It was shown, that hPSCs exposed to signalling gradients within a microfluidic system can 
differentiate in a polarised fashion to form structures similar to the embryonic disc and the 
amniotic ectoderm, respectively. In this chapter, I will be describing the microfluidic-based 
co-encapsulation of ES and XEN cells to generate composite cell aggregates in high-throughput 
to model peri-implantation events of in vivo embryonic development. 
  




5.2.1 Microgel co-culture of ES and XEN cells 
In the last two chapters I have described the microfluidic based culture of microgel 
encapsulated embryonic stem cells (ESC) and its effects on pluripotency and self-renewal. I found 
that biologically inert agarose microgels supported naïve pluripotency, however I hypothesised 
that the lack of extracellular matrix component would negatively affect cell viability as they 
differentiate towards somatic lineages. Indeed, when culturing encapsulated ESCs in 
differentiation permissive N2B27 medium, an increase in fragmented nuclei was detected in the 
periphery of cell colonies where cells interfaced with the agarose (Figure 5.1 a&c). This 
observation was absent when using Matrigel instead of agarose (Figure 5.1 b&c). Besides the 
lack of extensive peripheral cell death, Matrigel microencapsulated cells also acquired an apical-
basal polarity, determined by the polarised expression of aPKC, as they exited pluripotency. An 
observation that has been previously linked to corresponding events of pro-amniotic lumen 
formation in the embryo (Bedzhov and Zernicka-Goetz, 2014). However, using Matrigel always 
comes with its inherent drawbacks – an undefined composition of ECM components and growth 
factors as well as variability across different batches. In vivo, basal membrane formation is 
mainly driven by primitive endoderm (Murray and Edgar, 2000; Salamat et al., 1995). Hence, I 
asked if the in vitro counterpart, extraembryonic endoderm (XEN) cells, could substitute the use 
of Matrigel and support ESCs differentiation in agarose microgels, thereby maintaining a fully 
defined culturing system (Figure 5.1 d&e). Therefore, I initially tested the XEN cells’ ability to 
grow in agarose microgels and found that they grew and adopted a morphology dramatically 
different from their conventional culture on tissue culture plastic (Figure 5.1 e). Microgel 
encapsulated XEN cells that were in close proximity to each other, immediately started 
interacting via cell-cell adhesion. At 24 hours past encapsulation, XEN cells had started to arrange 
themselves into small colonies with a large central lumen. Over the next 24 hours this lumen 
would further expand and surrounding XEN cells appeared in different morphologies – from 
round and unpolarized to somewhat similar of a squamous epithelium. The phenomenon of lumen 
formation was observed in the serum-based XEN cell maintenance medium (RPMI) but also 
under fully defined conditions in N2B27. Next, I was intrigued to see how XEN and ES cells 
would interact when co-encapsulated into agarose microgels. Hence, I used a modified 
flow-focussing device that had two inlets, one for the XEN and another one for the ES cells 
(Figure 5.1 f). When encapsulating, I used an excess of XEN cells to ensure every ES cell would 
be paired with at least one XEN cell. In a typical experiment this would result in ~72% of 
microgels containing both cell types, ~23% only XEN cells, ~4 % only ES cells and ~1% empty 
gels (Figure 5.1 g). Subsequently, cells were grown in N2B27 medium for up to 72 hours.  
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Remarkably, despite being initially randomly distributed within the gel, after 24 hours structural 
reorganization became apparent, in which the XEN cells would end up on the outside of the 
nascent colony, surrounding an inner core of ES cells (Figure 5.1 h-k). When the inner ES cells 
were completely surrounded by XEN cells, these aggregates were then termed ‘EX-structures’. 
To elucidate the formation of these EX-structures I used time-lapsed confocal imaging of 
co-encapsulated XEN-GFP and membrane-tdTomato (m-tdT) ESCs (Figure 5.2 a&b). Directly 
after encapsulation, XEN cells began to form cell-cell contacts with ESCs via highly dynamic 
membrane protrusions (Figure 5.2 a). These protrusions extended and retracted in rapid 
succession over the first 24 hours. Even after mitosis, XEN or ES, cells did not separate from 
Figure 5.1 | Microgel co culture of embryonic stem cells (ESC) and extraembryonic endoderm (XEN) cells. a, 
Representative confocal z-slice images of agarose microgel encapsulated ESCs cultured in N2B27. Filamentous actin 
was stained with phalloidin and nuclei were stained with Hoechst. b, ESCs in N2B27 medium in Matrigel microgels. 
ESCs were labelled with a membrane attached GFP and cells were further stained for aPKC. c, schematic illustration 
of polarised ESCs in Matrigel and unpolarised and dying cells in agarose under differentiation-permissive conditions. 
d, Illustration of the embryonic origin of ES and XEN cells. e, Confocal z-slice images of agarose microgel 
encapsulated XEN-GFP cells cultured in RPMI or N2B27. Cells were additionally stained with phalloidin and Hoechst. 
Lumen formation is indicated with white asterisks. f, Schematic illustration of a double-inlet FFD. Microscopic view 
of double-inlet FFD (1), cell mixing (2), droplet formation (3) and FFD outlet with droplets containing ES and XEN 
cells. g, Microgel occupancy after co-encapsulation of ES and XEN cells. h, Confocal z-slice images of 
co-encapsulated ES and XEN-GFP cells after 0 h, 24 h and 48 h in N2B27. Cells were additionally stained with 
phalloidin and Hoechst. i, EX-structures formed from ES-m-tdT and XEN-GFP cells and representative fluorescence 
intensity profiles of successful and unsuccessful EX-structure formation. n j, Schematic illustration of EX-structure 






Figure 5.2 | EX-structure formation is orchestrated by highly dynamic XEN cell membrane protrusions. 
Time-lapsed confocal imaging of co-encapsulated XEN-GFP and m-tdT ES cells. a, Initial cell-cell contact between 
a single ES and single XEN cell. b, XEN cell coordinated re-arrangement of ES cells. Imaging was started after 
24 hours of culture in N2B27 medium. 
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each other. Finally, ESCs would always end up in the centre whilst being surrounded by XEN 
cells. Besides probing and restraining ESCs, XEN cells additionally showed the ability to merge 
separate clusters of ESCs with one another (Figure 5.2 b). This was surprising as the agarose 
does not provide any extracellular matrix and adhesion sites. Consequently, ESCs grown in 
agarose were not able to actively migrate within the gel. Yet, XEN cells had the ability to hold 
on to separately growing ESC clusters and actively moving them together initiated  
 
5.2.2 XEN cells support transition from naïve pluripotency to lineage specification of microgel 
cultured ESCs 
To understand EX-structure formation and the underlaying mechanisms, I further 
scrutinized them via single-cell sequencing and immunostainings. For single-cell sequencing I 
used the commercially available 10x Genomics platform (Figure 5.3 a). EX-structures were 
cultured in chemically-defined N2B27 medium for ~50 hours before releasing them from the 
gels, disrupting to single-cell suspension and subsequent sequencing. In total, I obtained 1870 
transcriptomes. To visualize gene expression across the different cell types I used T-distributed 
stochastic neighbour embedding (t-SNE) (van der Maaten and Hinton, 2008). Cell types were 
then assigned using the ESC-specific genes Nanog and Pou5f1, whereas XEN cells were defined 
by Sox17, Gata4 and Gata6 expression (Figure 5.3 b). Surprisingly, XEN cells appeared in two 
separate clusters indicating at least two different cell states. When investigating differential gene 
expression between these clusters, I found one subpopulation to be exclusively expressing Peli2, 
an ubiquitin ligase, whereas the other one displayed expression of Srgn, a proteoglycan first 
isolated from a rat yolk sac tumour cell line and also known to be expressed in the murine uterine 
decidua and the parietal endoderm (Keith Ho et al., 2001; Oldberg et al., 1981) (Figure 5.3 c). 
When immunostaining for Serglycin, XEN cells expressed cytoplasmic and membrane-bound 
protein, whereas it was not detectable in most XEN cells that had formed EX-structures in 
symbiosis with ES cells (Figure 5.3 d). However, at this point I cannot say with certainty the 
origin of these distinct cell populations. Hence, additional experiments will be required to fully 
elucidate the origin of the different XEN cell subpopulations. When EX-structures formed, a 
single layer of squamous epithelial, FOXA2-positive XEN cells surrounded the ES cells which 
in turn also epithelised with columnar morphology (Figure 5.3 e). Contrary, ES cells on their 
own did not change their morphology upon differentiation in N2B27, failed to polarise and 
detected fragmented nuclei in the periphery of the majority of colonies. To confirm cell death I 
immunostained for the apoptosis marker cleaved caspase-3 (Porter and Janicke, 1999), and found 
that fragmented nuclei on the outside of the colonies were positive for cleaved caspase-3 (Figure 
5.3 f), most likely due to the lack of extra cellular matrix in form of a basal membrane as it is 
known that the absence of basal membrane, in particular its laminin component, causes 
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peri-implantation lethality (Coucouvanis and Martin, 1995; Smyth et al., 1999). Interestingly, in 
co-culture wit XEN cells, ESCs did not exhibit the previously observed systemic apoptosis and 
only few and scattered cells within the epithelium underwent cell death. In the developing 
embryo, basal membrane deposition is mainly driven by endodermal precursors (Li et al., 2004; 
Li et al., 2003; Li et al., 2002), hence I was intrigued to elucidate the XEN cells’ ability to deposit 
a basal membrane. Therefore, I initially analysed on transcriptional level the expression of the 
core basal membrane component laminin and found that both XEN subpopulations displayed 
strong and homogeneous expression of Lama1, Lamb1 and Lamc1 (Figure 5.4 a). Subsequently, 
I immunostained EX-structures after 72 hours in N2B27 for laminin protein and found a distinct 
layer of laminin in between the two epithelia – the squamous XEN cells and the columnar ES 
cells (Figure 5.4 b). Furthermore, EX-structures were characterised by a central lumen, 
reminiscent of the pro-amniotic cavity in the embryo. Due to the deposition of the basal 
membrane component laminin and the cavity formation, I hypothesised, that the ESCs would  
Figure 5.3 | Characterisation of EX-structures via single-cell transcriptomics. a, Schematic illustration of 
transcriptional profiling of EX-structures via 10x GENOMICS. b, Lineage allocation was based on known marker 
expression. t-SNE plots Nanog, Pou5f1 (ES cells) and Sox17, Gata4 as well as Gata6 (XEN cells). c, t-SNE plots for 
Peli2 and Srgn. d, Confocal z-slice images of encapsulated XEN-GFP cells with or without contact to ESCs stained 
for Serglycin. e&f, Confocal z-slice images of EX-structures and encapsulated ESCs after 48 hours in N2B27 stained 




Figure 5.4 | XEN cells deposit the basal membrane component laminin, thereby supporting polarisation of ESCs. 
a, t-SNE plots for the laminin isoforms Lama1, Lamb1 and Lamc1. b, Representative confocal z-slice image of an 
EX-structure after 72 hours of culture in N2B27 stained for laminin (basal lamina formation indicated by white arrow 
heads. Central lumen outlined by a white, dotted line). c, Confocal z-slice images of an encapsulated ESC colony and 
an EX-structure cultured for 48 hours in N2B27 stained for OCT4 and aPKC. 
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display localised apical marker proteins towards the lumen. To confirm the acquisition of correct 
apical-basal polarity, I then stained for the polarity marker aPKC (Ohno, 2001) 48 hours past 
encapsulation. I found, that EX-structures would display clear localisation of aPKC towards the 
centre of the colony (Figure 5.4 c). Having shown, that the co-culture of XEN and ES cells 
Figure 5.5 | XEN cells support the transition from naïve to primed pluripotency and subsequent lineage 
specification in EX-structures. a, t-SNE plots for general and naïve pluripotency associated genes as well as markers 
for peri-implantation and germ layer specification. b, Confocal z-slice images of EX-structures after 72 hours in N2B27 
stained for the neuroectodermal precursor marker SOX1 and the mesendodermal precursor marker T (Brachyury). 
c, Confocal z-slice images of EX-structures and encapsulated ESCs after 48 hours in N2B27 stained for E-cadherin, 
b-catenin and plakoglobin. 
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resulted in a fundamentally different morphology, basal membrane deposition, polarization and 
lumen formation, none of which can be detected in the absence of XEN cells, I next investigated 
the transcriptional state of ES cells in more detail (Figure 5.5 a). Two days into the differentiation 
process of EX-structures in N2B27, ESCs still homogeneously expressed the general 
pluripotency transcription factors Pou5f1 and Utf1 whereas Sox2 and Fgf4 already appeared 
heterogeneously. In contrast, the naïve pluripotency gene regulatory network had been 
completely downregulated. In the vast majority of cells, the naïve pluripotency associated 
transcription factors such as Nanog, Esrrb, Tfcp2l1 or Klf4 were detectable anymore. 
Simultaneously, peri-implantation markers, such as Otx2, Pou3f1, Fgf5 and Lef1 were 
upregulated, indicating the transition into primed pluripotency. Further evidence for the 
acquisition of primed pluripotency, was the complete absence of lineage specific marker genes 
including Sox1(neuroectoderm), Mixl1 (mesoderm), Foxa2 (endoderm) and primitive streak 
associated transcription factor Brachyury. To confirm the EX-structure’s ability to enter 
lineage-specific differentiation, I extended the culture period to 72 hours in N2B27.  At this point, 
EX-structures did not upregulate Brachyury (T) but consistently displayed expression of the 
neuroectodermal precursor marker SOX1(Figure 5.5 b). This result was expected, since N2B27 
as a serum-free medium, and the absence trophectoderm did not supply any inductive cues such 
as BMPs or WNTs, which are known to be necessary for mesendoderm specification. Finally, 
with regard to the previous chapter, in which I investigated the functions and mechanisms of 
plakoglobin and b-catenin during different states of pluripotency, I was naturally also interested 
in analysing expression of these proteins in EX-structures. Consistent with my previous data, EX-
structures but also ES cells encapsulated on their own, maintained expression of b-catenin and 
E-cadherin during differentiation towards primed pluripotency and subsequent lineage 
specification, whereas plakoglobin was not detectable anymore (Figure 5.5 c). 
 
5.3 Conclusions 
Biologically inert agarose microgels are a suitable culturing format for embryonic stem 
cells (ESCs) when kept under self-renewing and pluripotent conditions (see chapter 3). However, 
due to the lack of extracellular matrix components and their concomitant adhesion sites, agarose 
has a very limited ability to support the exit from pluripotency or promote lineage specification. 
Upon release from 2i+LIF (pluripotency) into N2B27 (differentiation), ESCs were able to exit 
from naïve pluripotency, but failed to enter proper lineage specific differentiation due to extensive 
apoptotic cell death. Previous studies have shown that differentiating ESCs can acquire 
morphological features, similar to the peri-implantation rosette structure of the embryo, when 
cultured in Matrigel (Bedzhov and Zernicka-Goetz, 2014). Yet, Matrigel is an undefined 
combination of extracellular matrix components and growth factors, making mechanistical 
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studies troublesome. To circumvent this issue, I made use of extraembryonic endoderm (XEN) 
cells that are known for their ability to deposit extracellular matrix components such as laminin. 
In this chapter I have used the previously described microgel culture system, to co-encapsulate 
XEN and ES cells. I hypothesised that matrix deposition by XEN cells would support the 
differentiation of ES cells in the otherwise biologically inert microgels. Microgel encapsulated 
XEN cells had a distinct phenotype from the conventional culture on plastic – in the gels, cells 
were perfectly spherical and, unlike on plastic, and interacted immediately via cell-cell contacts 
with one another. These interactions lead to the formation of a central lumen with the first 
24 hours, a morphology that was observed in serum-based XEN cell maintenance medium 
(RMPI), but also in serum-free N2B27. Remarkably, when co-encapsulating both cells types, a 
morphological self-organisation was observed in which the XEN cells ended up in the periphery 
of the nascent colony, surrounding an inner core of ES cells. Upon complete enclosure of the ES 
cell by the XEN cells, these aggregates were termed EX-structures. Time-lapsed confocal 
imaging revealed that this sorting process into EX-structures was mostly orchestrated by the XEN 
cell, through highly dynamic membrane protrusions. I then used a combined approach of single 
cell sequencing with immunostainings to further investigate EX-structure formation and 
progression. Transcriptionally, ES and XEN cells were easily identified by lineage specific 
markers such as Pou5f1 and Gata4, respectively. However, unexpectedly, XEN cells appeared 
with at least two distinct transcriptional signatures of hitherto unknown origin. However, 
differential gene expression analysis revealed specific genes for each XEN subpopulation, e.g. 
Srgn and Peli2. Subsequent immunofluorescent analyses suggested that physical contact with 
ESCs might be the cause for a distinct population of XEN cells. Nonetheless, additional 
experiments are required to fully elucidate the origin and function of the different type of XEN 
cells. Furthermore, XEN cells surrounding the ESCs took on a squamous epithelial morphology 
whereas ES cells appeared to have acquired a columnar epithelial shape. This change in 
morphology was accompanied by a reduction in apoptotic cell death which had been observed 
upon exit from pluripotency in the absence of XEN cells. Hypothesised due to the absence of any 
extracellular matrix. Indeed, XEN cell did express high levels of laminin transcripts and deposited 
it resembling the basal lamina in the embryo. Besides laminin deposition by the XEN cells, 
EX-structures had acquired an overall apical-basal polarity as seen by localised aPKC expression 
towards the centre of the colonies. Followed by lumen expansion and subsequent lineage 
specification. Taken together, these data elucidate that microgel co-culture of ES and XEN cells 
as EX-structures, enables the transit from naïve pluripotency into a state of primed pluripotency, 
similar to the peri-implantation embryo.  
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Over the course of this dissertation, I have outlined the interdisciplinary approach of 
combining microfluidic technologies with traditional cell biology. In the first part, I have 
described the establishment of a microgel culture system for mouse embryonic stem cells (ESCs) 
and elucidated how such microenvironmental changes would affect general cell behaviour, but in 
particular, their pluripotent potential (Chapter 3). After identifying plakoglobin as one of the most 
differentially expressed proteins between conventional tissue culture plastic and microgel culture, 
I further investigated its role in ESC maintenance, pluripotency and differentiation (Chapter 4). 
In the final results chapter, I then explored how microgels could potentially be used as co-culture 
systems for different cell lines from the embryo (Chapter 5). Over the next several paragraphs I 
will be discuss the salient conclusions of the individual chapters in detail, and also give an outlook 
on what direction this research might take in the future. 
 
6.1 Advantages and drawbacks of microgels for the culture of embryonic stem 
cells 
Over the last several years, the trend towards sophisticated three-dimensional (3D) tissue 
culture and the use of synthetic bioengineering has allowed researchers to answer a multiplicity 
of question that could have not been elucidated solely by the use of conventional, 
two-dimensional (2D), tissue culture. New tissue-specific adult stem cells continue to be 
identified and are subsequently used to establish 3D ‘organoids’ in the hope to model diseases 
better and to understand how organs develop and gain function (Huch and Koo, 2015; Rossi et 
al., 2018). Similarly, ESCs, and more recently extraembryonic cell lines, have been utilised for 
‘synthetic embryogenesis’, as such systems are much better at representing the complex 
developmental mechanisms of embryogenesis compared to 2D culture. Furthermore, they allow 
access to the otherwise in vivo inaccessible counterparts (Vianello and Lutolf, 2019). 
Simultaneously with the rise of 3D systems, physical properties of the culture environment, such 
as stiffness, adhesion, topography and degradability, shifted into focus as it became apparent that 
tissues and their occupying cells can mechano-sense their microenvironment and react 
correspondingly (Discher et al., 2005). To study such mechanical effects, a variety of natural and 
synthetic as well as 2D and 3D hydrogels have been used (Lutolf et al., 2009). In particular, 
microgels (instead of bulk gels) offer the advantage of large-scale production in bioreactors, 
better diffusion on nutrients and waste products, their compatibility with other microfluidics 
systems (e.g. droplet sorting and long-term perfusion culture) and they hold the possibility to 
evaluate matrix composition in a high-throughput fashion (Allazetta and Lutolf, 2015; Kleine-
Bruggeney et al., 2019). As such, they have become a valuable tool for biology with a variety of 
applications (Allazetta and Lutolf, 2015; Orive et al., 2004; Theberge et al., 2010).  
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Our lab has previously shown, that agarose microgels are a suitable system for the culture 
of mouse ESCs, but how this culture method would affect cell behaviour remained to be 
investigated (Kleine-Bruggeney et al., 2019). Agarose is a naturally occurring thermosensitive 
polysaccharide and has the advantages of being cheap, optically transparent and well suited for 
the use in microfluidics. When using low-melting agarose, it can be kept liquid at 37 °C for cell 
encapsulation, but subsequently stays gellified at 37 °C after polymerisation by cooling on ice. 
Furthermore, agarose can be digested by the simple addition of the bacterial enzyme ‘agarase’ 
(Yaphe, 1957), allowing cell retrieval at any given time for down-stream analysis including 
FACS, RNA-seq and chimera injection studies. Consequently, agarose cannot be intrinsically 
degraded by mammalian cells, a property which effects remain to be investigated. Also, agarose 
is ‘biologically inert’ and does not provide ECM molecules and adhesion sites, which could 
potentially render it unsuitable for cell differentiation as integrin-ECM interactions are known to 
be of crucial importance (Hayashi et al., 2007). In return, this property could actually be beneficial 
for maintenance of the pluripotency network as differentiation inducing cues by the ECM are 
lacking. Additional support for the pluripotency network could be grounded in the relative 
softness of agarose microgels. For adult stem cells, it is widely accepted, that substrate stiffness 
can influence lineage choice (Engler et al., 2006), however, mechano-sensing in ESCs remains 
debated. Whilst some studies claim that ESCs only become mechanosensitive upon exit from 
pluripotency (Chowdhury et al., 2010b; Evans et al., 2009; Verstreken et al., 2019), others 
implicate maintenance of the pluripotency network to be directly affected by the stiffness/softness 
of the microenvironment (Chowdhury et al., 2010a; Lu et al., 2014). In a recent pre-print study, 
Labouesse and colleagues use 2D polyacrylamide gels, spanning a wide range of substrate 
stiffness and adhesion-sides, to elucidate how soft substrates act in ‘boosting’ pluripotency by 
supressing ERK, and promoting STAT3 signalling (Labouesse et al., 2019). Yet, all the studies 
above focus on S+LIF cultured ESCs, which appear to show more pronounced phenotypes 
regarding mechano-signalling, and do not investigate the microenvironmental effects on 
naïve/ground state pluripotency. This approach makes sense, in particular due to the ERK 
inhibition under 2i+LIF conditions, but also means, that one might miss potentially small albeit 
meaningful differences.  
 
In vivo, at the state of naïve epiblast formation, the embryo undergoes repetitive changes 
in blastocoelic pressure, leading to mechanosensitive tight junction formation in the 
trophectoderm (Chan et al., 2019). Although this study did not investigate the effects of 
luminal-pressure changes on the nascent naïve epiblast, it certainly allows us to contemplate a 
potential role of mechano-signalling in the establishment of pluripotency. Consistent with the 
previously mentioned studies, I also have observed a ‘boost’ in pluripotency, upon microgel 
encapsulation of S+LIF cultured ESCs. These cells showed an increase of naïve-state associated 
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transcription factors and acquired the round and stress fibre-free phenotype of naïve cells. 
Remarkably, even under naïve culture conditions (2i+LIF), microgel-encapsulated cells exhibited 
an upregulation across the naïve gene regulatory network as measure by whole-transcriptome 
analysis. What this observation means, in particular with regard to 2i+LIF cells already being 
transcriptionally very close to their in vivo counterpart, the epiblast, needs further investigation. 
Besides changes in pluripotency associated transcription factors, genes regulating epigenetic 
plasticity and genome structure appeared to be differentially regulated when cultivating cells in 
agarose microgels. This finding is consistent with the hypothesis, that soft and chemically defined 
3D environments can enhance reprogramming of somatic cells to iPSCs by promoting epigenetic 
remodelling (Caiazzo et al., 2016; Downing et al., 2013). Therefore, in the future of this project, 
it will be interesting to investigate if, and how, microgel culture influences the epigenome of 
S+LIF and 2i+LIF cultured ESCs.  
 
Consistent with Labouesse’s work, I also observe an increase in the LIF/STAT3 and additionally 
also in the WNT/b-catenin signalling pathways, based on the upregulation of their downstream 
negative regulators SOCS3 and AXIN2, respectively. Yet, unexpectedly no differences across 
the expression of the typical signalling components of these pathways were observed. 
Consequently, I also analysed the extended protein network and found that the b-catenin 
homologue plakoglobin (g-catenin) and another armadillo protein, p120 (d-catenin) were 
significantly upregulated. The role of p120 in stabilising adherens junctions has been well 
established (Xiao et al., 2007). Furthermore, p120 has been shown to influence stem cell 
differentiation (Lee et al., 2014b) and regulate WNT signalling as well as EMT induction during 
primitive streak formation in the embryo (Hernandez-Martinez et al., 2019). Interestingly, in 
Drosophila, p120 has recently been shown to undergo mechanosensitive re-localisation, which 
in turn leads to restructuring of the junctional network (Iyer et al., 2019). Plakoglobin’s role 
however, is more ambiguous. 
 
6.2 Plakoglobin, a previously unknown member of the naïve gene regulatory 
network? 
In comparison to b-catenin and d-catenin, little is known about the b-catenin vertebrate 
homologue plakoglobin, also known as g-catenin (Gene name: Jup). Originally identified as a 
member of the desmosomal plaque (Cowin et al., 1986; Franke et al., 1983), it was then mostly 
studied in the 90’s but quickly disregarded due to its less severe knockout phenotype in 
comparison to b-catenin. b-catenin null embryos fail to undergo gastrulation and cannot establish 
the AP-axis, whereas plakoglobin null embryos develop until around E10.5 at which point they 
die due to severe failure in heart and skin formation (Bierkamp et al., 1996; Haegel et al., 1995; 
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Huelsken et al., 2000b; Ruiz et al., 1996). In mouse ESCs, b-catenin’s transcriptional role in the 
maintenance of pluripotency has been well established (Lyashenko et al., 2011; Wray et al., 
2011). Although plakoglobin gets upregulated upon knockout of b-catenin, it cannot compensate 
for its transcriptional activity (Lyashenko et al., 2011). And still, upon agarose microgel 
encapsulation of naïve mouse ESCs, typical WNT/b-catenin targets, such as Axin2, Esrrb and 
Sp5, were upregulated and simultaneously accompanied by an upregulation of plakoglobin 
expression, but surprisingly not b-catenin. Due to the concomitant ‘boost’ across the pluripotency 
network and the significant upregulation of plakoglobin, I hypothesised that these two 
observations might be connected.  
 
At this point, it is not known what causes the upregulation of plakoglobin in microgel 
encapsulated ESCs, but one might suspect that mechano-sensing could be involved. To test this 
idea, several different systems could be tested and plakoglobin levels examined. If it is indeed 
the stiffness of the substrate orchestrating plakoglobin expression, the 2D polyacrylamide gels 
designed by Labouesse and colleagues could be used as they cover a broad range of stiffnesses 
(Labouesse et al., 2019). However, if confinement and pressure rather than stiffness is the 
underlaying cause of plakoglobin upregulation, 2D surfaces (even with varying stiffnesses) would 
not be able to deliver the desired physical properties. Hence, future experiments will also include 
the comparison of microgel and hanging drop cultured ESCs, and the release of ESC colonies 
after microgel culture followed by culture in the hanging drop format to see if plakoglobin will 
be immediately degraded upon the release from the microgel-mediated pressure. Additionally, a 
plakoglobin knockout cell line will be required to confirm that the stabilisation of the pluripotency 
network upon encapsulation is exclusively mediated through plakoglobin. 
 
To further test the idea, that a causation between increase in plakoglobin and boost in pluripotency 
exists, I generated a plakoglobin overexpression cell line. Previous work has demonstrated, that 
stabilisation of plakoglobin in ESCs leads to neuroectodermal differentiation defects due to 
retention of pluripotency factors, however, this study failed to fully assess the state of 
pluripotency and did not include any in vivo references (Mahendram et al., 2013). Yet, consistent 
with this work, my plakoglobin overexpressing cells also failed to upregulate neuroectodermal 
markers upon differentiation, regardless of their starting condition (2i+LIF or S+LIF). 
Remarkably, when reaching a critical threshold, plakoglobin overexpressing ESCs in S+LIF, 
became morphologically indistinguishable, from naïve ESCs in 2i+LIF. Further, these cells 
exhibited a homogeneous REX1-GFPd2 signal as well as homogeneous expression of the naïve 
state associated transcription factors such as KLF4 and TFCP2L1. Due to this unexpected shift 
towards naïve pluripotency upon overexpression of plakoglobin, I decided to fully characterise 
General discussion and outlook 
113 
 
the state of pluripotency via extensive transcriptional single-cell profiling. Subsequent analysis, 
confirmed the re-establishment of a naïve-like pluripotency. Plakoglobin overexpressing cells 
distinguished themselves from all other S+LIF based ESCs by the strong and homogeneous 
expression of the naïve gene regulatory network as described by Boroviak and colleagues 
(Boroviak et al., 2014; Boroviak et al., 2015), and the absence of early differentiation markers 
such as Otx2 and Pou3f1. Additionally, plakoglobin overexpressing cells differed in their 
expression of the metabolic enzyme Thd, which is known to be downregulated upon 
differentiation (Kalkan et al., 2017; Wang et al., 2009) and several epigenetic regulators including 
Tets and Dnmts. It is well known that ESCs in S+LIF and 2i+LIF have distinct epigenetic 
signatures regarding histone modifications and DNA methylation state (Marks et al., 2012). 
Hence, future analysis of the epigenome in plakoglobin overexpressing cells will allow an even 
more comprehensive understanding of the state of pluripotency. Re-establishment of naïve 
state-like pluripotency was based on the observation, that plakoglobin overexpressing cells 
displayed homogeneous expression of the members of the naïve gene regulatory network. 
However, to doubtlessly confirm the existence of ground state pluripotency, a functional read out 
in the form of chimera-contribution efficiency was needed. When injecting single S+LIF cultured 
ESCs into the 8-cell state embryo, contribution efficiency is generally very poor, but improved 
upon culture in 2i+LIF (Martin Gonzalez et al., 2016; Wang and Jaenisch, 2004). Surprisingly, I 
did not observe a significant difference in chimera contribution efficiency between the wild type 
cells, regardless of their culture conditions. However, plakoglobin overexpressing cells in S+LIF 
displayed a doubling in contribution efficiency, thereby supplying further evidence, that these 
cells are indeed bona fide naïve-like stem cells.  
 
In ESCs, naïve pluripotency can be maintained by any dual combination of the components of 
2i+LIF (Wray et al., 2010). If cultured in LIF, PD or CH alone, pluripotency gets dismantled and 
ESCs initiate differentiation. In contrast, high plakoglobin overexpressing cells can be maintained 
self-renewing and pluripotent in the sole presence of LIF or PD. Though, it was still possible, that 
plakoglobin acted indirectly through b-catenin, by releasing it from the membrane and thereby 
promoting its transcriptional activity. However, my evidence suggests otherwise, because low 
plakoglobin overexpressing cells can be maintained by CH alone. This result suggests, that 
plakoglobin might have transcriptional targets distinct from b-catenin, which remain to be 
identified via e.g. ChIP-seq. If plakoglobin would have acted indirectly through b-catenin, 
maintenance in CH alone should have not been possible due to the necessity for dual 
inhibition/stimulation (Wray et al., 2010). This hypothesis was further supported by the 
observation that plakoglobin appeared to be unaffected by XAV treatment, a known inhibitor of 
b-catenin mediated transcription (Zimmerlin et al., 2016). Still, to fully eliminate any remaining 
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ambiguity regarding the differences in b-catenin and plakoglobin mediated transcription, clonal 
and homozygous knockouts for both proteins will need to be generated. If plakoglobin 
overexpressing cells can then be maintained naïve pluripotent in the absence of b-catenin with 
the sole treatment of either LIF or PD then we could say with certainty that plakoglobin can 
promote pluripotency independently of b-catenin. To this end, the exact mechanism by which 
plakoglobin promotes pluripotency remains elusive. Previous studies have shown differential 
interactions of b-catenin and plakoglobin with the TCF/LEF transcription factors (Shimizu et al., 
2008). In particular the abrogation of the repressive function of TCF7L1 on the pluripotency 
network by b-catenin has been described in detail, however it is believed that plakoglobin cannot 
substitute in b-catenin knockout cells (Lyashenko et al., 2011; Wray et al., 2011). This 
observation and my finding that low overexpressing cells can be maintained pluripotent with CH 
alone, suggest two separately working ways of maintaining pluripotency. However, due to their 
structural similarity I believe that plakoglobin, just like b-catenin, acts as a transcriptional 
co-factor in regulating the transcriptional pluripotency network by either promoting the 
expression of pluripotency supporting transcription factors or alleviating the effects of 
differentiation initiating transcription factors. 
 
As I had previously observed differentiation defects in the plakoglobin overexpressing cells, I 
was wondering at what point during differentiation, plakoglobin became inhibitory. Therefore, I 
transferred the naïve-like plakoglobin overexpressing cells from S+LIF, to primed conditions 
generating epiblast-like cells (EpiLCs) (Hayashi et al., 2011). I was surprised to find, that 
although plakoglobin transcription remained stable, protein levels had almost disappeared 
completely, suggesting post-translational regulation via intrinsic activation of the degradation 
pathway upon exit from naïve pluripotency. This discovery prompted me to further investigate 
plakoglobin expression during primed pluripotency in epiblast-derived stem cells (EpiSCs) 
(Brons et al., 2007; Tesar et al., 2007). Consistent with the observation in EpiLCs, EpiSCs were 
devoid of plakoglobin, but remained positive for b-catenin. These experiments showed for the 
first time a hitherto unknown differential expression of plakoglobin during naïve and primed state 
pluripotency.  
 
Although in developmental biology quickly disregarded as a less important homologue of 
b-catenin, plakoglobin received special attention in the field of cancer biology. In particular, due 
to its distinct function from b-catenin in acting as a tumour suppresser rather than having 
oncogenic potential like b-catenin (Alaee et al., 2018; Kolligs et al., 2000; Korinek et al., 1997). 
So, is it possible, that there are also more plakoglobin-specific developmental functions, that we 
might have overlooked? To answer this question, I investigated plakoglobin and b-catenin levels 
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throughout early embryonic development. Consistent with previous reports, I found b-catenin to 
be expressed throughout all stages of pre- and post-implantation development, whereas 
plakoglobin only emerges with the formation of the blastocysts and therefore, simultaneously 
with the establishment of pluripotency (Boroviak et al., 2014; Ohsugi et al., 1996; Ohsugi et al., 
1997). In particular, due to the absence of desmosomes in the pre-implantation epiblast (Fleming 
et al., 1991; Hardy et al., 1996), the question arises why plakoglobin is suddenly expressed and 
where exactly it locates to adjunct to the membrane? With regard to its location there are two 
seemingly obvious options. Option 1: Since binding of b-catenin and plakoglobin to E-cadherin 
is mutually exclusive (Nathke et al., 1994; Ozawa et al., 1989), plakoglobin might partially 
replace b-catenin in the adherens junctions of the epiblast resulting in two different types of 
complexes – one with b-catenin and one with plakoglobin. Option 2: Plakoglobin associates with 
another and yet to be determined membrane-bound protein. In vitro, plakoglobin as well as 
b-catenin have been shown to interact with the epidermal growth factor receptor (EGFR) (Lorch 
et al., 2004; Miravet et al., 2003). Interestingly, EGFR appears to be another mechanosensitive 
signalling component which might be of interest regarding our findings of mechano-responsive 
(in particular pressure) upregulation of plakoglobin in embryonic stem cells (Saxena et al., 2017). 
In future experiments I will therefore address plakoglobin’s potential association with the EGFR 
in vivo. Furthermore, I will try and regulate the pressure within the embryonic blastocoel as 
described by Chan and colleagues to investigate if the sudden appearance of plakoglobin within 
the epiblast is caused by the increase in pressure during cavity expansion (Chan et al., 2019).   
 
Just as surprising as plakoglobin’s sudden appearance, is its abrupt loss upon implantation, further 
supporting the hypothesis of a pluripotency-specific role of plakoglobin. Overexpression of 
b-catenin in the pre-implantation embryo leads to premature EMT and failure in AP-axis 
formation due to lack of neuroectodermal specification (Kemler et al., 2004). Embryonal 
overexpression of plakoglobin was only studied in Xenopus where it leads to axis duplication, 
indicating additional plakoglobin functions beyond mediating cell-adhesion (Karnovsky and 
Klymkowsky, 1995). The question remains: If plakoglobin has indeed a specific role in naïve 
pluripotency, what happens when plakoglobin is ectopically expressed during primed 
pluripotency? b-catenin mediated transcription is known to support naïve pluripotency in ESCs 
(Lyashenko et al., 2011; Wray et al., 2011), but leads to rapid differentiation in primed EpiSCs 
(Kim et al., 2013; Sumi et al., 2013). Consistent with these studies, stabilisation of b-catenin by 
CH treatment caused EpiSCs to differentiate. In contrast, forced plakoglobin expression appeared 
to actually stabilise pluripotency as indicated by an increase in OCT4 reporter signal. 
Conclusively these data indicate, that b-catenin and plakoglobin’s transcriptional function 
diverge upon transition from naïve to primed pluripotency.  




EpiSCs do not spontaneously revert to naïve pluripotency when transferred to 2i+LIF (Brons et 
al., 2007; Tesar et al., 2007), but require the forced expression of a naïve state-associated 
transcription factor such as KLF4 (Guo et al., 2009). So far, ectopic plakoglobin expression did 
not yield naïve induced pluripotent EpiSCs. However, although overexpressed, plakoglobin 
levels remained low in EpiSCs. Most likely due to the strongly activated, but unidentified, 
degradation pathway of plakoglobin. Future experiments concerning the short-term proteasomal 
inhibition with the small molecule inhibitor MG-132 or replacing destabilising phosphorylation 
sites via mutagenesis, might be beneficial for reprogramming purposes. Additionally, it has been 
shown, that the cadherin-catenin-complex associates with the epidermal growth factor receptor 
(EGFR) (Hoschuetzky et al., 1994), and that inhibition of the receptor can stabilise plakoglobin 
keratinocytes and squamous cell carcinoma cells (Lorch et al., 2004; Yin et al., 2005). Hence, 
one might try to regulate plakoglobin levels by treating ESCs and EpiSCs with the 
well-established EGFR inhibitor PKI-166. 
 
Intriguingly, b-catenin’s promotion of naïve pluripotency appears to be a mouse ESC-specific 
feature. Although naïve rat ESCs have been derived in 2i+LIF (Buehr et al., 2008), they remain 
susceptible to spontaneous differentiation if the amount of b-catenin signalling is not well 
mediated through correct titration of CH (Chen et al., 2013). The same observation was made 
during the first resetting experiments of human pluripotent stem cells (PSCs) towards the naïve 
state (Takashima et al., 2014). Recently, it was shown, that indeed inhibition of 
b-catenin-mediated transcription with XAV, rather than stabilisation of b-catenin by CH, is 
beneficial for stabilising pluripotency in human stem cells (Zimmerlin et al., 2016). Since then, 
the majority of studies involving human PSCs have shifted towards using a combination of PD, 
XAV, LIF and GÖ (PXLG) to maintain naïve pluripotency (Bredenkamp et al., 2019; Guo et al., 
2017). Remarkably, I have observed a strong increase in plakoglobin levels, but not b-catenin 
when comparing primed against naïve hPSCs. Similar results were obtained when resetting 
conventional marmoset stem cells towards naïve-like pluripotency. Since my previous results 
indicate a plakoglobin-specific role in the establishment of naïve pluripotency, it would be of 
great value to investigate how primate stem cells behave upon forced expression of plakoglobin.  
 
6.3 Microgel co-culture of embryonic and extraembryonic cell lines  
After having establishing a microfluidic-based 3D culture system for embryonic stem 
cells followed by in-depth characterisation of these microgel encapsulated cells, in particular with 
regard to their state of pluripotency, I was naturally interested in taking the system one step further 
and investigate ESC differentiation. Hence, the last part of this dissertation was devoted to the 
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preliminary exploration into the suitability of the microgel-system as a tool for stem cell 
differentiation. Although well suited for the maintenance of pluripotent cells, agarose turned out 
to perform poorly in supporting differentiation. This finding was most likely due to the complete 
absence of any extra cellular matrix which is crucial for integrin binding and subsequent 
differentiation (Hayashi et al., 2007). In particular, laminin knockout embryos fail to develop past 
the per-implantation stage due to failure in basal lamina formation (Coucouvanis and Martin, 
1995; Smyth et al., 1999). Although basal lamina can be provided by supplementing media with 
Matrigel (Bedzhov and Zernicka-Goetz, 2014), I intended to keep working under defined 
conditions. Since in the developing embryo, basal membrane deposition is mainly driven by 
endodermal precursors (Li et al., 2004; Li et al., 2003; Li et al., 2002), extraembryonic endoderm 
(XEN) cells appeared to be a promising candidate for aiding ESC differentiation in agarose 
microgels. Indeed, co-encapsulation of ES and XEN cells led to formation of self-organising 
aggregates with a phenotype similar to the peri-implantation epiblast (Bedzhov and Zernicka-
Goetz, 2014). These aggregates, termed EX-structures, exhibited basal lamina deposition, 
acquired correct apical-basal polarity, which is followed by central lumen formation and 
lineage-specific differentiation. Intriguingly, RNA-seq revealed the existence of two XEN cell 
transcriptional subpopulations when cultured in EX-structure format. To this end, their origin 
remains elusive and could be caused by several different reasons: 1) XEN cells already exists as 
two distinct populations in regular maintenance culture – or 2) XEN cells separate into these 
apparent sub-populations upon co-culture with embryonic stem cells. For the first point the 
observation speaks that freshly derived, as well as long term cultured, XEN cells appear in two 
distinct morphologies, either as highly refractile or epithelial-like (Kunath et al., 2005; Niakan et 
al., 2013). However, paracrine signalling (soluble signalling molecules and direct cell-cell 
interactions) between the encapsulated ESCs and XEN cells, might also be contributing to the 
existence of transcriptionally distinct XEN cell clusters. To address this question, XEN cells will 
need to be single cell sequenced on their own before starting the co-culture with ESCs. Although 
XEN cells have been described as the in vitro representative for the primitive endoderm, they are 
transcriptionally distinct from the in vivo primitive endoderm(Zhong and Binas, 2019). XEN cells 
as well as ESC-derived END2 and PYS2 endoderm-like cells lack the expression of OCT4, 
however, OCT4 is present in the in vivo primitive endoderm (Brown et al., 2010). Reducing the 
concentration of serum and the additional supplementation with PDGF in the culture medium 
eventually allowed the derivation of primitive XEN cell (pXEN) (Zhong et al., 2018). pXEN cells 
do express OCT4 but still cluster separately from their supposed in vivo counterpart. 
Alternatively, one could consider the use of expanded potential stem cells (EPSCs) (Yang et al., 
2017a; Yang et al., 2017b). EPSCs have the potential to contribute to extraembryonic lineages 
and thereby bypass the need to maintain endoderm-like cells for prolonged period in culture. In 
the future, this system could be an addition to the already existing systems for studying 
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spatiotemporal differentiation events in vitro. Microgels can be used to co-encapsulate any 
possible combination of cell types into a chemically defined matrix. Already, we are developing 
new ways of investigating cell-cell communication by co-culturing different cell types, such 
systems include e.g. the co-culture of: 
1) Trophoblast stem cells and endometrial cells to investigate the mechanisms of how the 
trophectoderm initiates interactions with, and eventually invades the decidua of the maternal 
uterus.  
2) Marmoset ESCs and fibroblasts to elucidate early lineage decision of non-human primate 
PSCs. To this end we have generated a fully-defined system that enables us to control 
differentiation towards an amnion-like population or the emergence of an embryonic disc-like 
structure.  
3) Liver organoid progenitor cells and mesenchymal cells to investigate how liver homeostasis is 
maintained (Cordero-Espinoza et al, 2020 preprint https://doi.org/10.1101/2020.09.21.306258) 
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Over the course of this dissertation, I have (1) established a microgel culture system for 
embryonic stem cells, which (2) led to the identification of a hitherto unknown function of 
plakoglobin in the establishment and maintenance of naïve pluripotency and finally, (3) extended 
the microgel system for the co-culture of embryonic and extraembryonic cells resulting in 
aggregate formation with morphological and transcriptional features of the peri-implantation 
epiblast. Although rather an unsophisticated hydrogel, agarose microgels turned out to be a 
well-suited system for the culture of embryonic stem cells due to unexpected beneficial effects 
regarding the pluripotency network. Microenvironmentally-induced upregulation of plakoglobin 
appeared to be one of the main contributing factors. Overexpression of plakoglobin in S+LIF 
cultured ESCs was able to re-establish a state of naïve-like pluripotency. Furthermore, I found 
b-catenin and plakoglobin expression to be distinct from one another during naïve and primed 
states of pluripotency (Figure 7.1). This feature seems to be evolutionary well-conserved as 
similar observation were made in human and marmoset stem cells. The data suggests, that 
b-catenins functions in promoting naïve pluripotency switches to inducing differentiation upon 
the transition into primed pluripotency, whereas plakoglobin expression remains to have 
beneficial effects on the pluripotency network, regardless of which pluripotent state the cells are 
in (Figure 7.1). 
  
Figure 7.1 | Plakoglobin and b-catenin’s function diverge upon transition from naïve to primed pluripotency. 
Depending on their culture conditions, ESCs express varying levels of plakoglobin. However, plakoglobin abruptly 
disappears upon differentiation towards primed pluripotency. Current data suggests, that plakoglobin and b-catenin 
both support maintenance of the naïve pluripotency network in ESCs. Yet, during primed pluripotency, b-catenin’s 
function shifts towards differentiation induction effects whereas ectopic plakoglobin expression remains beneficial to 
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11.1 List of antibodies 
 
Table 3 | List of primary antibodies. 
Prim. Antibody Clone Host IF Company Source/Cat. # 
aPKC C-20 Rabbit 1:200 Santa Cruz Biotec sc-216 
Cleaved caspase 3 5A1E Rabbit 1:400 CST 9663 
Connexin 31 Polyclonal rabbit 1:100 Thermo Fisher 36-5100 
E-cadherin ECCD-2 Rat 1:100 Thermo Fisher TF/13-1900 
Esrrb H6705 Mouse 1:300 R&D Systems PP-H6705-00 
FoxA2 D56D6 Rabbit 1:400 CST 8186 
Ki-67 D3B5 Rabbit 1:400 CST 9129 
Klf4 Polyclonal Goat 1:400 R&D Systems AF3158 
LaminB1 Polyclonal Rabbit 1:1000 abcam ab16048 
Laminin Polyclonal Rabbit 1:500 Sigma Aldrich/Merck L9393 
Nanog eBioMLC-51 Rat 1:200 eBioscience/Thermo Fisher 14-5761-80 
Oct3/4 C-10 Mouse 1:200 Santa Cruz Biotec SC/5279 
p120-catenin D7S2M Rabbit 1:800 CST CST/59854 
Plakoglobin Polyclonal Rabbit 1:400 CST CST/2309 
SOCS3 1B2 Mouse 1:200 Thermo Fisher 37-7200 
Sox1 Polyclonal Rabbit 1:200 CST 4194 
Sox17 Polyclonal Goat 1:400 R&D Systems AF1924 
Sox2 245610 Mouse 1:100 R&D Systems MAB2018 
T(Brachyury) Polyclonal Goat 1:200 R&D Systems AF2085 
Tfcp2l1 Polyclonal Goat 1:300 R&D Systems AF7526 
Vinculin SPM227 Mouse 1:200 abcam ab18058 
b-catenin D10A8 Rabbit 1:200 CST 8480 
 
